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Abstract 
In Eukaryotes vesicular transport mechanisms collectively ensure the transport and 
distribution of proteins and lipids between cellular compartments to maintain their unique 
composition and their specialized functions. COPI vesicles mediate retrograde transport from 
the ERGIC/Golgi to the ER as well as intra-Golgi transport. Formation as well as 
consumption of COPI-coated transport vesicles is directly controlled by small GTPases of the 
Arf family, which in turn are regulated via specific Guanine nucleotide exchange factors 
(GEFs) and GTPase Activating Proteins (GAPs). COPI vesicle formation is initiated by 
recruitment of Arf1 to membranes, which subsequently recruits the heptameric coat complex 
coatomer. GTP hydrolysis within Arf1 is a prerequisite for COPI vesicle uncoating. Three 
ArfGAPs are associated with COPI vesicle formation in mammalian cells: ArfGAP1, ArfGAP2 
and ArfGAP3. During the course of this work mechanistic aspects of COPI vesicle biogenesis 
were investigated: i) the interaction of ArfGAPs with coatomer isoforms, ii) the regulation of 
ArfGAP activity by p24 family proteins, and iii) the molecular mechanism of COPI vesicle 
uncoating. We have determined the dissociation constants of the ArfGAPs for each of the 
four individual coatomer isoforms and found that all three ArfGAPs displayed a higher affinity 
for the γ1ζ1 isoform than for the other isoforms. This result is in accordance with the 
localization of both ArfGAP2/3 and γ1ζ1 to the cis-Golgi, whereas ArfGAP1 is equally 
distributed throughout the Golgi apparatus. Furthermore, we have investigated an effect on 
the GAP activity of ArfGAP1 and ArfGAP2 of the cytoplasmic tail of the transmembrane 
protein p23, a COPI vesicle machinery protein. p23 was reported to induce a conformational 
change in coatomer, resulting in a structure that resembles coatomer conformation within the 
polymerized COPI coat. Interestingly, p23 influenced the activity of ArfGAP1 and ArfGAP2 in 
an opposite fashion: whereas ArfGAP2 displayed a higher rate of Arf1 GTP hydrolysis in the 
presence of p23, ArfGAP1 displayed a lower rate. Thus, ArfGAP2/3 might preferentially 
interact with polymerized coatomer as found on a completed COPI vesicle. Although GTP 
hydrolysis in Arf1 is commonly considered necessary for coat disassembly, it remains 
obscure whether it is sufficient to complete this process. To investigate this pivotal 
mechanistic question, we have established a real-time assay to follow the fate of the COPI 
coat components of purified vesicles upon addition of ArfGAPs, and discovered an 
unanticipated essential role of the non-catalytic domains of ArfGAPs. While GTP-hydrolysis 
within Arf1, induced by the isolated catalytic domain of the ArfGAP, released the small 
GTPase from the coat, the network of coatomer remained associated with vesicle 
membranes. Only in the presence of full-length ArfGAP1, including the non-catalytic part, the 
coat network was completely disassembled. We propose that the energy released upon 
GTP-hydrolysis in Arf1 is coupled by GAP-coatomer interactions to mediate conformational 
changes in coatomer that are required for COPI coat disassembly.
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Zusammenfassung 
In Eukaryoten stellt das Zusammenwirken vesikulärer Transportmechanismen den Transport 
und die Verteilung von Proteinen und Lipiden zwischen zellulären Kompartimenten sicher, 
um ihre spezifische Zusammensetzung aufrecht zu erhalten und ihre spezialisierte Funktion 
zu gewährleisten. COPI-Vesikel vermitteln den retrograden Transport vom ERGIC/Golgi zum 
ER sowie den intra-Golgi-Transport. Die Bildung sowie der Verbrauch von COPI-umhüllten 
Transportvesikeln wird direkt durch kleine GTPasen der Arf-Familie kontrolliert, die wiederum 
von spezifischen GTP Austauschfaktoren (GEFs) und GTPase aktivierende Proteine (GAPs) 
reguliert werden. Der erste Schritt bei der Bildung von COPI Vesikeln wird durch Aktivierung 
von Arf1 durch Beladung mit GTP und Bindung an die Donormembran eingeleitet. Arf1-GTP 
rekrutiert anschließend den heptameren Hüllkomplex Coatomer. Die Hydrolyse von GTP in 
Arf1 ist Voraussetzung für die Freisetzung der Vesikelhülle von COPI Vesikeln. In 
Säugerzellen sind drei ArfGAPs mit der Bildung von COPI-Vesikeln assoziiert: ArfGAP1, 
ArfGAP2 und ArfGAP3. 
Im Verlauf dieser Arbeit wurden verschiedene Aspekte der COPI-Vesikel-Biogenese 
untersucht: i) die Interaktion von ArfGAPs mit Coatomer-Isoformen, ii) die Regulation von 
ArfGAPs durch p24 Proteine und iii) der molekulare Mechanismus der Freisetzung der COPI-
Hüllproteine.  
Wir haben die Dissoziationskonstanten für ArfGAPs mit allen Coatomer-Isoformen bestimmt, 
wobei alle ArfGAPs eine höhere Affinität zur γ1ζ1 Isoform im Vergleich zu den anderen 
Isoformen aufwiesen. Dieses Ergebnis steht in Einklang mit der Lokalisation von sowohl 
ArfGAP2/3 als auch γ1ζ1 am cis-Golgi, wohingegen ArfGAP1 eine gleichmäßige Lokalisation 
überall im Golgi-Apparat aufweist. Des Weiteren haben wir den Effekt des zytoplasmatischen 
Teils des Transmembranproteins p23, eines Proteins der COPI Vesikel Maschinerie, auf die 
GAP-Aktivität von ArfGAP1 und ArfGAP2 untersucht. Es ist beschrieben, dass p23 eine 
Konformationsänderung in Coatomer induziert. Die resultierende Konformation ähnelt der 
Struktur des Komplexes in der polymerisierten COPI-Hülle. Interessanterweise beeinflusst 
p23 die Aktivität von ArfGAP1 und ArfGAP2 in gegenläufiger Weise. Während ArfGAP2 eine 
höhere Arf1-GTP-Hydrolyserate in Gegenwart von p23 aufwies, zeigte ArfGAP1 eine 
geringere Rate. Demnach interagiert ArfGAP2/3 möglicherweise bevorzugt mit Coatomer in  
polymerisierter Form, wie er auf COPI-umhüllten Vesikeln vorliegt.  
Obgleich die GTP-Hydrolyse in Arf1 für die Freisetzung der Proteinhülle im Allgemeinen als 
notwendig betrachtet wird, ist bisher unklar, ob sie auch ausreichend ist, um diesen Prozess 
zu komplettieren. Um diese zentrale mechanistische Frage zu untersuchen, haben wir einen 
Echtzeit-Assay etabliert, um das Schicksal einzelner COPI-Hüllkomponenten aus gereinigten 
Vesikeln nach Gabe von ArfGAPs zu verfolgen. Unsere Ergebnisse haben zur Aufdeckung 
einer unvorhergesehenen, essentiellen Rolle der nicht-katalytischen Domäne von ArfGAP 
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geführt. Während die durch die katalytische Domäne der ArfGAPs alleine vermittelte GTP-
Hydrolyse zur Freisetzung der kleinen GTPase von der Vesikelhülle führt, bleibt das 
Coatomer-Netzwerk  mit der Vesikelmembran assoziiert. Nur in Gegenwart des vollständigen 
ArfGAP1 inklusive des nicht-katalytischen Teils erfolgte die vollständige Auflösung des Hüll-
Netzwerks. Wir schlagen vor, dass die durch die GTP-Hydrolyse in Arf1 freigesetzte Energie 
an eine Interaktion des GAP Proteins mit Coatomer gekoppelt ist. Diese Interaktion ist 
notwendig, um die für das Zerlegen der COPI-Hülle benötigte Konformationsänderungen im 
Coatomer zu bewirken.
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1 Introduction 
Eukaryotic cells feature an elaborated internal membrane system. The individual 
compartments of a cell are able to communicate with one another, a process which is to a 
large extend achieved by coated vesicles. These coated vesicles are thought to mediate 
sorting and transport of proteins and lipids between adjacent membranes in the secretory 
and endocytic pathways. 
In eukaryotic cells, each organelle has a distinct lipid and protein composition. In order to 
make possible the constant communication between compartments while keeping their 
identity intact, numerous transport vesicles bud off from one membrane and fuse with 
another. This traffic is strictly organised, the secretory pathway leads outwards from the ER 
through the Golgi apparatus and to the cell surface while the endocytic pathway leads 
inwards from the cell surface via endosomes and to lysosomes. The tight regulation of these 
processes ensures that a transport vesicle budding from an individual compartment 
incorporates only specific cargo and fuses with no other but the target membrane. 
 
1.1 The Secretory Pathway 
Transport of cargo along the secretory pathway has been first described based on an 
electron microscopy study performed on exocrine pancreatic cells (Caro and Palade, 1964; 
Jamieson and Palade, 1967). These early findings and a series of follow-up studies led to the 
postulation of  the vesicular transport hypothesis (Palade, 1975) according to which transport 
between individual compartments of a cell is mediated by directed and strictly regulated 
vesicular transport.  
The secretory pathway involves various vesicular transport systems, of which COPI-, COPII- 
and Clathirin-coated vesicles (working with a variety of adaptor proteins) are the best 
characterized ones. COPII-mediated vesicular transport is involved in the export of secretory 
cargo from the ER (Barlowe et al., 1994; Kuehn et al., 1998) (Figure 1.1). COPI coated 
vesicles are responsible for the retrieval of ER resident and cycling machinery proteins from 
the ER Golgi intermediate compartment (ERGIC) and the Golgi apparatus to the ER (Cosson 
and Letourneur, 1994; Letourneur et al., 1994), for retrograde (Lanoix et al., 1999; Lanoix et 
al., 2001; Love et al., 1998) and aterograde (Orci et al., 1997) intra Golgi transport. The late 
endocytic pathway is governed by clathrin-coated vesicles, and various less well 
characterized vesicular coats and comprises transport between the plasma membrane, the 
trans Golgi network (TGN), lysosomes and endosomes (reviewed in Robinson and Pimpl, 
2014). 
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Figure 1.1: Intracellular Transport Pathways. The three main coating systems: COPI, COPII and 
Clathrin share structural and mechanistic features. Proteins transported along the early secretory 
pathway are secreted proteins, soluble proteins and lysosomal/vacuolar proteins with a common 
signal sequence. Secretory protein transport can be subdivided into four steps: ER import/quality 
control, transport from the ER to the Golgi, intra-Golgi transport/ER retrival and post Golgi transport, 
reviewed in (Barlowe and Miller, 2013). COPI vesicular transport is involved in retrograde transport 
from the Golgi/ERGIC to the ER as well as in intra Golgi transport. COPII vesicles are responsible for 
anterograde transport from ERES to the ERGIC and to the Golgi. Post-Golgi transport is governed by 
the Clathrin system involving various adaptor proteins. Figure adapted from (Szul and Sztul, 2011). 
 
 
1.1.1 ER to Golgi Transport 
ER to Golgi transport is bidirectional: the anterograde direction goes to the Golgi while the 
retrograde one from the Golgi back to the ER. Forward transport comprises uptake of cargo 
by both bulk flow (reviewed in Thor et al., 2009), and by specific cargo recognition (Kuehn et 
al., 1998). Most secreted proteins undergo the conventional ER to Golgi pathway. After 
completion of folding and initiation of glycosylation, those soluble and membrane proteins 
that have passed the ER quality control systems (ERQC) are packed into COPII vesicles and 
transported to the ERGIC/Golgi apparatus. The budding sites of the COPII carriers are 
restricted to long-lived subdomains, termed ER exit sites (ERES) (Bannykh et al., 1996; 
Hammond and Glick, 2000). According to some of the current views, the ERES scaffold is 
organized by the large multidomain protein Sec16, and in turn recruits the COPII machinery 
via multiple interactions with the coat (reviewed in Miller and Barlowe, 2010). Dependent on 
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the cell type, the COPII carriers need to cover varying distances in order to reach the target 
membrane.  
In mammalian cells, COPII vesicles form the ERGIC by homotypic fusion (Xu and Hay, 
2004). Anterograde carriers are than guided from the ERGIC via microtubules towards the 
Golgi complex (Mogelsvang et al., 2003; Presley et al., 1997) (reviewed also in Appenzeller-
Herzog and Hauri, 2006).  
 
1.1.2 Structure and Function of the Golgi apparatus 
The mammalian Golgi apparatus, described for a first time by Camillo Golgi in 1898, consists 
of four to six cisternae and is localized in an area near the nucleus and the centrosome 
(Rambourg and Clermont, 1990). Anterograde cargo enters the Golgi at the cis-Golgi 
network (CGN) and exits at the trans-Golgi network (TGN). Once at the TGN, the cargo 
molecules are sorted and subsequently transported to the endo-lysosomal compartments, 
the plasma membrane or the extracellular space (reviewed in Gu et al., 2001; Rodriguez-
Boulan and Musch, 2005). Vesicle machinery is recycled to earlier compartments by COPI 
vesicular transport (Cosson and Letourneur, 1994; Letourneur et al., 1994; Majoul et al., 
2001). On their way through the Golgi apparatus secretory proteins can undergo a large 
variety of post-translational modifications: glycosylation, sulfatation and phosphorylation. To 
facilitate this process, each cisterna is equipped with a unique set of enzymes: in this way 
the individual steps are spatially and temporally separated (de Graffenried and Bertozzi, 
2004; Munro, 2001; Nilsson et al., 2009; Opat et al., 2001; Schoberer and Strasser, 2011; Tu 
and Banfield, 2010). 
 
1.1.3 Structure of the Golgi apparatus 
The Golgi apparatus takes a central position in the secretory pathway as here takes place 
the sorting of proteins into anterograde and retrograde cargo. While highly conserved, the 
structure of the Golgi apparatus still differs in certain aspects between organisms. The 
budding yeast Saccharomyces cerevisiae features unstacked Golgi compartments 
distributed along the cytoplasm. In contrast, Schizosaccharomyces pombe, Pichia pastoris 
and mammalian cells display a stacked Golgi with 4 to 11 independent cisternae, the number 
being depended on the organism and the cell type. Golgi architecture is maintained by 
tethering proteins of the GRASP and golgin family. These very long rod-like proteins create a 
structural scaffold (Goud and Gleeson, 2010; Munro, 2011; Ramirez and Lowe, 2009). The 
mammalian Golgi apparatus can be subdivided into five distinct regions: ,1) cis-Golgi network 
(CGN), 2) cis-Golgi, 3) medial-Golgi, 4) trans-Golgi and 5) trans-Golgi network (TGN), which 
display different functions and posses a distinct set of enzymes, respectively (Dunphy et al., 
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1981; Dunphy and Rothman, 1983; Griffiths et al., 1983; Quinn et al., 1983). Mannosidases 
are located in the cis-Golgi, glycosyl transferases in the medial-Golgi and acid phosphatases 
as well as the galactosyl transferases in the trans-Golgi. ER resident proteins that have 
escaped from the ER in COPII vesicle, are returned back to the ER via COPI vesicles 
budding from the ERGIC and cis-Golgi membranes.  
The TGN is the next sorting hub. Proteins destined for constitutive and regulated secretion 
are sorted into secretory vesicles. Proteins marked with a Mannose-6-phospate and destined 
to the lysosomes are packed in AP-1/GGA-dependent Clathrin-coated vesicles, whereas 
proteins destined to other organelles of the endo-lysosomal system (e.g. early and late 
endosomes or lysosome-related organelles (LRO)), as well as proteins of the plasma 
membrane are sorted into distinct transport vesicles. For a more comprehensive reviews see 
(Bonifacino and Glick, 2004; Hinners and Tooze, 2003; Nakatsu and Ohno, 2003; Robinson, 
2004). 
 
1.1.4 Intra-Golgi Transport: lateral Diffusion versus Vesicular Transport 
The exact mechanism of intra-Golgi transport is still under debate and two main current 
hypotheses exist: cisternal progression/maturation versus vesicular transport (reviewed in 
(Glick and Luini, 2011; Glick and Malhotra, 1998; Glickman et al., 1989; Pfeffer, 2010; 
Rothman and Wieland, 1996; Suda and Nakano, 2012). According to the vesicular transport 
model, cargo is transported along the Golgi apparatus by COPI vesicles that bud from one 
stationary cisterna and fuse with the next. This model requires the existence of two distinct 
populations of COPI vesicles, one responsible for anterograde and the other one for 
retrograde transport. On the contrary, in the cisternal progression/maturation model 
anterograde cargo is transported through the Golgi without leaving the cisterna (Glick and 
Malhotra, 1998). Anterograde carriers coming from the ER fuse with each other at the CGN 
and form a new cisterna at the cis-Golgi. Then machinery from the previous cis-most cisterna 
is recycled in COPI vesicles to the new cisterna. The cisterna move stepwise through the 
stack and mature by recycling machinery in the cis direction and receiving machinery from 
the trans direction, and are eventually consumed at the trans Golgi. Nevertheless, both 
models fail to account for the complete mechanism. While the cisternal 
progression/maturation model cannot explain the varying rates of anterograde transport 
(Bonfanti et al., 1998; Karrenbauer et al., 1990), the vesicular model fails to explain the 
mechanism by which cargo bigger than COPI vesicles is transported (Bonfanti et al., 1998). 
Recently a new model, the cisternal progenitor model, has been proposed, which combines 
the cisternal progression/maturation model with the vesicular transport (Pfeffer, 2010). 
According to this model, the Golgi is a stable structure, which is able to generate subsequent 
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compartments. A different Rab protein governs each of the tightly packed stacks. RabA 
recruits a guanine nucleotide exchange factor, which subsequently activates RabB. An 
interaction with an effector protein stabilizes the activated Rabs on the membrane. RabB in 
turn recruits a GTPase activating protein, which inactivates RabA creating a separate RabB 
domain. The RabB domain, including its cargo, can now undergo fission and fuse with a 
stable RabB cisterna. In this way sequential domains are built from stable progenitor 
domains. Likewise, vesicles budding from the RabA domain and fusing with the RabB 
domain can transport cargo. 
 
1.2 Classes of Coated Vesicles within the Secretory Pathway 
1.2.1 Clathrin-Coated Vesicle 
Clathrin-coated vesicles are involved both in the late secretory pathway and the endocytic 
pathway (Mellman, 1996; Pearse and Robinson, 1990). The late secretory pathway includes 
transport between the trans Golgi network (TGN), lysosomes, endosomes and the plasma 
membrane. Clathrin consists of three large (Clathrin heavy chain) and three small (clathrin 
light chain) polypeptide chains that together form a three-legged structure called a triskelion 
(Kirchhausen and Harrison, 1981; Ungewickell and Branton, 1981). Clathrin triskelions 
assemble into a basket-like convex framework of hexagons and pentagons to form coated 
pits on the cytoplasmic surface of membranes and subsequently organise recruitment of 
proteins to these coated pits and facilitates vesiculation of the lipid bilayer (Kirchhausen, 
2000). The clathrin terminal domain is a seven-blade beta propeller, a structure well adapted 
to interact with multiple partners, such as the AP-1 and AP-2 sorting adaptor complexes but 
also monomeric clathrin adaptor proteins, e.g. Golgi-localised γ-ear-containing Arf-binding 
proteins (GGAs), Epsin1-3; EpsinR, AP180, and beta-arrestins (reviewed in Robinson and 
Pimpl, 2014).  
The numerous Clathrin mediated transport processes are promoted by the use of different 
adaptor complexes (AP), which build the inner coat of the vesicle (Bonifacino and Glick, 
2004; Owen et al., 2004; Robinson, 2004). AP1, AP2, AP3, AP4, AP5 belong to a family of 
homologous tetrameric adaptor protein complexes, which show distant sequence and 
structural homology to the tetrameric subcomplex of coatomer (β-, δ-, γ-, ζ-COP) (reviewed in 
Kirchhausen et al., 2014; Paczkowski et al., 2015). AP1 localizes to the TGN and 
endosomes (Ahle et al., 1988) and functions with Arf1 (Stamnes and Rothman, 1993; Traub 
et al., 1993). AP2 is recruited by a direct interaction with PI(4,5)P2 (Collins et al., 2002; 
Gaidarov et al., 1996; Gaidarov and Keen, 1999; Rohde et al., 2002) and mediates vesical 
formation of endocytic Clathrin-coated vesicles from the plasma membrane (Ahle et al., 
1988). The endosomal AP3 (Dell'Angelica et al., 1997; Simpson et al., 1997) has also been 
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shown to be recruited via the small GTPase Arf1 (Ooi et al., 1998), however, its potential role 
as a cargo adaptor and its acossiation with clathrin remains to be clarified (Dell'Angelica et 
al., 1998; Peden et al., 2002; Rehling et al., 1999). AP4 localizes to the TGN (Dell'Angelica et 
al., 1999; Hirst et al., 1999) and like AP1 and AP3 functions with Arf1 (Boehm et al., 2001), 
however, it seems not to be accociated with clathrin (Borner et al., 2012). The last adaptor 
protein to be discovered is AP5 (Hirst et al., 2011) and while it is known to localize to 
endosomes, its membrane recruitment mechanism has not been elucidated yet. Another 
independent class of adaptor proteins are the Golgi-localised γ-ear-containing Arf-binding 
proteins (GGAs) (Boman et al., 2000; Dell'Angelica et al., 2000; Hirst et al., 2000; Puertollano 
et al., 2001). There are three mammalian GGAs, which are involved in transport between the 
trans-Golgi and the endosome/lysosome system (reviewed in Bonifacino and Glick, 2004; 
Robinson and Pimpl, 2014).  
 
 
1.2.2 COPI Vesicles 
The COPI minimal machinery consists of the small GTPase Arf1, dimeric proteins of the p24 
family and the heptameric coat protein coatomer (Bremser et al., 1999), which occurs in four 
different isoforms. Escaped ER resident proteins are retrieved to their proper location by a 
direct interaction between their conserved C-terminal KKXX or KXKXX motif (Jackson et al., 
1990), or KDEL motif (Arakel et al., 2016) and the coat complex of COPI vesicles (Duden et 
al., 1991; Serafini et al., 1991b; Waters et al., 1991). For more details see 1.3.1 
 
1.2.3 COPII Vesicle 
COPII-mediated vesicular transport is involved in the export of secretory cargo and proteins 
destined for almost all organelles from the ER (Adolf and Wieland, 2013; Miller and 
Schekman, 2013). Most of the components of the COPII vesicular system were first 
discovered in a screen in S. cerevisiae, where temperature-sensitive mutants displaying a 
defect in protein secretion and cell surface growth (Novick et al., 1980). These vesicles, 
which are destined for the ERGIC and/or the Golgi apparatus, bud from a specialised region 
of the ER called ER exit sites (ERES) or transitional elements, whose membrane lacks 
bound ribosomes. ERES acumulate at regions juxtaoposed to the Golgi apparatus, but can 
be found also spread throughout the cell.  
The protein coat of COPII vesicles is made of one inner layer: the Sec23/24 complex and 
one outer layer: the Sec13/31 complex (Barlowe et al., 1994). The formation of COPII 
vesicles at the ER is induced by the activation of the Ras-like small GTPase Sar1, which 
undergoes a GDP to GTP exchange facilitated by the COPII specific GEF: a type 2 integral 
membrane glycoprotein termed Sec12 (Barlowe and Schekman, 1993; d'Enfert et al., 1991; 
  
	 INTRODUCTION	 		 	
17 
Nakano and Muramatsu, 1989). Sar1 is soluble and located in the cytosol in its inactive 
GDP-bound state but becomes membrane associated when transferred to its active GTP 
form. The interaction of Sar1 with the membrane is mediated by an intramolecular 
conformation change within Sar1 involving a reorientation of the two switch regions and a 
subsequent exposure of the N-terminal, non-acylated helix, which then anchors the protein to 
the ER membrane (Bi et al., 2002; Huang et al., 2001). Activated Sar1 recruits the COPII 
inner complex subunits, Sec23/24, from the cytosol to the membrane via an interaction 
between Sec23 and Sar1-GTP. Once associated, the Sec23/24/Sar1 complex recruits the 
Sec13/31 heterotetramer from the cytosol, leading to polymerization of the COPII coat 
(Matsuoka et al., 1998). The binding site for Sec23/Sec24 in Sec13/31 includes a 50-residue 
long stretch of an unstructured prolin-rich region within Sec31. This stretch is sufficient to 
trigger GTP hydrolysis in the Sar1/Sec23 complex. COPII vesicle targeting is governed by 
Rab1 GTP, which recruits p115 and thus tethers the vesicles to the final destination. Fusion 
is then mediated by the Q-SNARE complex comprising Syntaxin5, GS27 (also known as 
membrin), Bet1, and the R-SNARE Sec22b (Parlati et al., 2000; Weber et al., 1998).  
As the pathway from the ER via the Golgi apparatus to the cell surface is considered to be 
the default pathway, vesicles budding from the ER transitional elements were initially thought 
to be non-selective (Karrenbauer et al., 1990; Wieland et al., 1987). In later studies, a variety 
of biochemical and genetic studies have identified individual cargo binding sites in the COPII 
coat subunit Sec24 pointing that sorting of some cargo proteins into COPII vesicles is 
mediated by specific export signals (Buchanan et al., 2010; Miller et al., 2002; Miller et al., 
2003; Mossessova et al., 2003). 
 
 
1.3 Components and Molecular Mechanism in COPI Vesicles Biogenesis 
1.3.1 The small GTPases of the Arf family 
Small GTPases of the Ras superfamily are key regulators of a number of important cellular 
functions (Vetter and Wittinghofer, 2001). The Arf subfamily is highly conserved and is itself 
subdivided into Arfs and Arf-like (Arls) proteins. In mammals, there are six Arf isoform, which 
function as molecular switches and cycle between an inactive GDP-bound state and an 
active GTP-bound state. Arf's soluble GDP state is transformed to a membrane bound GTP 
state by an ArfGEF. Arf1 is reversed to its soluble from by ArfGAPs mediated GTP 
hydrolysis. The six Arfs can be allocated to three different classes (Kahn et al., 2006). Arf1, 
Arf2 and Arf3 belong to class I, Arf4 and Arf5 to class II and Arf 6 to class III. While Arf6 is 
localized at the plasma membrane (Cavenagh et al., 1996; D'Souza-Schorey et al., 1998; 
Peters et al., 1995), Arf1-5 are primarily found at the Golgi (Chun et al., 2008) and to some 
extent at the endosomes (Lenhard et al., 1992; Volpicelli-Daley et al., 2005).  
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Arf1 recruits the COPI coat protein, the clathrin adaptor proteins (APs) AP1 and AP3, the 
Golgi-localized γ-ear-containing Arf-binding proteins (GGAs) (D'Souza-Schorey et al., 1998), 
and the Mints (Hill et al., 2003) to Golgi membranes. In addition, Arf1 associates with AP4 in 
the late secretory pathway (Boehm et al., 2001). It has been found in a recent study that not 
only Arf1 but also Arf4 and Arf5 associate with in vitro generated COPI vesicles (Popoff et 
al., 2011b). Furthermore, Arf1, Arf4 and Arf5 proved to be sufficient to individually mediate 
COPI vesicle formation in vitro (Popoff et al., 2011b). Interestingly, Arf3, which was not found 
in the vesicle fraction by mass spectrometry analysis, was also able to initiate COPI vesicle 
biogenesis in vitro when incubated with purified coatomer, nucleotide and isolated Golgi 
membranes (Popoff et al., 2011b). 
The small GTPase Arf1 is a structural coat component of COPI vesicles (Bremser et al., 
1999; Serafini et al., 1991a; Spang et al., 1998). It regulates both coating (Donaldson et al., 
1992; Orci et al., 1993; Ostermann et al., 1993; Serafini et al., 1991a; Palmer et al., 1993) 
and uncoating of the vesicles (Tanigawa et al., 1993). Likewise, Arf1 plays a key role in the 
recruitment of the tetrameric adaptor protein complexes AP1 (Austin et al., 2000), AP3 (Ooi 
et al., 1998) and AP4 (Boehm et al., 2001). Although the subunits of coatomer and tetrameric 
adaptor protein complexes share only weak sequence homology (Schledzewski et al., 1999), 
they are comprised of conserved structural elements (McMahon and Mills, 2004), indicating 
mechanistic similarities between vesicle biogenesis mediated by COPI and these adaptor 
protein complexes.  
 
1.3.2 Coatomer - the COPI Coat Complex  
Coatomer is the coat protein complex of COPI vesicles, which consists of seven subunits: α-, 
β-, β`-, γ-, δ-, ε- and ζ-COP. Higher eukaryotic organisms possess two isoforms of γ- and ζ-
COP, which are termed γ1-, γ2-, and ζ1-, ζ2-COP, respectively (Wegmann et al., 2004) 
(Figure 1.2). According to a immunoelectron microscopy study, coatomer isoforms display 
heterogeneity in their localisation within the Golgi apparatus: while γ1- and ζ2-COP is mainly 
located at the pre-Golgi and early Golgi compartment, the γ2-COP isotype is found 
preferentially at the trans side of the organelle (Moelleken et al., 2007). 
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Figure 1.2: Coatomer Isoforms. Coatomer consists of seven subunits α-, β-, β`-, γ-, δ-, ε- and ζ-COP. 
Higher eukaryotes feature two isoforms of γ- and ζ-COP, which allows assembly of four possible 
complexes (γ1ζ1, γ1ζ2, γ2ζ1, and γ2ζ2). Approximated abundance and preferential localization of the 
four coatomer isoforms within NRK cells are indicated.  
 
 
1.3.3 p24 Family Proteins in the Early Secretory Pathway 
The p24 proteins comprise a family of type I transmembrane proteins of 23 to 27 kDa that 
can be subdivided into four subfamilies (p24α, -β, -γ and -δ) (Dominguez et al., 1998). The 
six best understood family members in mammalian systems are p23, p24, p25, p26, p27 and 
tp24. All p24 proteins cycle between the Golgi and the ER in different oligomeric forms 
(Dominguez et al., 1998; Emery et al., 2000; Gommel et al., 1999; Sohn et al., 1996; Blum et 
al., 1999; Fullekrug et al., 1999; Nickel et al., 1997) and share similar domain architecture: an 
N-terminal Golgi-dynamics domain (Anantharaman and Aravind, 2002), a predicted coiled-
coil region, a membrane spanning domain and a short cytoplasmic tail (13 to 20 amino 
acids). Within the sequence, several highly conserved motifs required for the binding of COPI 
and COPII coat complexes are distinguishable. Interactions between the p24 proteins occur 
via their cytoplasmic tails (Reinhard et al., 1999; Weidler et al., 2000) and presumably also 
via their predicted coiled-coil regions (Ciufo and Boyd, 2000). The cytoplasmic tails have two 
conserved motifs: a diphenylalanine motif and a dibasic motif. While in mammalian p25 and 
its yeast orthologs the dibasic motif is identical to the KKXX motif, this is not the case for the 
other family members. 
p24 proteins are strictly dependent on each other in terms of localisation, stability and 
transport. The overexpression of a single member leads to the mislocalisation of the entire 
p24 family in ER-derived structures (Emery et al., 2000; Fullekrug et al., 1999; Gommel et 
al., 1999). Knock out of all the p24 family proteins in yeast leads only to a minor defect in 
cargo transport and thus the strain remains viable (Springer et al., 2000). In contrast, in mice 
even a single homozygous knock out is lethal at an early embryonic stage (Denzel et al., 
2000). This discrepancy might be based on the different levels of complexity of the early 
secretory pathway in the two systems. The early secretory pathway is relatively simple in 
yeast as it contains an unstacked Golgi and involves only limited N-glycan processing. The 
disruption of the system activates the unfolded protein responce (UPR), which enables the 
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p24-deficient cells to counteract the transport defects (Aguilera-Romero et al., 2008; Belden 
and Barlowe, 2001a). On the other hand, mammals possess a more complex early secretory 
pathway, which might be more sensitive to the absence of the p24 family and is more likely 
to be affected to a degree that cannot be compensated by the UPR. 
The exact function of the p24 family is under debate and still remains to be elucidated. In one 
of the models, p24 proteins are suggested to be cargo receptors for the specific incorporation 
of secretory molecules into transport vesicles (Stamnes et al., 1995). Evidence for that is 
provided by the finding that a deletion of one of the p24 family members disrupts the 
anterograde transport of certain cargo proteins in yeast (Gas1p and invertase), but not of 
others (α-factor, acid phosphatase, carboxypeptidase Y, alkaline phosphatase and Gap1p) 
(Belden and Barlowe, 2001b; Marzioch et al., 1999; Muniz et al., 2000; Schimmoller et al., 
1995; Stamnes et al., 1995). In another model, p24 proteins are proposed to play a role in 
COPI vesicle biogenesis and function as machinery (Bremser et al., 1999). Here, dimeric p24 
recruits Arf1 to sites of COPI vesicle formation and thus functions as an Arf1 receptor at the 
cis-Golgi (Gommel et al., 2001; Majoul et al., 2001).  
 
1.3.4 ArfGEFs in COPI-mediated Transport 
The 15 eukaryotic ArfGEFs can be divided into five families based on overall structure and 
domain organisation: Golgi BFA resistance factor 1/BFAinhibited GEF (GBF/BIG), Arf 
nucleotide binding site opener (ARNO)/cytohesin, exchange factor for Arf6 (EFA6), Brefeldin 
resistant Arf GEF (BRAG) and F-box only protein 8 (FBX8). Every mammalian cell expresses 
at least six different GEFs and some isoforms display a tissue-specific pattern. It has been 
proposed that each GEF functions in a specific subcellular compartment and thus is 
dependent on different kinds of upstream regulation (reviewed in Casanova, 2007).  
Arf GEFs are characterised by a central catalytic Sec7 domain of approximately 200 amino 
acids. It is named based on its homology to the yeast protein Sec7p. The Arf1 specific GEFs 
are GBF1, BIG1 and BIG2. While GBF1 activates Arf1 at the cis-Golgi, BIG1 and BIG2 
govern the Arf1 activation at the trans-Golgi and the trans-Golgi network. Once in its GTP 
bound state, Arf1 is able to interact with various effectors and to recruit coat components to 
specific sites of vesicle formation.  
The COPI-specific GEF is the Golgi-specific BFA resistance factor 1 (GBF1), which binds to 
the cis-Golgi elements as well as to the ERGIC, where it undergoes an interaction with the 
tethering protein p115 (Garcia-Mata et al., 2003; Zhao et al., 2006) (Figure 1.3). A treatment 
of cells with the fungal toxin Brefaldin A (BFA) leads to the dissociation of coatomer from the 
membrane. This effect can be abolished by the overexpression of GBF1 (Claude et al., 1999) 
and mimicked by the overexpression of the catalytically inactive GBF1 mutant E794K 
(Garcia-Mata et al., 2003). 
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Figure 1.3: Domain structure of the ArfGEF GBF1. ArfGEFs are characterised by a central catalytic 
Sec7 domain of approximately 200 amino acids. The N-terminal DCB domain plays a role in 
dimerization. The highly conserved HUS1 domain and the HDS1, 2 and 3 domains are of unknown 
function. Figure adapted from (Casanova, 2007) 
 
 
It has been shown via fluorescence recovery after photobleaching (FRAP) that GBF1 has a 
shorter residence time on the Golgi membrane in comparison to Arf1 (Niu et al., 2005; Szul 
et al., 2005; Zhao et al., 2006), suggesting that the GEF dissociates rapidly from Arf1-GTP 
once nucleotide exchange has taken place while the activated Arf1 remains tightly 
associated with membrane (Niu et al., 2005; Szul et al., 2005).  
GBF1 and its two yeast homologues Gea1 and Gea2 bind directly to coatomer (Deng et al., 
2009). In a yeast two-hybrid screen, Sec21p (the homologue of γ-COP) proved competent to 
bind the N-terminus of Gea1 (Deng et al., 2009). The interaction site was mapped to the C-
terminal domain of Sec21p (Deng et al., 2009). Furthermore, the N-terminus of the human 
GBF1 binds bovine γ1-COP in a co-immunoprecipitation experiment when both proteins are 
co-expressed in COS7 cells (Deng et al., 2009). This interaction is even enhanced in the 
presence of BFA (Deng et al., 2009). In addition, Gea1 and Gea2 interact with TRAPPII, a 
tethering complex, which as well directly interacts with coatomer and thus assists COPI 
vesicle trafficking (Chen et al., 2011). Interestingly, neither of the interactions is necessary to 
recruit coatomer to liposomes in vitro (reviewed in (Jackson, 2014). It is solely the interaction 
with Arf1-GTP that is responsible for coat membrane association. Based on this data, it was 
speculated that the interaction between the coat protein and the corresponding GEF is rather 
needed in order to increase the local concentration of the coat at sites where Arf1 activation 
takes place (Jackson, 2014).  
Based on the experimental data, two different models have been proposed for the role of 
GBF1 in the temporal and special organisation of COPI coat recruitment and vesicle 
biogenesis. According to the widely accepted model, the association of GBF1, Arf1 and 
coatomer with the Golgi membrane are sequential events.  GBF1 is first recruited to the 
membrane by a direct interaction with a still unknown receptor. Then Arf1 is recruited to the 
membrane and undergoes the GBF1-mediated GDP to GTP exchange. Finally, Arf1-GTP 
recruits coatomer. In a newer model, the interaction between Arf1, coatomer and GBF1 takes 
place on the membrane prior to the GDP to GTP exchange (Deng et al., 2009). Here Arf1, 
GBF1 and coatomer are recruited individually and once present at the membrane, they 
undergo a direct transient interaction with each other. This interaction plays a critical role in 
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the specific recruitment of coatomer only at the site of Arf1 activation at the cis-Golgi (Deng 
et al., 2009).  
 
1.3.5 ArfGAPs in COPI-mediated Transport 
The ArfGAP family of proteins consists of more than 30 members in mammals. It is 
characterised by a conserved, catalytic ArfGAP-domain of approximately 130 amino acids 
containing a characteristic zinc finger motif (Cukierman et al., 1995; Goldberg, 1999). The 
non-catalytic domains of these proteins differ significantly, which underlines their individual 
mechanisms of recruitment. 
There are four ArfGAPs that function within the Golgi apparatus and are responsible for the 
hydrolysis of Arf-GTP to Arf-GDP (Cukierman et al., 1995; Frigerio et al., 2007). Three of the 
ArfGAPs, namely ArfGAP1, ArfGAP2 and ArfGAP3 interact with coatomer, indicating a role 
in COPI transport (Frigerio et al., 2007; Goldberg, 1999; Lee et al., 2005) (Figure 1.4). 
Whereas the catalytic parts of the three proteins share 80 % identity, the non-catalytic 
domains of ArfGAP1 differs significantly from the non-catalytic domains of ArfGAP2 and 
ArfGAP3. The three proteins are believed to originate from a common ancestor, as there is a 
single gene in G. lamblia. Very early in evolution the family split into ArfGAP1 and ArfGAP2 
subfamilies. In S. cerevisiae, there are only two homologous of the three mammalian 
ArfGAPs. Gcs1 is the ArfGAP1 homologue and Glo3 is the ArfGAP2/3 homologue (Poon et 
al., 1999). For more details see 1.4. 
 
Figure 1.4: Structure of the ArfGAPs involved in COPI vesicle biogenesis: ArfGAP2, ArfGAP2 
and ArfGAP3. All three ArfGAPs feature a conserved catalytic zinc finger GAP domain but differ in 
their non-catalytic domains. Whereas ArfGAP1 contains two ALPS domains, which can sense 
membrane curvature, ArfGAP2 and ArfGAP3 are display 58 % identity and contain a highly conserved 
Glo 3 motif of unknown function (Frigerio et al., 2007).  
 
 
1.3.6 COPI Vesicle Biogenesis 
COPI vesicle biogenesis is initiated by the recruitment of the small GTPase Arf1 (ADP-
ribosylation factor 1) from the cytosol, where it is located in its inactive, soluble form, to Golgi 
membranes (Figure 1.5) by a direct interaction with p23/p24. A unique feature of Arfs and 
Arls is their N-terminal, amphipathic helix, which is myristoylated on its N-terminal glycine 
residue and is hidden within the protein core in the GDP-bound state. At the membrane Arf1 
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is activated by GBF1 (Claude et al., 1999). Once in its GTP bound state, Arf1 dissociates 
from p23/p24 dimers (Gommel et al., 2001), exposes its N-terminal α- helix and inserts the 
myristic acid residue in the lipid bilayer, which leads to its stable association with the 
membrane. Upon activation on the membrane, Arf1 was suggested to from a dimer (Beck et 
al., 2008). This dimerization seems to be essential for vesicle formation as a mutant not able 
to dimerize leads to a scission arrest of COPI vesicles (Beck et al., 2011b). In a more recent 
cryo-EM structure (Dodonova et al., 2015; Faini et al., 2012) only monomeric Arfs bound to 
coatomer were observed. This, however, does not exclude a potential role of dimeric Arfs at 
the vesicle bud neck required for vesicle scission. Subsequently, Arf1 GTP recruits coatomer 
en bloc (Hara-Kuge et al., 1994) via multiple interactions with its subunits (Bethune et al., 
2006; Harter and Wieland, 1998; Sun et al., 2007; Zhao et al., 1997; Zhao et al., 1999). 
Activated Arf1 binds to the trunk domains of β- and γ-COP and to δ-COP (Sun et al., 2007; 
Yu et al., 2012; Zhao et al., 1997; Zhao et al., 1999) whereas p24 proteins bind to the trunk 
and appendage domains of γ-COP (Bethune et al., 2006). The interaction with the p24 family 
proteins induces a conformational change within coatomer (Bethune et al., 2006; Langer et 
al., 2008; Langer et al., 2007; Reinhard et al., 1999). The polymerizing coat deforms the 
membrane, which leads to the formation of COPI coated vesicles.  
Prior to fusion with the target membrane, vesicles must be uncoated (Tanigawa et al., 1993). 
This process is at least partly mediated by the enzymatic activity of the ArfGAPs, which 
catalyse the hydrolysis of the GTP within the Arf1, returning it to its inactive cytosolic 
conformation (Cukierman et al., 1995; Reinhard et al., 2003; Tanigawa et al., 1993) and 
presumably leads to the release of coatomer to the cytosol. 
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Figure 1.5: COPI vesicle biogenesis. The small GTPase Arf1 is recruited to Golgi membranes in its 
GDP bound state by an interaction with dimeric p23/p24 tails. It is then transferred to its active GTP 
state by the guanine nucleotide exchange factor GBF1. Upon activation, Arf1 disassembles from 
p23/p24 and the transmembrane proteins together with Arf1 recruit coatomer. Membrane budding 
occurs and the newly formed vesicles are released. Figure adapted from (Popoff et al., 2011). 
 
 
1.4 Arf GTPase Activating Proteins 
1.4.1 ArfGAP Superfamily of Proteins 
The ArfGAP superfamily of proteins comprises of 10 subfamilies with more than 30 different 
members in humans, which are responsible for GTP hydrolysis within the Ras superfamily of 
GTPases including Ras, Rho, Rab, Arf and Ran. Each family of small GTPase has a distinct 
set of GAPs, which do not only serve as molecular switches but also play a key role as 
effectors in vesicle biogenesis (Gillingham and Munro, 2007; Inoue and Randazzo, 2007).  
The highly conserved catalytic ArfGAP domain was first identified in rat ArfGAP1 and was 
shown to catalyze GTP hydrolysis on Arf1 (Cukierman et al., 1995). It consists of 
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approximately 130 amino acids and contains a characteristic C4-type zinc finger motif and a 
conserved arginin. Based on the crystal structure the zinc finger was proposed to have a 
structural role (Goldberg, 1999), while the arginin finger seems to play a catalytical role, a 
mechanism also proposed for other GAPs (Scheffzek et al., 1998). 
The various members of the ArfGAP family display a different degree of specificity for certain 
Arf GTPases. Most of the ArfGAPs possess an activity on one or more Arfs (Arf1-6), while 
the Arf-like (Arls) and Sar GTPases work with distinct subset of GAPs. However, the yeast 
orthologue of ArfGAP1, Gcs1p can hydrolyse GTP both within Arf1p and Arl1p (Liu et al., 
2005). 
 
1.4.1.1 ArfGAP1		
ArfGAP1 shuttles between the cytosol and the Golgi. It has been shown to interact with 
coatomer, clathrin and AP-1 (Watson et al., 2004). The activity of ArfGAP1 was initially 
reported to be dependent on coatomer in a membrane-free system (Goldberg, 1999). Later 
studies show, however, that in a liposomal system the activity of ArfGAP1 is dependent on 
membarne curvature rather than on coatomer (Bigay et al., 2003; Weimer et al., 2008). For 
more details see 1.4.2. 
 
1.4.1.2 ArfGAP2	Subfamily	
ArfGAP2 and ArfGAP3 belong to the ArfGAP2 subfamily of proteins. The two proteins display 
58 % identity to each other. Both ArfGAP2 and ArfGAP3 have been found to strongly interact 
with coatomer (Frigerio et al., 2007; Watson et al., 2004), which in turn regulates the activity 
of the two ArfGAPs (Weimer et al., 2008). For more details see 1.4.2. 
1.4.1.3 ADAP	Subfamily	
ArfGAPs with dual PH domains (ADAPs) are Arf6 GAPs and are thus involved in actin 
cytoskeleton remodelling, neuronal differentiation and membrane trafficking (Thacker et al., 
2004; Venkateswarlu et al., 2004). The ADAP family consists of two members ADAP1 and 
ADAP2. ADAP1 displays a high affinity for Ins(1,3,4,5)P4 and PI(3,4,5)P3. In accordance with 
its role in neuronal differentiation, ADAP1 localizes at dendrites, spines and synapses of 
developing and adult neurons. 
 
1.4.1.4 SMAP	Subfamily	
The human small ArfGAP proteins (SMAPs) are approximately 50 kDa and are involved in 
endocytosis and oncogenesis (Tanabe et al., 2006). Two SMAP proteins, which share 47 % 
identity, are expressed in humans. SMAP1 function with Arf6 and SMAP2 also Arf1 (Tanabe 
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et al., 2006; Tanabe et al., 2005). SMAPs bind via their LLGLD binding motif to clathrin 
heavy chain and to the clathrin assembly protein, CALM (Natsume et al., 2006). The 
primarily cytosolic SMAP1 is recruited to membranes where it plays a crucial role in the 
regulation of constitutive endocytosis. SMAP2 is membrane bound and localizes to 
endosomes. It has been implicated in the retrograde transport of TGN46 from early endomes 
back to the TGN (Natsume et al., 2006).  
 
1.4.1.5 AGFG	Subfamily	
Two members of the nucleoporin-related Arf-GAP domain and FG repeats-containing 
proteins (AGFG) subfamily were identified up to date: AGFG1 and AGFG2. Their 
corresponding small GTPases still remain unknown. The AGFG1 protein contains 10 
phenylalalnin-glycin (FG) repeats similar to the ones found in nucleoporins. It has been 
shown to be an important HIV Rev cofactor as it seems that the ArfGAP domain of AGFG1 is 
essential for the release of Rev-directed HIV-1 RNAs from the perinuclear region (Sanchez-
Velar et al., 2004). 
 
1.4.1.6 GIT	Subfamily	
Two G-protein-coupled receptor (GPCR)-kinase-interacting proteins 1 and 2 (GIT) genes are 
expressed in vertebrate, expressing GIT1 and GIT2. The two proteins presumably serve as 
GTPase activating proteins for Arf6 (Claing et al., 2000; Di Cesare et al., 2000; Vitale et al., 
2000). GIT1 is predominately expressed in endothelial cells and completely lacking in muscle 
cells, hepatocytes, pneumocytes and adipocytes (Schmalzigaug et al., 2007). GIT2 is 
ubiquitous in most cells types. A hallmark of the proteins of the GIT subfamily is that they 
form oligomeric complexes together with the PIX/Cool proteins (Premont et al., 2004), which 
serve as GEFs for Cdc42 and Rac1 GTPases. These complexes play a role as scaffolds for 
different signalling enzymes and thus receive multiple inputs from different GTPases and 
function as signal integration sites. Among the signalling enzymes are p21 activated kinases, 
MEK/Erk, phospholipase Cγ and some G protein receptor kinases. The recruitment of 
GIT/PIX to specific cellular locations is achieved by a direct interaction with a distinct set of 
proteins.  
 
1.4.1.7 ASAP	Subfamily	
The ArfGAP with SH3 Domain, Ankyrin Repeat and PH Domain (ASAP) subfamily of proteins 
are encoded in three genes in humans expressing ASAP1, ASAP2 and ASAP3 respectively. 
ASAPs are found at specializations of the plasma membrane like in filodopodia and focal 
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adhesions and have been reported to play a regulative role in actin remodelling and 
endocytic traffic (Inoue and Randazzo, 2007; Nie et al., 2006). Thus, ASAP1-3 are involved 
in Arf1 and presumably Arf5 activation (Andreev et al., 1999; Brown et al., 1998). The three 
human ASAPs share multiple domains but possess distinct C termini. ASAP1 features a SH3 
domain and tandem repeats of D/ELPPKP and directly interacts with CrkL, Src, CD2AP and 
CIN85.  ASAP2 has an SH3 domain as well but lacks D/ELPPKP repeats and associates 
with the focal adhesion kinase pyk2. ASAP3 has neither SH3 domain nor D/ELPPKP repeats 
but also localizes at focal adhesions and has been implicated in stress fibers regulation (Ha 
et al., 2008). 
 
1.4.1.8 AGAP	Subfamily	
Simmilar to the ASAP subfamily, the ArfGAP with GTPase Domain, Ankyrin Repeat and PH 
Domain (AGAP) subfamily is exclusively found in mammals. Eleven genes in humans have 
been predicted to encode AGAP proteins. AGAPs are implicated in Arf1 (Jacques et al., 
2002), and probabably also Arf5 (reviewed in Randazzo and Hirsch, 2004), activation as well 
as in regulation AP-3 (Nie et al., 2003a). AGAPs contain a GTP-binding domain, which 
directly associates with Akt and Ras effectors, an interaction required for the activation of Akt 
and Ras (Ye and Snyder, 2004). The most studied members AGAP1 and AGAP2 play a role 
in the endocytic system. AGAP1 functions with AP3 and AGAP2 with AP1 (Nie et al., 2005; 
Nie et al., 2003b). 
 
1.4.1.9 ACAP	Subfamily	
The ACAPs are found already in Dictyostelium and metazoans and consist of three genes in 
humans. ACAP stands for ArfGAP with coiled coil, ankyrin repeat and PH domains. The 
coiled coil has been later shown to be a BAR domain.  The ACAPs play a regulative role in 
endocytosis, Arf6-dependent actin remodelling and receptor tyrosin kinase-dependent cell 
movement (Inoue and Randazzo, 2007). ACAP1 serves as a part of an Arf6-regulated 
clathrin coat (Li et al., 2007).  
 
1.4.1.10 ARAP	Subfamily	
The ARAPs are a distinct feature of chordates and are represented by three genes in 
humans. They are involved in EGF receptor signalling, the dynamics of focal adhesions and 
lamellipodia formation (Inoue and Randazzo, 2007). The Arf specificity of the individual 
ARAPs remains unclear. ARAP1 and ARAP2 were proposed to function with Arf1 and Arf5 
rather than Arf6 (Miura et al., 2002). With respect to ARAP3, contradictory results can be 
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found in the literature. Earlier studies implicated ARAP3 in Arf6 activation (Krugmann et al., 
2002) whereas later ones showed that it functions with Arf1 and Arf5 rather than with Arf6 (I 
et al., 2004) The ARAPs possess ArfGAP, RhoGAP and Ras association domains as well as 
ankyrin repeats. This elaborated domain combination implies that they might be involved in 
the coordination of two or more GTPase signalling pathways. The three human ARAPs 
display similar domain architecture, however, they differ in function and cellular localization 
and thus show distinct preferences for Arf, Rho or Ras. 
 
1.4.2 Functions of ArfGAPs in COPI Vesicular Transport 
1.4.2.1 ArfGAP1	
ArfGAP1 is a 45 kDa protein, which cycles between the cytosol and the Golgi, and was the 
first member of the family to be identified (Cukierman et al., 1995; Randazzo and Hirsch, 
2004). ArfGAP1 binds via its N-terminal catalytic domain to switch 2 and the α3 helix within 
Arf1 and thus orients an Arf1 residue, and stimulates GTP hydrolysis (Goldberg, 1999). The 
crystal structure of the catalytic domain in a complex with Arf1 reveals that the catalytic 
domain does not supply an arginine to the active site of the GTPase (Goldberg, 1999). 
However, newer evidence based on a cryo EM structure of the COPI coat on a membrane 
challenges this hypothesis (Dodonova et al., 2015). The C-terminal region was predicted to 
be largely unstructured. It contains two ALPS motifs (amphipathic lipid packing sensor), 
which are unstructured in solution but are capable of forming an amphipathic helix on highly 
curved membranes by inserting bulky hydrophobic residues between loosely packed lipids 
(Bigay and Antonny, 2005; Bigay et al., 2003; Levi et al., 2008; Mesmin et al., 2007) (Figure 
1.6). These helixes differ from classical amphipathic helices by the abundance of serine and 
threonine residues on their polar face. Lipid packing is a physical parameter, which depends 
on the shape of the lipid molecules as well as on the curvature of the membrane. ArfGAP1 
was shown to have a higher activity in the presence of conical lipids (dioleolylglycerol) then in 
the presence of cylindrical lipids (phosphatidylcholine) at a constant liposomal radius 
(Antonny et al., 1997). Furthermore, at a constant lipid composition, the activity of ArfGAP1 
increases with decreasing liposomal radius (Bigay et al., 2003). This sensitivity of ArfGAP1 to 
membrane curvature might play a key functional role in the temporal and spatial organisation 
of GTP hydrolysis within a coated membrane area. Once associated with the membrane, 
ArfGAP1 would gradually eliminate Arf1-GTP molecules from the coat area with positive 
curvature leaving intact the molecules at the edge where the membrane curvature is 
negative (Bigay et al., 2003).  
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ArfGAP1 interacts with coatomer via a tryptophane based stretch in the most C-terminal part 
of the protein (Rawet et al., 2010). The motif was identified to be 405AADEGWDNQNW415. 
The binding site within coatomer is localized in the C-terminus of δ-COP (Rawet et al., 2010). 
Recent studies have revealed that ArfGAP1 also interacts with components of the Clathrin 
system, namely clathrin, AP-1 and AP-2 (Bai et al., 2011; Watson et al., 2004) . However, the 
biological relevance of these interactions still remains to be elucidated. 
 
Figure 1.6: Model for curvature sensitivity of ArfGAP1. ArfGAP1 has two ALPS (amphipathic lipid 
packing sensor) motifs within its noncatalytic region. These ALPS motifs are unstructured in the 
presence of flat membranes. Upon curvature induction, they recognise the defects in the lipid packing, 
fold into an amphipathic helix and insert into the membrane. Figure adapted from (Bigay and Antonny, 
2005). 
 
 
1.4.2.2 ArfGAP2	and	ArfGAP3	
Less is known about the more recently discovered ArfGAP2 and ArfGAP3. These two 
proteins are closely related and show 58 % identity to each other (Frigerio et al., 2007). The 
non-catalytic domains of ArfGAP2 and ArfGAP3 lack classical ALPS motifs. A sequence 
comparison between different species has led to the identification of a highly conserved Glo3 
motif at the C-terminus (Yahara et al., 2006), whose function is not yet known.  
ArfGAP2 and ArfGAP3 are dependent on the COPI coat protein for their association with the 
Golgi membrane (Kliouchnikov et al., 2009; Weimer et al., 2008). The Golgi localization of 
ArfGAP2 and ArfGAP3 is based on two different motifs within the proteins: a central basic 
stretch and a C-terminal amphipathic motif (Kliouchnikov et al., 2009). The central basic 
stretch, 235QKL237 in ArfGAP3 (QKV in ArfGAP2), binds to the γ-COP subunit of coatomer 
(Eugster et al., 2000; Kliouchnikov et al., 2009; Watson et al., 2004). This stretch is also 
governing the catalytic activity of ArfGAP3 (Kliouchnikov et al., 2009). The carboxy terminal 
motif, residues 485-510 in ArfGAP3, is conserved in ArfGAP2, ArfGAP3 and the yeast Glo3. 
It contains predominantly hydrophobic residues on the one face and primarily hydrophilic 
ones on the other thus representing an amphipathic helix. Despite its pronounced differences 
in terms of length and types of hydrophobic residues to the ALPS motifs described within 
ArfGAP1, the carboxy stretch in ArfGAP3 also assumes helical fold in the presence of 
liposomes. This effect was, however, observed only with the peptide stretch on its own and 
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not with the full-length protein. Nevertheless, mutations in the carboxy stretch abrogated the 
Golgi localization of ArfGAP3 pointing to a direct interaction with the lipid bilayer 
(Kliouchnikov et al., 2009). 
In a recent study, it was shown that coatomer components also modulate the activity of 
ArfGAP2 (Pevzner et al., 2012). Based on homology to the clathrin adaptor complexes, 
coatomer can be subdivided into two subcomplexes. The adaptor-like CM4 comprises β-, δ-, 
γ- and ζ-COP, and the cage-like CM3, which contains α-, β`- and ε-COP. ArfGAP2 binds a 
hydrophobic pocket within the γ1-appendage domain of CM4 (Pevzner et al., 2012). CM4 
becomes membrane associated via a direct interaction with Arf1 and in turn recruits ArfGAP2 
(Pevzner et al., 2012). Nevertheless, a stimulation of ArfGAP2 activity has been observed 
only when the fully assembled heptameric coat protein was present (Pevzner et al., 2012). 
 
1.4.2.3 Functions	of	ArfGAP1,	ArfGAP2	and	ArfGAP3	
ArfGAPs were shown to function both in cargo sorting (Malsam et al., 1999; Nickel et al., 
1998; Pepperkok et al., 2000) and coat disassembly (Tanigawa et al., 1993). Although the 
precise mechanism of cargo sorting is unknown, a current hypothesis suggests that a cycle 
of Arf1 activation by GBF1 and Arf1 deactivation by an ArfGAP plays a key role in this 
process. The role of the ArfGAPs as a prerequisite for uncoating is well established, 
however, what is not completely understood is the molecular mechanism that underlies this 
process, and whether additional factors are required for completing coat disassembly. In an 
electron microscopy study Golgi-derived vesicles generated in the presence of the 
constitutively GTP loaded Arf variant ArfQ71L, vesicles remained coated and failed to fuse 
with the target membrane (Tanigawa et al., 1993).  
A series of contradictory studies have proposed a role of the ArfGAPs as coat components 
rather than accessory proteins. Hsu and collegues performed in vitro COPI vesicle 
reconstitutions using purified Golgi as donor membranes and observed an increased 
effciency of COPI vesicle formation in the presence of ArfGAP1 (Yang et al., 2002). GTPγS 
controls showed lower effciency of vesicle formation and a defect in uncoating, which led the 
authors to conclude that both effects are due to inefficient GAP recruitment (Yang et al., 
2002).  
 
1.5 Coat Disasembly of Transport Vesicles 
1.5.1 Uncoating of COPII Vesicle  
According to the prevalent view, GTP hydrolysis in the small GTPase is a prerequisite for 
vesicle uncoating. Early studies have shown that vesicles are incompetent to fuse with the 
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target membrane when GTP hydrolysis in Sar1 is blocked (Aridor et al., 1995; Barlowe et al., 
1994). Thus, both polymerisation and depolymerisation of the COPII coat is regulated by the 
small GTPase Sar1 (Barlowe et al., 1993; Nakano and Muramatsu, 1989). Sar1-bound GTP 
undergoes hydrolysis, promoting depolymerisation of the coat proteins, which are then 
recycled for further rounds of vesicle formation. The GTP hydrolysis in Sar1 is mediated by 
the coat component Sec23 (Yoshihisa et al., 1993). The catalytic mechanism involves an 
arginine residue provided by Sec23, which inserts in the catalytic site of Sar1 and stabilizes 
the phosphate groups of GTP (Bi et al., 2002). Sec23 GAP-activity is further enhanced by an 
interaction of Sec23 with the outer shell Sec13/31 complex, leading to re-orientation of the 
arginine finger (Antonny et al., 2001; Yoshihisa et al., 1993). 
Initial data points out to an essential role of post-translational modifications within Sec23 for 
COPII vesicle formation and trafficking. The Ferro-Novick lab, in a series of studies, has 
shown that the phosphorylation state of Sec23 is crucial for its interaction pattern, which in 
turn affects vesicle delivery. A phosphorylation site in the vicinity of the Sar1 interaction site 
is responsible for both Sar1 and transport protein particle (TRAPP) release. Sar1 presumably 
first binds Sec23 in order to trigger vesicle formation, then in turn Sec23 catalyses GTP 
hydrolysis and Sar1 is released from the membrane. As the binding site is now free, TRAPP 
can associate at the same position and recruit Ypt1/Rab1. Hrr25, which is a Golgi-localized 
kinase, is then able to phosphorylate Sec23 leading to TRAPP dissociation and potentially 
facilitatiing uncoating. This temporal organisation might be important for maintaing the 
directionality of COPII trafficking (Lord et al., 2011). 
As the Sec23 coat component both supports coat assembly and promotes uncoating, the 
COPII is stabilized by additional components. The cytosolic factor Sec16 is a large 
multidomain protein, which is crucial for ER export in vivo (Novick et al., 1980; Kaiser and 
Schekman, 1990). It is associated with the ER exit sites (ERES), which serve as platforms 
for COPII vesicle budding, and participates in their organisation and structural maintenance 
(Hughes et al., 2009; Watson et al., 2006). Sec16 interacts with all components of the COPII 
coat, can directly bind to membranes in vitro and remains longer membrane-associated in 
comparison to the COPII coat components (Espenshade et al., 1995; Gimeno et al., 1996; 
Hughes et al., 2009; Montegna et al., 2012; Supek et al., 2002; Whittle and Schwartz, 2010; 
Yorimitsu and Sato, 2012). Furthermore, Sec16 inhibits the Sec31-driven increase of 
GTPase activity in Sar1 and can thus control COPII vesicle biogenesis (Kung et al., 2012; 
Yorimitsu and Sato, 2012). However, Sec16 does not display an effect on the GAP activity of 
Sec23 (Supek et al., 2002). These findings imply that Sec16 can act as a scaffold for the 
COPII coat components, thus favouring ERES formation and stabilizing the COPII coat by 
modulating Sar1 GTPase activity (Hughes et al., 2009; Ivan et al., 2008; Kung et al., 2012; 
Supek et al., 2002; Yorimitsu and Sato, 2012). 
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Sec12, the COPII-specific GEF, seems also to play a role in the maintainance of coat 
stability. Sar1p, Sec23/24p, Sec13/31p and GTP do not suffice for vesicle budding in vitro as 
the GTP hydrolysis within Sar1p leads to a coat too unstable to allow vesicle formation. 
However, if GTP is substituted by its non-hydrolyzable analogue GMP-PNP, in vitro COPII 
budding reactions generate vesicles (Matsuoka et al., 1998). When the reaction was 
performed in the presence of GTP and the catalytic domain of Sec12p, Sar1p activity was 
10-fold higher than the enhanced GAP activity stimulated by the full coat, which led to a 
stable coat assembly at the liposomal membrane (Futai et al., 2004). 
Cargo proteins probably also play a role in the maintenance of coat stability as coat cargo 
interactions increase the dwelling time of the coat on membranes (Forster et al., 2006; Sato 
and Nakano, 2005).  
 
1.5.2 Uncoating of Clathrin-Coated Vesicle  
Uncoating of an endocytic vesicles requires the heat-schock cognate protein-70 (Hsc 70) 
(Braell et al., 1984; Schlossman et al., 1984; Ungewickell et al., 1995). The clathrin coat is 
build up of individual triskelions, comprising three clathrin molecules, which form a lattice 
upon polymerization (Fotin et al., 2004). Each clathrin molecule consists of a 30-kDa light 
chain and a 180-kDa heavy chain (Kirchhausen, 2000). After the fully formed vesicle pinches 
off, the coat needs to be disseassembled so that fusion with the target membrane can occur. 
The temporal regulation of the uncoating reaction is governed by the recruitment of auxillin, 
which in turn recruits Hsc70. Auxilin contains an C-terminal J-domain interacting with 
chaperons of the Hsp70-family and N-terminal PTEN-like region, which can distinguish 
between a vesicle still associated with the membrane and a vesicle that has already 
undergone fission (Massol et al., 2006). Hsc70 as a member of the Hsp70-family contains a 
substrate binding domain and an ATPase domain. Cryo-EM structures of the clathrin coat 
shed light on the uncoating mechanism (Fotin et al., 2004; Xing et al., 2010). Auxilin binds in 
such a way that three J-domains are positioned in the vicinity of each vertex of the clathrin 
coat. Auxilin binding brings about a conformational change, which allows Hsc70, recruited via 
a direct interaction with the J-domain of auxilin, to reach its target sequence QLMLT near the 
C-terminus of clathrin (Rapoport, 2008). As Hsc70 binds the peptide in a groove on its 
substrate binding domain, ATP hydrolysis occurs. This leads to two simultaneous events: the 
J-domain is released and the substrate becomes tightly clamped in the groove. In such a 
way, Hsc70 stabilizes the distorted conformation. Once a critical concentration of 
auxilin/Hsc70 is reached, the coat becomes irrevocablly destabilized and falls apart in a all-
or-none fashion (Bocking et al., 2011). 
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1.5.3 Uncoating of COPI Vesicle 
1.5.3.1 Role	of	the	ArfGAPs	in	COPI	Vesicle	Coat	Disassembly		
Simmilar to COPII, the older and still prevailing modell states that GTP hydrolysis within Arf1 
is the driving force for coat disassembly (Reinhard et al., 2003; Tanigawa et al., 1993). 
Initially this hypopthesis was based on two sets of experimental data. First it was discovered 
that GTPγS blocks transport and leads to the accumulation of coated vesicles (Melancon et 
al., 1987), and a few years later that Arf1 is a subunit of the COPI coat (Serafini et al., 
1991a). The effect of GTPγS on transport can be mimicked by an Arf1 mutant. Arf1Q71L-
GTP in its myristoylated form is competent to bind to membranes and recruit coatomer, 
however, in contrast to wild type fails to hydrolyse GTP (Tanigawa et al., 1993). Although the 
amount of vesicles formed in the presence of Arf1-Q71L is comparable to the one in the 
presence of wild type Arf1, cis to medial Golgi transport is inhibited by the mutant in a cell 
free system (Tanigawa et al., 1993). As observed by EM, vesicles displaying a distinct 
electron-dense coat accumulated as they probably failed to fuse with the target membrane 
(Tanigawa et al., 1993). Furthermore, the role of the ArfGAP induced GTP hydrolysis in 
uncoating was studied on artificial membranes. It was shown in a liposome based system 
that the GTP hydrolysis mediated by the catalytical domain of ArfGAP1 is sufficient to initiate 
uncoating (Reinhard et al., 2003). As the catalytical domains of the three ArfGAPs involved in 
COPI trafficking display 80 % identity, this rose the question if all three ArfGAPs: ArfGAP1, 
ArfGAP2 and ArfGAP3, are able to meadiate uncoating. Although the three Golgi associated 
ArfGAPs have been described to have overlapping functions (Cukierman et al., 1995; 
Frigerio et al., 2007), recent evidence suggests that the three enzymes might fulfill different 
purposes in COPI transport. Based on their distinct recruitment mechanisms: via the ALPS 
motifs for ArfGAP1 and via coatomer for ArfGAP2 and 3, two different hypotheses have been 
proposed. According to the Antonny lab, ArfGAP2/3 can be recruited to the flat Golgi 
membrane via a direct interaction with coatomer and remove single coatomers from the 
membrane thus antagonising the formation of COPI vesicles when not enough cargo is 
present.  ArfGAP1, on the other hand, is recruited to the curved membrane of a fully formed 
COPI vesicle and is rather responsible for uncoating and so rendering a fusogenic vesicle. In 
accordance with the same data, the Wieland lab suggested that ArfGAP2/3 are the uncoating 
ArfGAPs and are recruited by a direct interaction with coatomer to the polymerized COPI 
coat. ArfGAP1 is rather involed in the early steps of vesicle biogenesis and is recruited to the 
highly curved regions of COPI vesicle formation thus playing a role in cargo uptake. 
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1.5.3.2 Role	of	Tethering	factors	in	COPI	Coat	Disassembly	
According to a newer model, vesicle tethering might occur prior to uncoating and facilitate 
this process as tethers seem to directly interact with coat components (reviewed by Szul and 
Sztul, 2011). Dsl1p binds directly to α-COP and δ-COP (Andag and Schmitt, 2003; Reilly et 
al., 2001). More recently it has been shown that the interaction sites between Dsl1p and α-
COP are simmilar to the interaction sites between α-COP and ε-COP, suggesting that the 
Dsl1p-coatomer interaction might destabilize the polymerized coat (Zink et al., 2009). 
Downregulation of the Dsl1 gene leads to an accumulation of COPI and COPII coated 
vesicles in cells. Based on this data a model has been proposed, in which Dsl1p facilitates 
uncoating by a direct interaction with coatomer subunits and might even be the factor 
initiating the uncoating event once the vesicle has been tethered to the ER membrane. This 
specific interaction between Dsl1p and coatomer was further proposed to prevent 
repolymerisation of the COP-subunits and thus facilitate coat disassembly (Zink et al., 2009). 
 
On the basis of these data in the literature, the goals of my thesis were a biochemical 
analysis of the role of ArfGAP1, ArfGAP2 and ArfGAP3 in COPI vesicle biogenesis. To this 
end, the following issues were addressed: 
1. Determining the kD-values for the interaction between the four coatomer isoforms 
and the three ArfGAPs.  
2. Influence of the conformational state of the COPI coat on its affinity for ArfGAPs. 
3. Effect of type I transmembrane protein p23 on ArfGAP activity. 
4. Establishing a real-time assay with single molecule sensitivity to monitor the 
dynamics of COPI coat disassembly.
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2 Results 
2.1 Cloning, Expression and Purification of S-tagged ArfGAPs  
2.1.1 Cloning and expression of S-tagged ArfGAPs 
One of the goals of this thesis was to study the interactions of ArfGAP1, ArfGAP2 and 
ArfGAP3 with the four different coatomer isoforms. In order to address a potential difference 
in affinity of the ArfGAPs for the coatomer isoforms, a detection method was required, which 
recognizes all three GAPs with the same efficiency. For this purpose, ArfGAP1, ArfGAP2 and 
ArfGAP3 were recloned in such a way that they contain a S-tag. This tag allows a direct 
detection of the protein of choice with a secondary antibody coupled to horseradish 
peroxidase. ArfGAP1, ArfGAP2 and ArfGAP3 were previously cloned in a pFastBacHTB 
vector (Weimer et al., 2008). The S-tag was ordered as a synthetic oligomer and cloned in 
the ArfGAP containing pFastBacHTB vector via SfoI and Bam HI. This resulted in a vector 
containing first a S-tag and then a His-tag prior to the N-terminus of the ArfGAPs. In order to 
express S-tagged ArfGAP1, ArfGAP2 and ArfGAP3 in a baculoviral expression system, Sf9 
cells were infected with the corresponding amount of P2 virus (for preparation of the virus 
see Materials and Methods). The insect cells were then incubated for 72h at 27°C and the 
cell pellets, containing the expressed protein, were harvested (Figure 2.1). 
 
 
Figure 2.1: Expression of S-tagged ArfGAP1, 2 and 3 in a baculo virus expression system. After 
72-hour infection of Sf9 cells with a virus stock containing S-tagged ArfGAP1, 2 and 3, the cells were 
harvested and a fraction was lysed and loaded on a SDS-PAGE to test the expression efficiency. 
Bands appear at the corresponding molecular weight of S-tagged ArfGAP1, 2 and 3. 
 
 
2.1.2 Purification of S-tagged ArfGAPs 
After lysis of the Sf9 cells, the protein containing supernatant was separated from the cell 
debris by a centrifugation step. The protein was then purified by Immobilized Metal Affinity 
Chromatography (IMAC) purification and a subsequent gel filtration step on a Superdex200 
column  (for more details see Materials and Methods). All three S-tagged ArfGAPs displayed 
no differences from the His-tagged ArfGAPs described in (Weimer et al., 2008) in terms of 
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their behavior during the purification.  Figures 2.2 to 2.5 show representative purifications of 
S-tag ArfGAP1, ArfGAP2 and ArfGAP3. 
 
 
Figure 2.2: Purification of S-tag ArfGAP1, ArfGAP2 and ArfGAP3. S-tagged ArfGAPs were purified 
via Immobilized Metal Affinity Chromatography (IMAC). Equal volumes of the different purification 
steps were loaded on a 12 % SDS gel and separated by SDS gel electrophoresis. Staining was 
performed with coomassie brilliant blue. L= Lysate, S= supernatant after 100 000 x g 
ultracentrifugation, FT= flow through after incubation with Ni-Sepharose, 1, 2, 3= washing steps, Ni= 
pool after elution from Ni-Sepharose, PD= final pool after buffer exchange on a PD10 column. 
 
 
 
 
 
Figure 2.3: Gel filtration of S-tag ArfGAP1. The PD pool of IMAC-purified S-tag ArfGAP1 was 
further purified via size exclusion chromatography on a Superdex200 column. Fractions corresponding 
to S-tag ArfGAP1 were separated by SDS-PAGE on a 12 % gel and stained with coomassie brillian 
blue. Dashed lines correspond to the peaks of standard proteins. Black box indicates fractions loaded 
on the gel. 
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Figure 2.4: Gel filtration of S-tag ArfGAP2. The PD pool of IMAC-purified S-tag ArfGAP1 was 
further purified via size exclusion chromatography on a Superdex200 column. Fractions corresponding 
to S-tag ArfGAP2 were separated by SDS-PAGE on a 12 % gel and stained with coomassie brillian 
blue. Dashed lines correspond to the peaks of standard proteins. Black box indicates fractions loaded 
on the gel. 
 
 
 
Figure 2.5: Gel filtration of S-tag ArfGAP3. The PD pool of IMAC-purified S-tag ArfGAP1 was 
further purified via size exclusion chromatography on a Superdex200 column. Fractions corresponding 
to S-tag ArfGAP3 were separated by SDS-PAGE on a 12 % gel and stained with coomassie brillian 
blue. Dashed lines correspond to the peaks of standard proteins. Black box indicates fractions loaded 
on the gel. 
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2.1.3 Functionality test of the S-tagged ArfGAPs 
To make sure that the addition of the S-tag did not compromise the functionality of ArfGAP1, 
2 and 3, we performed a tryptophane fluorescence based binding assay. To this end, we 
prepared liposomes with Golgi-like composition (for details see Materials and Methods) and 
incubated them with Arf1, coatomer and GTP. GDP to GTP exchange within Arf1 was 
triggered by the addition of EDTA and monitored as change in tryptophan fluorescence. 
Upon the conformational change of Arf1 associated with GTP binding, a conserved 
tryptophan in switch region one gets exposed and an increase in tryptophane fluorescence 
was observed. Once a plateau was reached, the GTP state was stabilized by the addition of 
MgCl2 and uncoating was subsequently triggered by the addition of ArfGAP. The GTP to 
GDP exchange resulted then in a decrease in tryptophan fluorescence. As depicted in Figure 
2.6, the addition of the S-tag did not alter the functionality of ArfGAP1, 2 and 3. 
 
 
Figure 2.6: S-tagged ArfGAPs are able to hydrolyse GTP within Arf1.  The functionality of the S-
tagged ArfGAPs was probed in a tryptophane fluorescence based assay. Liposomes of Golgi-like 
composition were incubated with Arf1, coatomer, GTP and EDTA in a quartz cuvette. The GDP to 
GTP exchange within Arf1, triggered by EDTA, leads to a conformational change within the protein 
and to the exposure of a tryptophane within switch region 1. Thus, the measured tryptophane 
fluorescence increases. Upon the addition of 50nM ArfGAP, GTP is hydrolysed and tryptophane 
fluorescence signal decreases again. 
 
 
2.2 Differential interactions of ArfGAP1/2/3 with coatomer isoforms 
One of the initial goals of this thesis was to investigate potential differences in the functions 
of ArfGAP2 and ArfGAP3. While different roles of ArfGAP1 on one side and ArfGAP2/3 on 
the other side were reported in the literature, up to date no functional difference between 
ArfGAP2 and ArfGAP3 were described. One aspect, which has not been addressed so far, is 
a potentially differential interaction of the three ArfGAPs with the four coatomer isoforms.  
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2.2.1 Analysis of ArfGAP interactions with coatomer isoforms by ELISA 
In order to investigate coatomer- ArfGAP interactions, we have established an enzyme-linked 
immonosorbent assay (ELISA)-like assay. In this assay, specific coatomer isoforms were 
immobilized on a surface and subsequently the individual ArfGAPs were added in solution. 
Binding of ArfGAPs was detected by an anti-ArfGAP specific primary antibody and visualized 
by a secondary antibody coupled to horseradish peroxidase (HRP). In these experiments we 
determined dissociation constants (KD-values) in the low micromolar range for the ArfGAP-
coatomer interaction. We observed a preference of all three ArfGAPs for the γ1-isoforms 
(Figure 2.7). ArfGAP1 displayed the highest affinity for all four coatomer isoforms (0.1-0.6µM) 
followed by ArfGAP2 (0.5-1.2µM).  ArfGAP3 showed the weakest interaction (1.2-4.3µM). 
 
 
 
Figure 2.7: Differential interactions between the ArfGAPs and coatomer isoforms.  96-well 
plates were coated with recombinant coatomer isoforms. Subsequently, the wells were incubated with 
ArfGAPs and then anti-ArfGAP antibodies. Detection was performed via secondary antibodies coupled 
to HRP and addition of 3,3,´5,´5-Tetramethylbenzidine. After measurement of the fluorescence at 
450nm, the absorbance values were plotted against the ArfGAP concentration. For the analysis, one 
site binding hyperbola model was fitted. The obtained kD values were plotted as a bar diagram. (N=4)  
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2.3 Effect of coatomer conformation on ArfGAP affinity 
Another aspect studied in this thesis is the mode of recruitment of ArfGAP2 and 3 from the 
cytosol to the Golgi membrane. While it was shown earlier that ArfGAP2 and 3 depend on 
coatomer for their association with the Golgi membrane (Weimer et al., 2008), the spatial and 
temporal regulation of this process remains unknown. In one model, ArfGAP2 and 3 bind to 
soluble coatomer already in the cytosol and are recruited en block with the heptameric 
complex to Golgi membranes. In another model, ArfGAP2 and 3 are recruited only once 
coatomer has polymerized on the donor membrane and the corresponding binding site was 
formed. In order to address this mechanistic question, we utilized an ELISA-like binding 
assays as well as a conventional pull down assay. 
 
2.3.1 Effect of coatomer conformation on ArfGAP affinity studied by ELISA-like 
assay: direct immobilization of coatomer 
To quantitatively analyse the interactions between the three ArfGAPs and coatomer, we used 
a modified version of the ELISA-like binding assay described above. As ArfGAP2 and 
ArfGAP3 show 49,6 % protein sequence identity and have a single homologue in yeast, Glo3 
(Frigerio et al., 2007), we used ArfGAP2 in most of the assays as a representative of both 
ArfGAP2 and ArfGAP3. The most abundant coatomer isoform in vivo is γ1ζ1 and thus only 
the affinity of ArfGAPs to this particular isoform was assessed. 
Coatomer was immobilized on a polystyrene surface directly. In order to change the 
conformation of coatomer to a conformation resembling the one on a COPI vesicle, the 
coatomer coated plate was incubated with peptides corresponding to the cytoplasmic tails of 
p23 dimer, which was shown previously to induce a conformational change in coatomer 
(Langer et al., 2008; Reinhard et al., 1999). As a negative control we used a C-terminal 
peptide of the ER resident protein Wbp1, a type I glycosyltransferase. In the next step, 
ArfGAP1, 2 (or 3) was added to the polymerized or non-polymerized coatomer samples. 
Bound ArfGAPs were detected using a primary antibody directed against ArfGAP1, 2 or 3 
and a secondary antibody conjugated to HRP. The determined kD values of ArfGAP1, 2 and 
3 for both coatomer treated with p23 and coatomer treated with Wbp1 were in the low 
micromolar range (Figure 2.8). In this in vitro system, no significant differences in the 
dissociation constants were observed.  
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Figure 2.8: Effect of the conformational state of coatomer on ArfGAP activity: direct 
immobilization of coatomer.  96-well plates were coated with recombinant coatomer of the isoform 
γ1ζ1. Subsequently, the wells were incubated with dimeric p23 peptide in order to alter the coatomer 
conformation or dimeric Wbp1 peptide or no peptide as a control. In the next step the different 
ArfGAPs and anti-ArfGAP antibodies were added. Detection was performed as described in Figure 
2.7. Absorbance values were plotted against the ArfGAP concentration. For the analysis, one-site 
binding hyperbola model was fitted. Dissociation constants (kD) were determined by fitting one-site 
binding hyperbola model and plotted as a bar diagram. (N=3) 
 
 
2.3.2 Effect of coatomer conformation on ArfGAP affinity studied by ELISA-like 
assay: immobilization of coatomer via CM1 
One potential limitation of the direct immobilization of coatomer is that the conformational 
change within coatomer might not take place as efficiently on the surface as it does in 
solution. In addition, the interaction with the polystyrene plate could lead to a perturbation of 
the functionality of coatomer. In order to select one specific orientation of coatomer and 
immobilize the protein more gently, we first coated the 96-well plate with CM1, a structure-
specific antibody against fully assembled coatomer, and then added coatomer in a second 
step. 
For this purpose, we recloned the ArfGAPs and added an S-tag to allow their direct detection 
with a HRP substrate (for more details see 2.1). Here, we measured significantly higher kD 
values in comparison to the ones measured in the set up based on direct coatomer 
immobilization (compare Figure 2.8 to Figure 2.9). In order to exclude a possibility that the 
addition of the S-tag has an effect on binding, we performed the experiment described in 2.2 
with the S-tagged ArfGAPs. Here, the 96-well plates were coated only with the coatomer 
isoform γ1ζ1. In the set up relying on direct immobilization (Figure 2.10), the S-tagged 
ArfGAPs displayed kD values similar to the ArfGAPs lacking the S-tag. However, upon 
coatomer immobilization via CM1, both ArfGAP1 and ArfGAP2 displayed higher kD values 
and thus significantly lower affinity for coatomer (Figure 2.11). Thus, it is possible that either 
the CM1 antibody masked the ArfGAP binding sites in coatomer or that the concentration of 
immobilized coatomer in these set-ups was lower than in the set-up relying on direct 
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immobilization. Thereby, this experimental approach proved not to be suitable to address the 
question of interest.  
 
 
Figure 2.9: Effect of the conformational state of coatomer on ArfGAP activity: coatomer 
immobilization via CM1.  96-well plates were coated overnight with 100µL of CM1 antibody, 
generated from hybridoma supernatant. Subsequently, the wells were incubated with coatomer of the 
γ1ζ1 isoform and the three individual ArfGAPs. Detection was performed with HRP substrate and the 
plate was measured at 450nm. The absorbance values were plotted against the ArfGAP 
concentration. For the analysis, one-site binding hyperbola model was fitted (N=2). NP= no addition of 
peptide. No kD constant could be calculated for the sample containing ArfGAP2 and no peptide. 
 
 
 
 
Figure 2.10: Affinity of S-tagged ArfGAPs for coatomer: direct coatomer immobilization. 96-well 
plates were coated overnight with 10pmol of purified coatomer of the γ1ζ1 isoform. Subsequently, the 
wells were incubated with the individual S-tagged ArfGAPs and in a second step with anti-ArfGAP 
antibodies. The detection and evaluation was performed as described in Figure 2.7. (N=2)  
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Figure 2.11: Affinity of S-tagged ArfGAPs for coatomer: coatomer immobilization via CM1. 96-
well plates were coated overnight with 100µL of CM1 antibody generated from hybridoma supernatant. 
Subsequently, the wells were incubated with coatomer of the γ1ζ1 isoform and the three different 
ArfGAPs. Detection was performed with HRP substrate and the plate was measured at 450nm. The 
absorbance values were plotted against the ArfGAP concentration. For the analysis, one-site binding 
hyperbola model was fitted. (N=2) 
 
 
2.3.3 Effect of coatomer conformation on ArfGAP affinity analysed in a pull down 
assay 
Another approach to assess the interaction between the ArfGAPs and coatomer, depending 
on coatomer conformation state, was a conventional pull down set-up. Here, we used two 
independent experimental designs.  
In the first set-up, One-STrEP-tag coatomer was immobilized on streptactin beads via its 
One-STrEP-tag located in α-COP and subsequently polymerized via the addition of dimeric 
p23. ArfGAP2 was added in the last step. To account for potential reversibility of the 
conformational change, we performed the experiment with and without washing away of the 
dimeric p23 meaning that the incubation with ArfGAP2 was performed either in the absence 
or presence of p23 dimer. The dimerized cytoplasmic tail of Wbp1 was used as a control. We 
did not detect a difference in the ArfGAP affinity for coatomer between the sample containing 
dimeric p23 and the sample containing the control peptide Wbp1 (Figure 2.12, upper panel). 
A possible drawback of this experimental set-up is that coatomer polymerization might not be 
as effective after binding to the beads as in solution. It was previously shown that the 
conformational change involves at least α-COP and γ-COP (Langer et al., 2007), and the 
One-STrEP-tag is located on the α-COP subunit, thus potentially preventing the interaction 
with the peptide.  
In the second set-up, we tried to circumvent this potential limitation by first inducing the 
conformational change in coatomer in solution and then immobilizing the protein via its One-
STrEP-tag on streptactin beads. Here, the incubation with ArfGAP was performed again 
either in the presence of dimeric p23 or after washing the peptide away. In this system, we 
observed a higher affinity of ArfGAP2 for coatomer in the absence of p23, however, only 
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under condition including p23 dimeric peptide throughout the entire experiment (Figure 2.12, 
lower panel). This result might be due to a reversible conformational change in coatomer as 
well as to a direct effect of the p23 cytoplasmic tail with ArfGAP2. One further possibility is 
that the polymerization in solution and the subsequent immobilization on the streptactin 
beads compromises coatomer functionality and thus its affinity for ArfGAP.  
 
 
Figure 2.12: Affinity of ArfGAPs for polymerized versus soluble coatomer.  
Upper panel: One-STrEP-tagged coatomer was immobilized via the OneStrepTag on streptactin 
beads. The conformation of coatomer was altered to the polymerized form via the addition of dimeric 
p23. Wbp1 in its dimeric form was used as a control. Incubation with ArfGAP2 was performed either in 
the absence or presence of the peptides.  
Lower panel: Polymerization of coatomer was induced in solution via the addition of dimeric p23. The 
control sample was treated with dimeric Wbp1. Coatomer was then coupled to streptactin beads via its 
OneStrepTag. The incubation with ArfGAPs was performed either in the presence or absence of 
excessive peptide. Proteins bound to the beads were analysed by SDS PAGE and western blot. N=3 
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2.4 Effect of p23 on the activities of ArfGAP1 and ArfGAP2 
2.4.1 Effect of p23 on ArfGAP activity assessed by Tryptophan Fluorescence and 
SLS 
Previous studies reported an inhibiting role of both p23 and p24 on ArfGAP1 (Lanoix et al., 
2001). In order to investigate if the cytoplasmic tail of p23 acts directly on the Arf1 
activation/deactivation cycle, we performed tryptophane fluorescence assays. This liposome-
based system utilizes the increase/decrease in tryptophane fluorescence in order to monitor 
the nucleotide-dependent conformational change in Arf1.  
Here, we investigated the effect of p23 lipopeptide on the rate of ArfGAP-mediated GTP 
hydrolysis in Arf1. For this purpose, we extruded liposomes with a Golgi-like composition 
through polystyrene filters with a pore size of 100nm. This pore size was chosen due to the 
curvature sensitivity of ArfGAP1 (Bigay et al., 2003). In the first step, we compared the 
absolute activities of ArfGAP1 and ArfGAP2 on GTP hydrolysis within Arf1. 100nm liposomes 
with a Golgi-like composition were incubated with Arf1, coatomer and GTP. Nucleotide 
exchange was triggered by the addition of EDTA, which chelates the Mg2+ ions stabilizing the 
phosphate groups, and thus allows GDP release and binding of the more abundant GTP, 
which then results in an increase in tryptophane fluorescence. Once a plateau was reached, 
the GTP state was locked by the addition of excess Mg2+. Subsequently, ArfGAP was added 
and the rate of hydrolysis was monitored by the decrease in tryptophane fluorescence (for 
more details see Materials and Methods). As shown in Figure 2.13, ArfGAP2 displayed 
higher activity than ArfGAP1 under these conditions. Still, 100nm liposomes were used for 
further experiments. 
 
 
Figure 2.13: Activities of ArfGAP1 and ArfGAP2 on GTP hydrolysis within Arf1. An optical 
tryptophane fluorescence assay allows monitoring of the activities of ArfGAP1 and ArfGAP2 on GTP 
hydrolysis within Arf1. The increase in tryptophane fluorescence corresponds to exchange of GDP 
with GTP, which was chemically triggered by the addition of EDTA. The decrease in fluorescence 
reflects the extent of GTP hydrolysis triggered by ArfGAP1 or ArfGAP2. 
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In order to test if the cytoplasmic tail of p23 exhibits an effect on the ArfGAP mediated GTP 
hydrolysis, Golgi-like liposomes were prepared in the presence of p23 lipopeptide. As p23 is 
a transmembrane protein, this approach is closer to the in vivo situation than the set-up 
utilizing soluble peptide. The experiment was performed in the presence of ArfGAP2 as 
described above. Here, the activity of ArfGAP2 seemed to be enhanced in the presence of 
p23 lipopeptide (Figure 2.14). However, the GDP to GTP exchange was also reduced in the 
absence of the lipopeptide, which makes it difficult to interpret these results. 
 
 
Figure 2.14: Activity of ArfGAP2 in the presence of p23 lipopetide. The activity of ArfGAP2 
depending on the presence of p23 lipopetide was assessed in a tryptophan fluorescence assay in the 
presence of coatomer. Liposomes with Golgi-like composition were prepared in the presence or 
absence of p23 lipopeptide, extruded through 100nm polystyrene filters and loaded with Arf1 in the 
presence of EDTA. After addition of MgCl2, which stabilizes the GTP-bound state of Arf1, GTP 
hydrolysis induced by ArfGAP2 was followed by the decrease in thryptophane fluorescence. N=2. 
 
 
In order to test the effect of the p23 cytoplasmic tail on ArfGAP mediated COPI vesicle 
uncoating, we utilized a static light scattering assay. For this purpose, liposomes, Arf1, 
coatomer and GTP were incubated at 37°C and GDP to GTP exchange was triggered 
chemically by the addition of EDTA. Arf1-GTP was stabilized by the addition of MgCl2, and 
GTP hydrolysis was induced by the addition of ArfGAP1 or ArfGAP2. Light scattering 
(excitation at 350nm, emission at 350nm) allows monitoring of an increase in mass, 
corresponding to coating, and subsequent decrease in mass during uncoating. Golgi-like 
liposomes were prepared in the presence of p23 lipopetide as described above. Uncoating 
was triggered either by 1nM ArfGAP1 or 1nM ArfGAP2. As shown in Figure 2.15, the addition 
of p23 lipopeptide affected both the coating and the uncoating step. Coat recruitment was 
increased in the presence of p23 lipopetide. The activities of ArfGAP1 and ArfGAP2 were 
influenced in a different manner. Whereas the activity of ArfGAP1 was slightly inhibited by 
p23 lipopeptide, the activity of ArfGAP2 was strongly enhanced.  
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Figure 2.15: Uncoating activities of ArfGAP1 and ArfGAP2 in the presence of p23 lipopeptide. 
Uncoating activities of ArfGAP1 and ArfGAP2 depending on the presence of p23 were assessed in a 
static light scattering assay. Liposomes (100nm) with Golgi-like composition were prepared in the 
presence or absence of p23 lipopeptide and loaded with Arf1 and coatomer in the presence of EDTA. 
After addition of MgCl2, GTP hydrolysis induced by ArfGAP1 or ArfGAP2 was followed by the 
decrease in static light scattering. N≤ 5, here is shown one representative concentration for ArfGAP1 
and ArfGAP2. 
 
 
The presence of p23 lipopeptide resulted in a three times higher mass recruitment. To test if 
this effect is due to more efficient recruitment of coatomer resulting from the increased 
nucleotide exchange within Arf1, we utilized the tryptophane fluorescence set up described 
above. We performed the experiment either in the absence or in the presence of coatomer. 
In samples not containing coatomer, the difference in the plateau in the presence or absence 
of p23 lipopeptide decreased from 3 to 1.4 (Figure 2.16).   
 
 
Figure 2.16: Nucleotide exchange is increased in the presence of p23 lipopetide. Liposomes 
(100nm) with Golgi-like composition were prepared in the presence or absence of p23 lipopeptide and 
loaded with Arf1 (left panels) or Arf1 and coatomer (right panels) in the presence of EDTA. The height 
of the plateau was quantified and the obtained absolute values were plotted as a bar diagram. (N≤2).  
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The experimental results shown in Figure 2.16 indicate that there might be a less efficient 
recruitment of coatomer to the liposomes in the absence of p23 lipopetide. To test this 
possibility, we performed a float up experiment. To this end, we incubated liposomes, Arf1, 
coatomer, GTP and EDTA for 10min at 37°C and subsequently stabilized the GTP loaded 
state of Arf1 by the addition of MgCl2. These samples were then adjusted to 47 % sucrose 
and transferred at the bottom of SW60 tubes. The 47 % bottom layer was overlayed with 44 
% weight per weight (w/w) sucrose, followed by 41 % w/w sucrose and then HKM buffer (for 
details see Materials and Methods). Liposomes together with the membrane-bound material 
were floated up by a 90-min spin in a SW60 rotor at 50 000rpm (Figure 2.17, upper panel). 
The amount of bound material was quantified in a western blot. A 1.5 times increase with 
respect to both Arf1 and coatomer recruitment was detected.  
 
Figure 2.17: Recruitment of coatomer to liposomes of Golgi-like composition in the presence or 
absence of p23 lipopeptide. Liposomes (100nm) of Golgi-like composition were coated with Arf1 and 
coatomer. The bound material was then isolated on a sucrose gradient, shown schematically in the 
upper pannel. Amount of Arf1 and coatomer recruited to the liposomes in the presence or absence of 
the p23 lipopeptide was quantified and shown as a percentage of the input (lower panel, N≤3). 
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2.4.2 Effect of p23 on ArfGAP activity assessed by a radioactivity assay 
Since the presence of p23 lipopeptide leads to a difference in the efficiency of Arf1 and 
coatomer recruitment to the liposomes, as found in both the tryptophane fluorescence and 
the light scattering assays, we attempted to establish a fluorescence-independent assay. For 
this purpose, we used radiolabeled nucleotide, which allows direct monitoring of GTP 
hydrolysis on Arf1. We applied a float up assay with radioactively labeled GTP. Golgi-like 
liposomes were prepared either in the presence or absence of p23 lipopeptide and extruded 
either through 30nm or through 100nm polystyrene filters. Upon recruitment of Arf1 and 
coatomer to the membrane in a 3H-GTP dependent manner, we isolated the membrane 
bound material via a sucrose gradient (see Figure 2.17 and Materials and Methods). The 
coated liposomes were then subjected to an incubation with ArfGAP1 or ArfGAP2 at 37°C, 
and samples were taken at 0, 2.5, 5, 10 and 15min. 3H-GTP was separated from 3H-GDP 
via thin layer chromatography and the radioactive signal was quantified in a ß-Imager. In this 
set-up, ArfGAP2 hydrolyzed higher amounts of GTP in the presence of the p23 lipopeptide 
than in the absence of the lipopeptide (Figure 2.18, middle and lower right panel). In contrast, 
the activity of ArfGAP1 was reduced in the presence of p23 lipopeptide (Figure 2.18, upper 
and lower left panel).  
 
 
Figure 2.18: Analysis of the effect of p23 lipopetide on the activity of ArfGAP1 and ArfGAP2 in a 
radioactivity based assay. Liposomes of Golgi-like composition were extruded through a 30nm or 
100nm filter, here a representative experiment performed with 100nm liposomes. Liposomes were 
subsequently coated with Arf1 and coatomer in the presence of 3H-GTP. The bound material was then 
isolated on a sucrose gradient. The degree of GTP hydrolysis exhibited by ArfGAP1 (upper panel) and 
ArfGAP2 (middle panel) was assessed via thin layer chromatography. The amount of GDP (cpm) 
dependent on the ArfGAP concentration added was plotted as a bar diagram (lower panel). N=2 
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To study the mechanism behind these differential effects, we tested if the higher activity is 
due to higher ArfGAP2 recruitment to the liposomes in the presence of p23 lipopeptide. To 
this end, we coated Golgi-like liposomes with Arf1 and coatomer. To prevent premature 
hydrolysis and potential ArfGAP2 disassembly, we performed the experiment in the presence 
of the non-hydrolyzable GTP analogue, GMP-PNP. Once coating was completed, ArfGAP2 
was added to the samples for 10min at 37°C. The bound material was then isolated via the 
sucrose gradient described above. Only a slight difference in the efficiency of ArfGAP2 
recruitment was observed depending on the absence or presence of p23 lipopeptide (Figure 
2.19).  
 
Figure 2.19: Recruitment of ArfGAP2 to liposomes of Golgi-like composition in the presence or 
absence of p23 lipoptide. Liposomes of Golgi-like composition were coated with Arf1 and coatomer 
in the presence of the non-hydrolyzable GTP analogue GMP-PNP. In a second step, the liposomes 
were incubated with ArfGAP2. The bound material was then isolated on a sucrose gradient. The 
degree of ArfGAP2 recruitment was quantified via western blot. N=2. I= Input, F= floated fraction, 
corresponding to liposomes and bound proteins. 
 
 
2.5 ArfGAP1 and ArfGAP2 inhibit the formation of COPI vesicles in vitro 
As some studies propose a role of ArfGAP1 as coat components (Lewis et al., 2004; Yang et 
al., 2002), we first tested the effect of the ArfGAPs on the yield of COPI vesicle. For this 
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purpose, we employed an in vitro vesicle preparation assay based on differential 
centrifugation using semi-intact cells as donor membranes (Adolf et al., 2013; Adolf and 
Wieland, 2013). Vesicle preparation was performed either in the presence or in the absence 
of ArfGAP1 and ArfGAP2. Vesicle yield was assessed by quantifying the amount of the 
membrane COPI markers Sec22b and p24, and controlled by blotting for the ER resident 
protein Calnexin, which is excluded from COPI vesicles. The amount of ArfGAP was titrated 
in a stochiometry of 0.05:1, 0.1:1 and 1:1 (molar ratio) to coatomer.  
In contrast to previous reports (Lewis et al., 2004; Yang et al., 2002), we observed a 
decrease in the overall yield of COPI vesicles formed in the presence of ArfGAP1 or 
ArfGAP2 (Figure 2.20). This decrease displays a concentration-dependence and is more 
pronounced in the case of ArfGAP2 than in the case of ArfGAP1. These findings argue 
against a possible role of both ArfGAP1 and ArfGAP2 as coat components. 
 
 
 
Figure 2.20: ArfGAP1 and ArfGAP2 inhibit the formation of COPI vesicles in vitro. COPI vesicle 
were formed in the presence of ArfGAP1 or ArfGAP2 by incubation of semi-intact cells with Arf1, 
coatomer and GTP as indicated. Newly formed vesicles were separated from donor membranes by 
differential centrifugation. 100 % of the vesicle fraction and 5 % of the semi-intact cells used for 
reconstitution (Input) were analyzed by western blotting for the presence of the non-cargo marker 
Calnexin and the two COPI cargo proteins Sec22b and p24 (upper panel). Vesicle yield was assessed 
by quantifying the COPI cargo proteins Sec22b and p24 utilizing the Li-Cor image studio (lower 
panels). Coat= Arf1 and coatomer. (N≤2, mean ± SD). 
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When ArfGAP was introduced from the beginning of the incubation, the number of the 
vesicles formed decreased with higher concentrations of ArfGAP. This could be due either to 
the GAP activity inhibiting vesicle formation, or to fusion of vesicles with endomembranes 
within the semi-intact cells, once they were formed and uncoated,. To assess a possible 
contribution of the latter mechanism to the yield of recovered vesicles, experiments in which 
ArfGAP was present during the formation of vesicles (time= 0-30min, Figure 2.21) were 
compared to conditions, in which ArfGAP was added after the initial formation of the vesicles 
(time= 30-60min, Figure 2.20). No significant change was observed between the two 
approaches (compare Figure 2.21, lane 10 with lane 7 (60min) and lane 3 (30min)), arguing 
against vesicle fusion playing a substantial role in the loss of vesicles observed in the 
presence of ArfGAP. 
 
Figure 2.21: Formation of COPI vesicles in vitro in the presence of ArfGAP1 or ArfGAP2. Upper 
panel: COPI vesicle were generated in vitro from semi-intact cells in the presence of ArfGAP1 or 
ArfGAP2, and isolated by differential centrifugation. 100 % of the vesicle fractions and 5 % of the 
semi-intact cells used for reconstitution (Input) were analyzed by western blotting for the presence of 
the non-COPI marker calnexin and the COPI membrane proteins Sec22b and p24.  
Lower panels: Vesicle yield was assessed by quantifying the intensities of the Sec22b (N=2) and p24 
(N=3) bands. Coat= Arf1 and coatomer. 
 
 
2.6 Role of ArfGAP1 and ArfGAP2 in COPI coat disassembly 
Previous studies have reported that the ArfGAPs are involved in uncoating (Reinhard et al., 
2003; Tanigawa et al., 1993). However, it still remains controversial to what extent the 
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ArfGAPs are determinants of completing coat disassembly. A series of open questions still 
remains to be answered 1) Does GTP hydrolysis in Arf1 trigger coat disassembly?; 2) Are 
additional factors required for uncoating?; and 3) Do the coat components leave the 
membrane simultaneously?.  
2.6.1 Experimental set up  
In an attempt to answer the above-mentioned questions, we established an ensemble 
measurement with single molecule sensitivity, which is based on fluorescence cross 
correlation set-up. This system allows real time monitoring of COPI coat disassembly. 
Previous studies of the uncoating reaction have mostly utilized artificial membranes (Bigay 
and Antonny, 2005; Bigay et al., 2003; Rawet et al., 2010; Reinhard et al., 2003). Liposomes, 
however, do not provide the multiple interactions that the COPI coat undergoes with the 
variety of transmembrane proteins present in an endogenous vesicle. Although coatomer is 
recruited by an interaction with Arf1-GTP, once at the membrane coatomer can interact with 
the cytoplasmic tails of cargo receptors and cargo proteins. Furthermore, membrane-bound 
coatomer polymerizes and thereby coatomer-coatomer interactions contribute to coat 
stabilization. To take into account all these determinants of coat stability, we prepared COPI 
vesicles from endogenous membranes. For this purpose, Golgi-enriched fractions were 
isolated from rat liver (for details see Materials and Methods) and used them as donor 
membranes for COPI vesicle formation. In order to monitor the individual kinetics of Arf1 and 
coatomer, we coupled the two proteins to different fluorescent dyes.  
To allow efficient labeling, Arf1 was first recloned in such a way that its unique cystein at 
position 159 was mutated to a serine residue and the C-terminal lysin (Position 181) was 
exchanged for a cystein (Beck et al., 2011a). The protein was then coupled to a maleimide 
reactive Alexa647. Coatomer was labeled with NHS-reactive ATTO488. 
The single molecule set-up was based on a confocal microscope suited for fluorescence 
cross correlation spectroscopy (Figure 2.22). The emitted photons were first collected by the 
same objective, passed through a pinhole and then separated by a dichroic mirror. After 
filtering, the detection was performed in each channel on avalanche photo diodes (APDs). 
This allows monitoring of vesicle populations diffusing in and out of the focus. Each vesicle 
passing through the confocal volume generates a peak in the fluorescence trace (Figure 
2.23). The height of this peak is mainly determined by four different factors: 1) the exact path 
of the fluoresce molecule through the focus; 2) the concentration of coat protein on the 
membrane; 3) the degree of labeling of the protein and 4) the brightness of the dye. Thus, a 
vesicle passing through the center of the excitation volume will give a higher signal than the 
same vesicle passing through the rim.  
 
  
	 RESULTS	 		 	
54 
 
Figure 2.22: Confocal single molecule set-up. Fluorescence intensity traces were recorded with ms 
resolution with a LSM 710 microscope equipped with a confocor 3 and 488nm and 633 nm laser lines. 
Emitted photons were collected with the same objective, passed through a pinhole, separated by a 
dichroic mirror, and detected after filtering in each channel on avalanche photo diodes (APDs).  
 
 
 
Figure 2.23: Experimental set up for the analysis of coat release. Schematic view of assessment 
of coat release from COPI coated vesicles. Fluorescent coat components are imaged with a confocal 
microscope equipped with avalanche photo diodes (APDs). Hour-glassed confocal volume is shaded 
in blue. Depending on their degree of coating, vesicles passing through the focus generate 
fluorescence intensity peaks.  
 
 
In order to assess kinetics of coat disassembly, the raw data was subjected to a burst 
analysis (Figure 2.24). Burst analysis for all experiments was conducted utilizing custom 
scripts written in Matlab. Intensity traces were binned in 20 equally spaced time windows 
(length 15 seconds). A 0.9 percentile of the intensity values was chosen as a threshold to 
distinguish bursts (= vesicles containing bound coat proteins) from fluorescence background 
(= free proteis). The number of intensity values above the threshold was used as a measure 
for the number of peaks. As a second analysis approach, the average intensity above the 
threshold for both Arf1 and coatomer in each bin was calculated and used as a measure for 
the amount of vesicle-bound fluorophores. From this, we calculated for each bin the intensity 
ratio between red and green channels, which reports the relative abundance of both proteins 
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on the vesicles. The half-times for each component were calculated from a robust 
exponential decay fit and were displayed as decay constants.  
 
Figure 2.24: Scheme of data evaluation. After binning of the fluorescence trace in 15s time 
windows, the number of peaks in each bin above a 0.9 quantile (= cut-off) is determined. Results are 
displayed either as number of peaks (bursts) per bin for Arf1 and for coatomer, or as the intensity ratio 
in these peaks (IntArf1/Intcoatomer). Half-times were calculated from robust exponential decay fits. 
 
2.6.2 GTP hydrolysis induced by ArfGAP1 
COPI vesicles were prepared from rat liver Golgi membranes in the presence of Arf1-
Alexa647, coatomer-ATTO488 and GTP, and stored at -80°C until shortly before the 
measurement. The vesicles were then imaged in a LSM 710 microscope equipped with a 
confocor 3 and 488nm and 633 nm laser lines. As shown in Figure 2.25 (upper panels) only 
a very slight change in fluorescence intensity was observed when the vesicles were imaged 
in the absence of ArfGAPs. This minor effect might be due to the internal GAP activity of the 
Golgi membranes as it was not the case in the vesicle sample generated with the non-
hydrolysable GTP analogue, GMP-PNP (Figure 2.25, lower panels). After addition of full-
length ArfGAP1, the fluorescence signal for both Arf1 and coatomer was reduced (Figure 
2.25, left panels). This resulted in a decrease of the number of peaks (bursts) per time 
interval for Arf1 and for coatomer (Figure 2.26 middle panels) as well as in a decrease in the 
intensity ratio on the vesicles of Arf1 to coatomer (Figure 2.26 right panels). In incubations of 
COPI vesicles with 10nM ArfGAP1, Arf1 was fully released from the membrane after 150s, 
whereas coatomer was almost completely dissociated only after 250s. The faster release of 
Arf1 in comparison to coatomer might be explained by interactions, which coatomer 
undergoes in additional to those with Arf1 that keep coatomer membrane-associated. With 
increasing ArfGAP1 concentration, the rate of coat release increased accordingly (Figure 
2.27). This data taken together shows that full length ArfGAP1 mediated GTP-hydrolysis in 
Arf1 is sufficient for complete COPI vesicle uncoating. 
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Figure 2.25: Release of the COPI coat: control experiments. Golgi-derived vesicles, coated with 
Arf1-Alexa647 and coatomer-ATTO488, prepared either with GTP or GMP-PNP, were imaged for 5 
minutes in the absence or presence of ArfGAP1. Left panels show the fluorescence trace and middle 
panels the number of bursts per time interval for Arf1 and coatomer. Right panels show the relative 
intensity of Arf1-Alexa647 and coatomer-ATTO488 in the bursts, which reflects the relative abundance 
of both proteins on the vesicles. 
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Figure 2.26: Release of the COPI coat by ArfGAP1. Golgi-derived vesicles, coated with Arf1-
Alexa647 and coatomer-ATTO488, were imaged for 5 minutes in the presence of 10nM or 25nM 
ArfGAP1. Left panels fluorescence traces, middle panels number of bursts per time interval for Arf1 
and coatomer and right panels relative intensity of Arf1-Alexa647 and coatomer-ATTO488 in the 
peaks. 
 
 
Figure 2.27: Release of the COPI coat by ArfGAP1: decay constants. Scatter plots of decay 
constants were calculated by fitting the curves for both the number of bursts for Arf1-Alexa647 and 
coatomer-ATTO488 (left and middle panel) and the relative intensity of Arf1-Alexa647 and coatomer-
ATTO488 in the bursts with a single-exponential decay model and displayed as scatter plots. (N≥ 4, 
mean ± SEM).   
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2.6.3 GTP hydrolysis induced by ArfGAP2 
Apart from ArfGAP1 also ArfGAP2 plays a role in COPI vesicle turnover. Recruitment to the 
membrane of ArfGAP1 and ArfGAP2 underlies different mechanisms. While ArfGAP1 
interacts with the C-terminal domain of coatomer subunit δ-COP (Rawet et al., 2010) and is 
recruited mainly by the interactions of its ALPS-motifs with curved membranes, ArfGAP2 
binds the appendage domain of γ-COP (Kliouchnikov et al., 2009; Watson et al., 2004) and is 
exclusively recruited by a direct interaction with coatomer. To investigate if ArfGAP2 
mediated GTP-hydrolysis in Arf1 likewise leads to COPI coat disassembly, essentially the 
same experiments as described above were performed in the presence of ArfGAP2 full 
length (Figure 2.28). In our in vitro set up, we observed very similar uncoating kinetics for 
both ArfGAP1 and ArfGAP2 (compare Figure 2.27 and Figure 2.29).  
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Figure 2.28: Release of the COPI coat mediated by ArfGAP2. Golgi-derived vesicles, coated with 
Arf1-Alexa647 and coatomer-ATTO488, were imaged for 5 minutes in the presence of ArfGAP2. Left 
panels fluorescence traces, middle panels number of bursts per time interval for Arf1 and coatomer 
and right panels relative intensity of Arf1-Alexa647 and coatomer-ATTO488 in the peaks. 
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Figure 2.29: Release of the COPI coat by ArfGAP2: decay constants. Scatter plots of decay 
constants were calculated by fitting the curves for both the number of bursts (left and middle panel) 
and the relative intensity of Arf1-Alexa647 and coatomer-ATTO488 in the bursts with a single-
exponential decay model and displayed as scatter plots. (N≥ 4, mean ± SEM).   
 
 
2.6.4 GTP hydrolysis induced by the catalytic domain of ArfGAP1 
To address contributions of individual domains of ArfGAP1 to coat disassembly, we 
investigated the activity of its recombinant catalytic domain (amino acid 1 to 137). As this 
constructs lacks the ALPS motifs, required for membrane recruitment, a twenty five- to 
hundred-fold higher protein concentration, compared to the full-length protein, was analysed. 
As shown in Figure 2.30, GTP hydrolysis within Arf1 induced by the catalytic domain of 
ArfGAP1 was sufficient to fully release Arf1 but not coatomer from the membrane. Coatomer 
remained mostly bound to the vesicles (Figure 2.30, lower middle panel), indicating a role of 
the non-catalytic domain in coat disassembly. Consistently, the intensity ratio of Arf1 to 
coatomer on the vesicles was reduced over time (Figure 2.29, right panel). The decay 
constant of Arf1 release depends on the concentration of the catalytic domain added to the 
reaction (Figure 2.31) whereas the decay constant of coatomer, even at the highest 
concentration of the catalytic domain analyzed, remains comparable to the one in the 
absence of ArfGAP (Figure 2.31, middle panel). Furthermore, the catalytic domain-induced 
dissociation of Arf1 but not of coatomer is evident when the curves obtained for the ratio of 
the intensities of the two proteins on the vesicles are fitted and the corresponding decay 
constants are calculated (Figure 2.31, right panel). 
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Figure 2.30: Release of COPI coat components triggered by the catalytic domain of ArfGAP1. 
Golgi-derived vesicles, coated with Arf1-Alexa647 and coatomer-ATTO488, were imaged for 5 
minutes in the presence of ArfGAP1 catalytic domain. Left panels fluorescence traces, middle panels 
number of bursts per time interval for Arf1 and coatomer and right panels relative intensity of Arf1-
Alexa647 and coatomer-ATTO488. 
 
 
  
	 RESULTS	 		 	
62 
 
Figure 2.31: Release of COPI coat components triggered by the catalytic domain of ArfGAP1: 
decay constants. Scatter plots of decay constants were calculated by fitting the curves for both the 
number of bursts (left and middle panel) and the relative intensity of Arf1-Alexa647 and coatomer-
ATTO488 in the bursts with a single-exponential decay model and displayed as scatter plots. (N≥ 4, 
mean ± SEM). 
 
 
To further explore the requirement for the non-catalytic part of ArfGAP1 for uncoating, we 
performed rescue experiments. In a first step COPI vesicles were incubated with the catalytic 
domain of ArfGAP1 alone. Consistent with the previous experiments, Arf1 was released from 
the membrane while coatomer remained bound (Figure 2.32, middle panels). In a second 
step, either full length ArfGAP1 (Figure 2.32A, right panel) or full length ArfGAP2 was added 
(Figure 2.33A, right panel), or the non-catalytic part of ArfGAP1 or ArfGAP2 (Figure 2.32B 
and Figure 2.33B, right panels) was added. After 150s, coatomer was to a large extent still 
associated with the membrane. These results show that coat disassembly requires GTP 
hydrolysis to occur concomitant with a direct interaction of ArfGAP1 with coatomer. 
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Figure 2.32: Sequential incubation of COPI coated vesicles with ArfGAP1 catalytic domain and 
non-catalytic domain or full length ArfGAP1. COPI vesicles were generated in vitro with Arf1-
Alexa647 and coatomer-ATTO488 and analysed for a total time of 450s: 0-150s without ArfGAP, 150-
300s after the addition of 500nM catalytic domain, 300-450s after the addition of A) 50nM full length 
ArfGAP1 or B) 500nM non-catalytic domain of ArfGAP1 (aa 137-337). The handling time for addition of 
the second and third component was less than 10s.   
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Figure 2.33: Sequential incubation of COPI coated vesicles with ArfGAP2 catalytic domain and 
non-catalytic domain or full length ArfGAP2. COPI vesicles were generated in vitro with Arf1-
Alexa647 and coatomer-ATTO488 and analysed for a total time of 350s: 0-50s without ArfGAP2, 50-
200s after the addition of A) 500nM and B) 250nM catalytic domain, 200-350s after the addition of A) 
50nM full length ArfGAP2 or B) non-catalytic domain of ArfGAP2 (aa 204-362). Handling time for 
addition of the second and third component was less than 10s each. 
 
 
In order to investigate if the overall loss in fluorescence is due to the presence of ArfGAP 
only, we determined the mean fluorescence intensity in each bin. A slight decrease in the 
signal, independent of ArfGAP activity, can be detected over time (Figure 2.34). However, a 
normalization of the curves and a direct comparison between the number of peaks (=bursts) 
for Arf1 and coatomer and the mean intensity shows that the decay is mainly due to ArfGAP 
activity.  
Altogether, this data show that hydrolysis of GTP, mediated by full length ArfGAP1 or 
ArfGAP2, is sufficient to dissociate the coat components, Arf1 and coatomer, from COPI 
vesicles, with Arf1 being released faster than coatomer.  
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Figure 2.34: Quantification of mean fluorescence intensities. Vesicles were formed in the 
presence of GTP and traces of the measured intensities were split into 20 bins. The mean intensity for 
each bin was calculated and normalized. Mean intensity values for Arf1-Alexa647 and coatomer-
ATTO488 are plotted against time (black triangles) and directly compared to the normalized number of 
bursts per time interval for Arf1 and coatomer (purple circles: Arf1, green circles: coatomer). A) in the 
absencence of ArfGAP and B) in the presence of 100nM ArfGAP1. 
 
 
2.6.5 Assessing the metastability of the COPI coat after incubation with the catalytic 
domain of ArfGAP1 
To obtain further insight into the mechanism of coat disassembly, the coat components of 
COPI vesicles that remain membrane bound after incubation with ArfGAP1 catalytic domain 
were characterized by chemical cross-linking. As the addition of ArfGAP1 catalytic domain to 
coated COPI vesicles led to Arf1 release, whereas coatomer remains membrane associated, 
we assumed that this remaining Arf1-free coat is metastable. Indeed, it was not stable 
enough to survive on the vesicle membranes during attempts to purify membranes and 
membrane-bound material by density gradient and differential centrifugation. In order to 
stabilize the coat on the membrane for the time necessary for isolation, a NHS-ester reactive, 
bifunctional cross linker (DTTSP), was applied to COPI vesicles. For this purpose, isolated 
coated COPI vesicles were initially treated with two sequential additions of various 
concentrations of DTTSP, twice 15min on ice. The cross-linked vesicles were adjusted to 40 
% Opti-prep and overlaid with 30 % and 20 % Opti-prep. The membrane-bound material was 
then separated from the free proteins via an overnight centrifugation (for details see 
Materials and Methods). Prior to SDS-PAGE and western blot analysis, the cross linker was 
cleaved with ß-mercaptoethanol. As shown in Figure 2.35, 0.25mM DTTSP proved to be the 
optimal concentration for further experiments.  
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Figure 2.35: Titration of DTTSP crosslinker for stabilization of the COPI coat. Coated COPI 
vesicles, formed in the presence of GTP or GMP-PNP, were incubated with increasing concentrations 
of NHS-reactive DTTSP cross linker. The membrane bound material was then isolated via an Opti-
prep gradient and analysed with SDS-PAGE and western blotting.  
 
 
Once the necessary amount of the cross-linker was determined, isolated coated COPI 
vesicles were incubated for 5 min either with full length ArfGAP1 or ArfGAP1 catalytic 
domain and subjected to two two sequential incubations with 0.25mM DTTSP cross linker on 
ice.  Membrane-bound material was then isolated on an OptiPrep gradient. As depicted in 
Figure 2.36, Arf1 and coatomer were found on the vesicular membrane only in the absence 
of both ArfGAP1 catalytic domain and ArfGAP1 full length. Thereby, the cross-linking 
reaction was not suitable to stabilize the metastable coatomer lattice after the release of Arf1. 
 
 
Figure 2.36: Cross linking of COPI vesicles with DTTSP. Coated COPI vesicles, formed in the 
presence of GTP or GMP-PNP, were incubated either with full length ArfGAP1 or ArfGAP1 catalytic 
domain. Membrane associated coat components were subsequently cross linked with 0.25mM NHS-
reactive DTTSP. The membrane bound material was then isolated via an Opti-prep gradient and 
analysed with SDS-PAGE and western blotting.  
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In order to analyze the metastability of the coat in a system, which does not involve time 
consuming purification steps, we performed the single molecule assay described above with 
vesicles generated with a donor membrane labeled with Alexa647 and coatomer labeled with 
ATTO488. Thereby the signal of the vesicle itself (followed by the labeled membrane) should 
hardly be affected even if coat disassembly takes place, while coatomer release should be 
reflected by changes in both the number of peaks and the ratio of the intensity of the 
membrane to the intensity of Arf1. As shown in Figure 2.37A, in the absence of ArfGAP1 no 
coat disassembly took place. Addition of 50nM ArfGAP1 full length led to the disassembly of 
coatomer (Figure 2.37B) as observed for the vesicles with labelled Arf1 and labelled 
coatomer. Thus, labelling of the membrane did not compromise the functionality of the 
vesicles, at least with respect to coat disassembly. After incubation with the catalytic domain 
of ArfGAP1, both number of peaks and the ratio of the intensity of the membrane to the 
intensity of Arf1 remained to a large extent unchanged (Figure 2.37C). Thus, although the 
coatomer lattice is less stable in the absence of Arf1, coatomer still remains largely 
membrane-bound within the measured time window.  
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Figure 2.37: Burst analysis of vesicles generated with membrane-Alexa647 and coatomer-
ATTO488. Golgi-derived vesicles, coated with Arf1 and coatomer-ATTO488, were imaged for 10 
minutes (A) in the absence or in the presence of either (B) 50nM ArfGAP or (C) 2.5µM ArfGAP1 
catalytic domain. Left panels fluorescence traces, middle panels number of bursts per time interval for 
membrane  and coatomer and right panels relative intensity of Arf1-Alexa647 and coatomer-ATTO488 
in the peaks. N=2. 
 
 
In conclusion, the hydrolysis of GTP in Arf1 is a prerequisite for release not only of Arf1 but 
also of coatomer by full length ArfGAP1 or ArfGAP2. However, for dissociation of both 
components of the COPI coat, not only the catalytic and but also the non-catalytic domains of 
ArfGAP are to be present within the same molecule at the time of GTP-hydrolysis. Thus, we 
propose that GTP hydrolysis in Arf1 provides energy, which is transmitted to the coat by the 
non-catalytic domain of ArfGAP to release coatomer from vesicular membranes. 
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3 Discussion 
3.1 Differential interactions of ArfGAP1/2/3 with coatomer isoforms 
One of the goals of this thesis was characterizing the interaction between the coatomer 
isoforms and the ArfGAPs involved in COPI vesicle biogenesis in mammalians. Four different 
isoforms of the coat complex coatomer have been described in the literature: γ1ζ1, γ1ζ2, γ2ζ1, 
and γ2ζ2 (Futatsumori et al., 2000; Wegmann et al., 2004). Up to date no differences between 
the roles of the different coatomer isoforms were described in the literature. An 
immunoelectron microscopy study showed that the coatomer isoforms differ in their 
localisation within the Golgi apparatus: whereas γ1- and ζ2-COP are mainly located at the 
early Golgi and pre-Golgi compartment, the γ2-COP isoform is found predominantly at the 
trans side of the organelle (Moelleken et al., 2007). In this study, it was probed if coatomer 
isoforms display preferences for a particular ArfGAP protein. Three ArfGAPs have been 
described to interact with the coat complex coatomer (Frigerio et al., 2007; Goldberg, 1999; 
Lee et al., 2005). Very early in evolution the family splits in two subfamilies: the ArfGAP1 and 
ArfGAP2 subfamily. In S. cerevisiae, Gcs1p is the ArfGAP1 homolog and Glo3p is the 
ArfGAP2/3 homologue (Poon et al., 1999). No difference in function could be attributed to 
ArfGAP2 and ArfGAP3 so far. The three ArfGAPs localize differently within the Golgi 
apparatus as found in immunogold labelling electron microscopy study (Weimer et al., 2008). 
ArfGAP1 was found equally distributed over the Golgi apparatus whereas both ArfGAP2 and 
ArfGAP3 localize predominantly at the cis-Golgi. Based on this localization of the coatomer 
isoforms, we hypothesized that ArfGAP2 and ArfGAP3 might display higher affinity for the γ1-
COP isoforms.  
To quantitatively analyse the interactions between ArfGAPs and coatomer isoforms, we have 
adapted a previously described microtiter plate ligand-binding assay (Bethune et al., 2006). 
For this purpose, coatomer was immobilized on a polystyrene surface directly and 
subsequently incubated with ArfGAPs. We observed not only a preference of ArfGAP2/3 for 
γ1ζ1 and γ1ζ2 over γ2ζ1, and γ2ζ2 but also of ArfGAP1. Furthermore, ArfGAP1 displayed the 
highest affinity for all four coatomer isoforms followed by ArfGAP2. ArfGAP3 showed the 
weakest interaction with a statistically significant difference in the affinity for γ1ζ1 and γ2ζ1. As 
none of the three ArfGAPs localizes preferentially to the trans-Golgi apparatus (Weimer et 
al., 2008) and consequently none displayed a preference for the trans-Golgi localizing γ2ζ1, 
and γ2ζ2, one could speculate that an as yet not identified ArfGAP specifically interacts with 
γ2ζ1 and γ2ζ2 and localize to the trans-Golgi apparatus. 
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3.2 Effect of coatomer conformation on ArfGAP affinity 
Another aspect studied in the course of this work focused on the mode of recruitment of 
ArfGAP1, 2 and 3 from the cytosol to Golgi membranes, and potentially differential roles of 
the three ArfGAPs in COPI biogenesis. ArfGAP1 and ArfGAP2/3 are recruited by different 
mechanisms to Golgi membrane. Whereas ArfGAP1 binds highly curved membranes via two 
amphipathic lipid packing sensor (ALPS) motifs (Bigay et al., 2003), ArfGAP2 and ArfGAP3 
are recruited to Golgi membranes by a direct interaction with coatomer (Weimer et al., 2008). 
While it was clearly shown that ArfGAP2 and 3 depend on coatomer for their association with 
the Golgi membrane (Weimer et al., 2008), the spatial and temporal regulation of this 
process is yet unknown. One possibility is that ArfGAP2 and 3 bind to soluble coatomer 
already in the cytosol and are recruited as a complex with the heptameric complex to the 
Golgi membrane. Another possibility is that ArfGAP2 and 3 are recruited only once coatomer 
has polymerized on the donor membrane and the binding site for ArfGAP2/3 within coatomer 
is formed. 
Based on the same experimental set of data, two opposing models about the roles of 
ArfGAP1, ArfGAP2 and ArfGAP3 in COPI vesicle biogenesis were forwarded.  
According to the first model, ArfGAP1, which binds directly to curved membranes, and thus 
does not require the presence of coatomer on the Golgi membrane for its recruitment, was 
proposed to be involved in cargo sorting (Popoff et al., 2011a). As vesicle biogenesis is 
initiated at the rims of Golgi membranes, sites that feature high curvature, ArfGAP1 can be 
recruited and stimulate GTP hydrolysis within Arf1 when low amounts of cargo are available. 
Thereby, ArfGAP1 will ensure the efficiency of COPI vesicle transport by preventing budding 
of empty transport vesicles. ArfGAP2 and ArfGAP3, which are dependent on their interaction 
with coatomer for membrane recruitment, bind only to fully formed COPI vesicles featuring a 
polymerized coat and rather are involved in vesicle uncoating.  
According to the second model, ArfGAP1 functions as the uncoating ArfGAP while ArfGAP2 
and ArfGAP3 are involved in cargo sorting (Antonny, 2011). Due to its curvature sensitivity, 
ArfGAP1 is recruited to the loosely packed lipids of the highly curved COPI vesicles. 
ArfGAP2 and ArfGAP3 are recruited by their interaction with coatomer to sites of COPI 
vesicle formation and stimulate GTP hydrolysis in Arf1 thus leading to the disassembly of 
both Arf1 and coatomer from the Golgi membrane in the absence of cargo.  
Assuming that a particular ArfGAP is involved in COPI coat disassembly rather than cargo 
sorting, this ArfGAP should display a higher affinity for polymerized coatomer than for soluble 
coatomer. In order to address this mechanistic question, we utilized both an ELISA-like 
binding assays as well as a conventional pull down assay. For the ELISA-like binding assay, 
coatomer was immobilized on a polystyrene surface either directly or via CM1A10, a 
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structure-specific monoclonal antibody against the heptameric coat complex coatomer. A 
conformational change was induced in the complex by the addition of a dimeric peptide 
mimicking the cytoplasmic tails of p23. The conformation obtained after binding to this 
peptide was previously shown to be similar to the one coatomer assumes when polymerized 
on COPI vesicles (Reinhard et al., 1999).  
In the set-up based on a direct immobilization of coatomer, the kD values for the interaction 
between ArfGAP and coatomer were determined to be in the low micromolar range. Here, no 
clear difference was detected between samples containing either p23 dimerized peptide, or 
the control peptide Wbp1, or no peptide. As the p23 induced conformational change in 
coatomer described in the literature was performed either in solution (Reinhard et al., 1999) 
or after coatomer immobilization via the antibody CM1A10 on a surface (Langer et al., 2008), 
it is possible that the reaction does not take place as efficiently when coatomer is directly 
immobilized on a polystyrene surface. To circumvent this drawback, existing ArfGAP baculo 
virus transfer vectors were recloned in order to introduce an S-tag upstream of the ArfGAP 
ORFs. With the modified constructs, we were able to perform a direct detection of ArfGAPs 
bound to coatomer with a S-protein-horseradish peroxidase (HRP) conjugate instead of 
detection via a secondary antibody coupled to HRP. Here, significantly higher kD values were 
determined for the interaction between all three ArfGAPs and the coatomer isoform γ1ζ1, 
which displays the highest abundance in cells and was thus used as a representative of all 
four coatomer isoforms. As the kD values of S-tagged ArfGAPs for directly immobilized 
coatomer were comparable to the ones determined for His-tagged ArfGAPs, this effect is 
unlikely to be due to the S-tagged influencing the affinity of ArfGAPs for coatomer. Thus, 
presumably either the CM1A10 antibody masked the ArfGAP binding sites in coatomer or the 
concentration of immobilized coatomer in the set-ups involving CM1A10 antibody was lower 
than in the set-up relying on direct immobilization. Accordingly, this experimental design 
proved not to be suitable to address the question of interest. 
Alternatively, we used a conventional pull down approach to measure interactions between 
the different ArfGAPs and coatomer, depending on the conformation of the coat protein. 
Here, we used two independent experimental set-ups. First, One-STrEP-tag coatomer was 
immobilized on streptactin beads and coatomer polymerization was triggered by the addition 
of dimeric p23 peptides. As a negative control, coatomer was incubated with the ER resident 
protein Wbp1. To avoid potential reversibility of the conformational change, we performed the 
incubation with the different ArfGAPs also in the presence or absence of the p23 peptide. In 
both cases, we were not able to detect any alteration in the affinity of ArfGAPs for coatomer. 
A possible drawback of this set-up could be that coatomer cannot be efficiently polymerized 
after binding to the beads. It was previously observed that the conformational change 
involves at least α-COP and γ-COP (Langer et al., 2008), and the One-STrEP-tag is located 
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on the C-terminus of α-COP subunit potentially preventing the conformational change. In a 
second setup, we tried to circumvent this limitation by first inducing the conformational 
change in coatomer in solution and then immobilizing the protein via its One-STrEP-tag on 
the streptactin beads. In the negative control sample, coatomer was treated with Wbp1. 
Here, we again either washed or did not wash away the peptide prior to the incubation with 
ArfGAP. In this system we unexpectedly observed a higher affinity of ArfGAP2 for soluble 
coatomer. This effect was visible only when the entire experiment was performed in the 
presence of the peptides pointing either to a reversible conformational change in coatomer or 
to a direct effect of the p23 cytoplasmic tail on ArfGAP2. Still, it cannot be excluded that the 
polymerization in solution and the subsequent immobilization on the streptactin beads 
compromises coatomer functionality and thereby its affinity for ArfGAP2.  
One further possibility, which might allow determining the affinity of ArfGAP1 and ArfGAP2 
for coatomer depending on its conformation, is establishing a float up assay where coatomer 
is recruited to the liposomal membrane either directly via its tag or via an interaction with 
Arf1. Coatomer recruited via the tag mimics the soluble form as found in the cytosol while 
coatomer recruited via an interaction with Arf1 and the cytoplasmic tail of p23 resembles 
polymerized coatomer as found on a fully formed COPI vesicle. Upon coatomer recruitment 
and subsequent ArfGAP incubation, the membrane-associated fraction can be isolated on a 
density gradient and the amount of bound ArfGAP can be assessed via SDS-PAGE and 
wetsren blot analysis. 
 
3.3 Effect of p23 on the activity of ArfGAP1 and ArfGAP2 
Another goal of this work was to analyse the effect of type I transmembrane proteins of the 
p24 family on the activity of ArfGAP1 and ArfGAP2 (as a representative of both ArfGAP2 and 
ArfGAP2). The literature points to an effect of p24 family proteins on the activity of ArfGAP1. 
It was reported that p23 and p24 inhibit ArfGAP1 mediated GTP hydrolysis in Arf1 (Lanoix et 
al., 2001).  
In order to investigate if the cytoplasmic tail of p23 acts directly on the Arf1 
activation/deactivation cycle, we performed tryptophane fluorescence assays. Here, we 
compared an effect of the p23 lipopeptide on the rate of GTP hydrolysis in Arf1, stimulated 
by either ArfGAP1 or ArfGAP2. The rate of GTP hydrolysis was altered in the presence of the 
p23 lipopeptide. The activity of ArfGAP1 was slightly inhibited by p23, whereas the activity of 
ArfGAP2 was significantly higher in the presence of p23. Furthermore, we utilized a static 
light scattering assay to test if ArfGAP1- and ArfGAP2-triggered uncoating of COPI coated 
liposomes is affected as well. The uncoating activities of the two enzymes were affected in 
the same way as observed in the tryptophan fluorescence assay: ArfGAP1 mediated a 
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slower disassembly in the presence of the lipopeptide while ArfGAP2 mediated a faster 
disassembly.  
In order to challenge the results in a system not based on a fluorescence read-out, we 
utilized a float up assay with radioactively labeled GTP. For this purpose, Golgi-like 
liposomes were prepared either in the presence or absence of p23 lipopeptide. Upon 
recruitment of Arf1 and coatomer to the membrane in a 3H-GTP dependent manner, we 
analyzed the degree of GTP hydrolysis exhibited by ArfGAP1 and ArfGAP2. In agreement 
with the results from the fluorescence based kinetic measurements, we observed both a 
higher rate of GTP hydrolysis as well as a higher absolute amount of hydrolysed GTP by 
ArfGAP2 in the presence of the p23 lipopeptide. ArfGAP1 displayed an opposite effect: a 
higher rate of GTP hydrolysis and a higher total amount of hydrolyzed GTP in the absence of 
p23 lipopeptide. 
It is important to note here that the two ArfGAPs interact with distinct subunits of coatomer 
(Kliouchnikov et al., 2009; Watson et al., 2004) and that these coatomer subunits contribute 
to COPI coat assembly in a different manner, as can be deduced from the structure of the 
COPI coat on a membrane (Dodonova et al., 2015; Faini et al., 2012) (for more details see 
3.6). Furthermore, it could be speculated that the binding site for the respective ArfGAP is 
build only after polymerization of the coat lattice. It was reported earlier that p23 leads to a 
conformational change in coatomer (Langer et al., 2007; Reinhard et al., 1999) and that this 
conformation is likely to resemble the heptameric complex in the polymerized COPI coat on a 
transport vesicle (Reinhard et al., 1999). Thus, the higher activity of ArfGAP2 in the presence 
of p23 might result from a higher affinity of ArfGAP2 for polymerized coatomer as found on a 
transport vesicle, which in turn speaks for a role of ArfGAP2 in coat disassembly rather than 
in cargo sorting. 
 
3.4 Effect of ArfGAP1 and ArfGAP2 on the yield of COPI vesicle formation 
Another aspect analyzed in this study is the function of the ArfGAPs in coat assembly and 
disassembly. The role of the ArfGAPs in COPI vesicle biogenesis remains controversial. 
Earlier studies have proposed a mechanism, by which the ArfGAPs catalytically act on Arf1 
and thereby induce GTP hydrolysis that is prerequisite for vesicle coat release (Tanigawa et 
al., 1993). Whereas originally, Arf1 was identified as a subunit of the COPI coat (Serafini et 
al., 1991a,), opposing reports suggest a model where, in analogy to the COPII system, 
ArfGAP1 is directly involved in coat formation. It was proposed that upon GTP hydrolysis 
(prerequisite for Arf1 release and COPI vesicle formation), ArfGAP1 together with coatomer 
remains associated with membranes to from the polymerized COPI coat (Yang et al., 2002). 
The amount of ArfGAP found on the vesicles was stoichiometric to the one of coatomer 
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whereas the level of Arf1 was reduced (Yang et al., 2002). Under GTPγS conditions, 
ArfGAP1 failed to induce COPI release from Golgi membranes. Isolation of the vesicles 
formed with GTPγS showed reduced labelling for ArfGAP1 pointing rather to an impairment 
of the GAP recruitment than to a direct inhibition of the GAP activity (Yang et al., 2002). 
Furthermore, others found the yeast orthologous of ArfGAP2/3, Glo3p on COPI vesicles 
generated in vitro from isolated yeast Golgi membranes (Lewis et al., 2004). 
In order to address a potential role of ArfGAP1 and ArfGAP2 as stoichiometric coat 
components and to overcome the drawbacks of earlier studies using density gradients for the 
isolation of the vesicles (Beck et al., 2009), we established an assay based on semi-intact 
cells described both for COPII (Mancias and Goldberg, 2007) and COPI (Adolf and Wieland, 
2013) reconstitutions. The major shortcoming of the density gradients is their selectivity for 
coated vesicles (vesicles formed and subsequently uncoated will not be taken into account, 
because these “naked” vesicles have a density different to coated vesicles and therefore 
would migrate to lower density in such gradients), which does not allow to tell apart formed 
vesicles that have subsequently undergone uncoating, or no vesicle formation having taken 
place to begin with (Hsu, 2011).  
Isolation of COPI vesicles formed from semi-intact cells relies on a differential centrifugation 
where both coated and uncoated vesicles are assessed via the amount of cargo 
incorporated. In contrast to earlier studies pointing to a role of ArfGAP1 or ArfGAP2 as a coat 
component, we detected fewer COPI vesicles in the presence of ArfGAP1/2. This effect was 
more pronounced in the case of ArfGAP2. This difference could be explained by the use of 
semi-intact cells in our in vitro assay, which make accessible all the membranes in a cell and 
thus could enable ArfGAP1 to bind with its ALPS domains to sites additional to the ones at 
the cis-Golgi, as described previously, such that the actual concentration relevant for COPI 
sites would be reduced (Bai et al., 2011; Rawet et al., 2010; Zendeh-boodi et al., 2013). 
Thus, the physiological relevance of the potentially stronger effect of ArfGAP2 needs to be 
addressed in another system.  
Results obtained from the semi-intact cell system argue strongly against a role of both 
ArfGAP1 and ArfGAP2 as stoichiometric coat components. 
 
3.5 Role of ArfGAP1 and ArfGAP2 in COPI vesicle uncoating  
It was proposed previously that the ArfGAP1 induced hydrolysis in Arf1 triggers uncoating of 
Golgi-derived COPI vesicles (Tanigawa et al., 1993). This hypothesis was based on a series 
of different studies. In early experiments, incorporation of GTPγS was found to block 
transport and led to an accumulation of coated vesicles (Melancon et al., 1987). 
Furthermore, an Arf1 variant, Arf1Q71L-GTP, which in its myristoylated form is competent to 
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bind membranes and recruit coatomer, but in contrast to wild type fails to hydrolyse GTP 
(Tanigawa et al., 1993), could mimic this effect. Cells expressing Arf1Q71L-GTP were shown 
by EM to feature vesicles with distinct electron-dense coats, which accumulated as they 
probably failed to fuse with the target membrane (Tanigawa et al., 1993). A similar effect was 
observed in cells expressing a defect Dsl/SNARE complex (Zink et al., 2009).  
Here, we established an assay with single molecule sensitivity to study the process of COPI 
coat disassembly in real time. This system allows both analysing vesicles generated from 
endogenous membranes as well as following the kinetics of individual coat components. 
Purification of COPI vesicles from endogenous membranes has the advantage that all 
modes of interaction that keep coatomer on the membrane are present. Thus, we attempted 
to resolve the question if GTP hydrolysis induced by full length ArfGAP does not only trigger 
Arf1 disassembly but is also sufficient by itself to release all coat components from the 
vesicular membrane. Full length ArfGAP1 protein proved to be sufficient to trigger COPI coat 
disassembly. In our in vitro system Arf1 was released from the membrane faster than 
coatomer. This effect might be due to the various types of interactions that keep coatomer 
membrane-associated. On a membrane coatomer is not only bound to Arf1 but also to the 
cytoplasmic tails of cargo receptors and cargo proteins, and in addition undergoes coat-coat 
interactions. This data is in accordance with earlier studies performed in live cells. The 
dynamics of GFP-tagged Arf1 and coatomer membrane association and dissociation was 
studied by FRAP in living cells. The half time for the recovery of Arf1 was two times shorter 
than the one for coatomer implying that coatomer remains stabilized on the membrane after 
GTP hydrolysis and Arf1 dissociation (Presley et al., 2002). 
To test if it is the ArfGAP induced hydrolysis of GTP in Arf1 that is sufficient for COPI coat 
disassembly; we performed experiments with only the catalytic part of ArfGAP1. Here, Arf1 
was released from the membrane, whereas, surprisingly, coatomer remained to a large 
extent membrane-associated. Furthermore, incubating these resulting Arf1-free vesicles with 
full length ArfGAP1 did not lead to further COPI coat disassembly. These findings show a 
requirement for GTP hydrolysis concurring with a direct interaction between coatomer and 
ArfGAP1 for COPI coat release. 
 
3.6 Comparison of the uncoating activities of ArfGAP1 and ArfGAP2 
ArfGAP1 and ArfGAP2 display distinct mechanisms of recruitment to membranes. Whereas 
ArfGAP1 associates with the membrane by inserting its ALPS domains between loosely 
packed lipids on a curved membrane (Bigay et al., 2003), ArfGAP2 is recruited by a direct 
interaction with coatomer (Weimer et al., 2008). Furthermore, ArfGAP2/3 were isolated 
together with COPI vesicles formed in vitro while ArfGAP1 was mainly found associated with 
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donor Golgi membranes (Frigerio et al., 2007). In addition, overexpression of ArfGAP1 or 
ArfGAP2/3 leads to different phenotypes. Overexpression of ArfGAP1 causes coatomer 
dissociation from Golgi membranes as well as a relocalization of Golgi enzymes to the ER 
(Aoe et al., 1997). In contrast, overexpression of both ArfGAP2 and ArfGAP3 did not alter 
coatomer localization or Golgi structure (Kartberg et al., 2010). ArfGAP2/3 knockdown, on 
the other hand, leads to reduced Golgi-stacking and a decrease in the number of cisternae 
(Kartberg et al., 2010). 
To address the question if these differences also result in distinctive coat disassembly 
efficiencies, we compared the efficiency of the two enzymes in our real time coat 
disassembly assay. To this end, we observed similar kinetics with respect to coat 
disassembly. As under our test conditions the composition of the components is not adapted 
to their in vivo ratios, more refined and subtle approaches will have to be taken in order to 
address such differences.  
It is of note that the two ArfGAPs interact with coatomer at two different sites. ArfGAP1 binds 
δ-COP (Rawet et al., 2010), while ArfGAP2 interacts with γ-COP (Kliouchnikov et al., 2009; 
Watson et al., 2004). These two coatomer subunits contribute to COPI coat assembly in a 
different fashion, as can be delineated from the structure of the coat on a membrane 
(Dodonova et al., 2015; Faini et al., 2012). The COPI coat is built up of coatomer triads as 
minimal structural component (Faini et al., 2012). In a triad each of the three coatomer 
complexes binds to two Arf1 molecules: one Arf1 molecule interacts with the trunk domain of 
γ-COP and the other one simultaneously with β- and δ-COP. The C-termini of δ-COP are 
involved in inter-triad interactions whereas the γ-COP subunits play a role in assembly of the 
triad itself (Dodonova et al., 2015). These structural features suggest a hypothesis that 
ArfGAP1 and ArfGAP2 might act differentially and synergistically in order to release both 
types of interactions: hydrolysis of GTP in Arf1 bound to γ-COP would stimulate dissociation 
of triads from each other, whereas hydrolysis of GTP in Arf1 bound to β-and δ-COP would 
drive dissociation of triads to yield single coatomer complexes. As a result, coat dissociation 
would occur efficiently in spite of the fact that about 100 GTP molecules must be hydrolysed 
in two different structural environments within a single vesicle. Again based on the structure 
of the triads and their interactions, it is tempting to speculate that it is ArfGAP2 that 
stimulates GTP hydrolysis in the Arf1 molecules attached to γ-COP, whereas ArfGAP1 would 
stimulate GTP hydrolysis in β-δ-bound Arf1. To test this model in the future, a more subtle 
and technically simpler method will be needed to follow coat dissociation. Isolated COPI 
vesicles could be incubated with 1:1 mixtures of ArfGAP1 and ArfGAP2 and the kinetics of 
uncoating could be compared with the one of each enzyme alone when applied at the same 
concentration as the mixture. A very precise titration of the amount of ArfGAP added would 
be required as presumably once the ArfGAP concentration is high enough so many Arf1s in 
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one of the two chemical environments would be released, which in turn results in coatomer 
dissociation, that also the Arf1 molecules in the second chemical environment would become 
assessable for the ArfGAP. 
 
3.7 A model of COPI coat disassembly 
The precise mechanism of coat disassembly is not understood for any of the vesicular 
transport systems. The coat of endocytic vesicles consists of an inner scaffold, built of by the 
adaptor complex AP2, and an out layer comprising the clathrin triskelions (Fotin et al., 2004; 
Kirchhausen, 2000). Dissociation of the outer (clathrin) layer of an endocytic vesicle requires 
the heat-schock cognate protein-70 (Hsc 70) (Massol et al., 2006; Schlossman et al., 1984; 
Schmid et al., 1984; Ungewickell et al., 1995) The temporal regulation of the uncoating 
reaction is governed by the recruitment of auxillin, which in turn recruits Hsc70 (Massol et al., 
2006). Auxilin binds with its three J-domains positioned in the vicinity of each vertex of the 
coat and brings about a conformational change, which allows Hsc70, recruited via a direct 
interaction with the J-domain of auxilin, to reach its target sequence QLMLT. As Hsc70 binds 
to this sequence in a groove on its substrate-binding domain, ATP hydrolysis occurs. This 
leads to two simultaneous events: the J-domain is released and the substrate becomes 
tightly clamped in the groove. In such a way, Hsc70 stabilizes the distorted conformation. 
Once a critical concentration of auxilin/Hsc70 is reached, the coat becomes irrevocably 
destabilized and falls apart in a all-or-none fashion (Bocking et al., 2011). It is still remains to 
be elucidated how and when the inner AP2 coat is released from the vesicular membrane. 
GTP hydrolysis within the Arf1 analogue Sar1 is thought to contribute to the disassembly of 
the COPII coat (Antonny et al., 2001; Barlowe et al., 1994). COPII vesicles are incompetent 
to fuse with the target membrane when hydrolysis of GTP in Sar1 is blocked (Aridor et al., 
1995; Barlowe et al., 1994). The GAP protein that stimulates GTP hydrolysis in Sar1 is the 
COPII inner coat component Sec23 (Yoshihisa et al., 1993), whose catalytic activity is further 
enhanced by its interaction with the COPII outer shell Sec13/31 complex (Antonny et al., 
2001; Yoshihisa et al., 1993). 
Here, I described a real-time assay to follow the fate of the COPI coat of purified COPI 
vesicles upon addition of ArfGAPs. Using this assay, I discovered an essential role of the 
non-catalytic domains of ArfGAPs. While GTP-hydrolysis within Arf1 by the catalytic domain 
of the ArfGAP alone released the small GTPase from the coat, the network of coatomer 
triads remained on the vesicle. Only with the non-catalytic part of ArfGAPs present within the 
ArfGAP molecule, the coat network was disassembled. We propose that the energy released 
upon GTP-hydrolysis in Arf1 is coupled by GAP-coatomer interactions to mediate 
conformational changes in coatomer that are required for COPI coat disassembly. This 
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mechanism is reminiscent of the activity of nucleotide dependent chaperones, e.g. Hsc70 
and thus similar to the process of coat disassembly described for clathrin coated vesicles. In 
this model, ArfGTP together with the catalytic domain of ArfGAP would functionally resemble 
the ATP binding domain of Hsc70, and the non-catalytic domain of ArfGAP would resemble 
the substrate-binding domain of Hsc70. 
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4 Material and Methods 
4.1 Materials 
4.1.1 Chemicals and Equipment 
4.1.1.1 Chemicals	
Avanti Polar Lipids    Alabaster, USA 
Agilent Technologies    Böblingen, Germany 
Avantor     Center Vallley, USA 
BD      Franklin Lakes, USA 
Biochrom     Berlin, Germany 
Biomers     Ulm, Germany 
BioRad     Mϋnchen, Germany 
Boehringer     Mannheim, Germany 
Fermentas     Vilnius, Lithuania 
Fluka      Taufkirchen, Germany 
GE-Healthcare    Freiburg, Germany 
Greiner Bio-One    Frickenhausen, Germany 
Life Technologies/Invitrogen   Carlsbad, USA 
Macherey-Nagel    Düren, Germany 
Merck      Darmstadt, Germany 
Millipore     Schwalbach, Germany 
New England Biolabs   Frankfurt, Germany 
PeqLab     Erlangen, Germany 
Roche      Mannheim, Germany 
Roth      Karlsruhe, Germany 
Sarstedt     Nümbrecht, Germany 
Sartorius     Goettingen, Germany 
Serva      Heidelberg, Germany 
Sigma-Aldrich    Taufkirchen, Germany 
Source     BioScience Nottingham, UK 
Thermo Fischer Scientific   Rockford, USA 
Qiagen     Hilden, Germany 
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4.1.2 Materials for Biochemical Methods 
4.1.2.1 Primary	Antibodies	
Antigen Name Species Application Dilution Creator 
ArfGAP1 GAP1 rab2 rabbit WB 1:2500 Weimer et al.,  
2008 
ArfGAP2 GAP2 rab2 rabbit WB 1:5000 Weimer et al.,  
2008 
ArfGAP3 GAP3 rab2 rabbit WB 1:5000 Weimer et al.,  
2008 
Arf 1  
(C terminus) 
Arf-C1 
Emma 
rabbit WB 1:5000 Reinhard et al., 
2003 
α-COP 1409A rabbit WB 1:2000 Wieland lab 
α-COP alpha- 
COP1-10 
rab3 
rabbit WB 1:500 Britta Brügger 
β-COP 899 rabbit WB 1:5000 Harter et al.,  
1993 
δ-COP 877 rabbit WB 1:5000 Faulstich et al., 
1996 
γ-COP 1/2 gamma-R rabbit WB 1:10000 Pavel et al.,  
1993 
p23 Henriette rabbit WB 1:10000 Jenne et al.,  
2002 
p24 Elfriede rabbit WB 1:5000 Gommel et al., 
1999 
p27 2087 rabbit WB 1:1000 Jenne et al.,  
2002 
ERGIC53 C6 mouse WB 1:200 Santa Cruz 
Mannosidase 
II 
Rab1 rabbit WB 1:1000 Wieland lab 
Tab. 4.1: Primary Antibodies. 
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4.1.2.2 Secondary	Antibodies	
Fluorophore-conjugated secondary antibodies were used for detection in the LI-COR 
Odyssey System (LI-COR BioSciences, Lincol, USA). 
 
Antigen Name Species Application Dilution Manufacturer 
anti-rabbit Alexa680 goat WB 1:10000 Invitrogen 
anti-rabbit Alexa800 goat WB 1:10000 Invitrogen 
anti-mouse Alexa680 goat WB 1:10000 Invitrogen 
anti-mouse Alexa800 goat WB 1:10000 Invitrogen 
Tab. 4.2: Secondary Antibodies. 
 
 
4.1.2.3 Lipids	
All of the following lipids were purchased from Avanti Polar Lipids (Alabaster, USA) 
and were stored as chloroform solutions under argon at -20 °C. 
Tab. 4.3: Lipids used for the preparation of the Golgi-like mix. 
 
 
 
Phospholipids Species Molecular Weight Order number 
PC Liver, Bovine 786.113 840055 
PE Liver, Bovine 768.005 840026 
PS Brain, Porcine 812.041 840032 
PI Liver, Bovine 909.110 840042 
Liss Rhod PE (18:1)  1301.715 810150 
Sphingolipids    
SM (18:0) Brain, Porcine 731.081  860062 
Sterols    
Cholesterol Wool, Ovine 386.654 700000 
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4.1.2.4 Protein	Standard	for	SDS-PAGE	
The Precision Plus Protein Standard All Blue was purchased from BioRad, Munich. 
The molecular weight size range is between 2 and 250 kDa and consists of highly 
purified recombinant proteins of the sizes 250, 150, 100, 75, 50, 37, 25, 20, 15 and 
10 kDa.  
 
4.1.2.5 Protein	Standard	for	Size	Exclusion	Chromatography	(SEC)	
The SEC protein standard was purchased from BioRad, Munich. It contains 
thyreoglobulin (670 kDa), bovine gamma-globulin (158 kDa), chicken ovalbumin (44 
kDa), equine myoglobulin (17 kDa), and vitamin B12 (1.35 kDa). 
 
4.1.2.6 Chromatography	Columns	
The chromatography columns were purchased from GE Healthcare (Munich, 
Germany). Ni Sepharose 6 Fast flow (GE Healthcare, Munich, Germany) was used 
for affinity purification of His-tagged proteins. One-STrEP-tag proteins were purified 
via Strep-Tactin Sepharose (iba, Goettingen, Germany). Size exclusion 
chromatography was performed on Superdex75, Superdex200 and Superose6 
columns of various sizes (GE Healthcare, Munich, Germany).  
 
4.1.2.7 Nucleotides	
All nucleotide stock solutions were prepared in 25 mM HEPES pH 7.4 (KOH) in a 
concentration of 25 mM and stored at -20 °C. 
 
Name Abbreviation Purity Manufacturer 
Guanosine 5′-triphosphate GTP 99 % Sigma-Aldrich 
Guanosine 5′-diphosphate GDP ≥ 85 % Sigma-Aldrich 
Guanosine 5′-[γ-thio]-triphosphate GTPγS ≥ 75 % Sigma-Aldrich 
Guanosine  
5′-[β,γ-imido]-triphosphate 
GMP-PNP ≥ 85 % Sigma-Aldrich 
Adenosine 5′-triphosphate ATP > 98  % Roche 
Tab. 4.4: Nucleotides. 
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4.1.2.8 ATP	Regenerating	System	
The ATP regeneration system was prepared according to  (Beckers et al., 1987) in 
assay buffer and utilized for the preparation of COPI vesicles in vitro.  
 
10 mM ATP (Roche) 
400 mM Sodium creatine phosphate (Sigma-Aldrich) 
2000 µg/ml Creatine phosphokinase (Roche) 
 
4.1.2.9 Protease	Inhibitors	
Complete Protease Inhibitor Cocktail Mix from Roche (Mannheim, Germany) was 
used for the purification of recombinant proteins. 
 
4.1.3 Materials for Molecular Biology and Cell Culture Methods  
4.1.3.1 Prokaryotic	Strains	
 
Strain Species Application Manufacturer 
DH5α E.coli subcloning Invitrogen 
Nova Blue E.coli subcloning Novagen 
BL21 star E.coli protein 
expression 
Invitrogen 
BL21 pLysS E.coli protein 
expression 
Invitrogen 
DH10MultiBac E.coli Bacmic 
production 
I. Berger 
(Zürich) 
Tab. 4.5: Prokaryotic Strains. 
 
 
4.1.3.2 Eukaryotic	strains	
 
Strain Species Application Manufacturer 
HeLa human Semi-intact cells ACC57 (DSMZ) 
Sf9 Spodoptera 
frugiperda 
Protein 
expression 
Invitrogen 
Tab. 4.6: Eukaryotic Strains. 
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4.1.3.3 Restriction	Enzymes	
All restriction enzymes were purchased from New England Biolabs (Frankfurt, 
Germany). T4 DNA ligase was purchased from Fermentas (Vilnius, Lithuania), Pfu 
turbo DNA polymerase from Agilent Technologies (Boeblingen, Germany), alkaline 
phosphatase from Roche (Mannheim, Germany). 
 
4.1.3.4 Plasmids	
Plasmid Plasmids Insert Creator 
pFB-rAG1#1 pFastBac HT B Rat ArfGAP1 C. Weimer 
pFB-rAG2#1 pFastBac HT B Rat ArfGAP2 C. Weimer 
pFB-rAG3#2 pFastBac HT B Rat ArfGAP3 C. Weimer 
pFB HT B ArfGAP1 
S-tag 
pFastBac HT B S-tag This thesis 
pFB HT B ArfGAP2 
S-tag 
pFastBac HT B S-tag This thesis 
pFB HT B ArfGAP3 
S-tag 
pFastBac HT B S-tag This thesis 
pFBHTb 1-137 
ArfGAP1 
pFastBac HT B 1-137 ArfGAP1 This thesis 
Tab. 4.7: Plasmids. 
 
 
4.1.3.5 Oligonucleotide	and	PCR	Primers	
Primer Sequenz Manufacturer 
S-tag Sfo GCCAAAGAAACCGCTGCTGCTAAATTCGAACGCC
AGCACATGGACAGCG 
Biomers 
S-tag 
BamHI 
GATCCGCTGTCCATGTGCTGGCGTTCGAATTTAG
CAGCAGCGGTTTCTTTGGC 
Biomers 
Tab. 4.8: Oligonucleotides. 
 
 
 
 
 
  
	 MATERIALS	AND	METHODS	 		 	
85 
Primer Sequenz Manufacturer 
1-137 ArfGAP1 
BamHI 
GGAGGAGGATCCATGGCCAGC Biomers 
1-137 ArfGAP1 
XhoI 
GAAGAACTCGAGCTAAGGTGGGGTCCAGTT Biomers 
Tab. 4.9: PCR Primers. 
 
 
4.1.3.6 Media	for	Prokaryotic	Cell	Culture	
Medium Ingredients Concentration  Manufacturer 
LB Bacto-Trypton 
Bacto Yeast Extract 
Sodium chlorid 
10 g/L 
5 g/L 
5 or 10 g/L 
BD 
BD 
Roth 
LB-Agar Bacto-Trypton 
Bacto Yeast Extract 
Sodium chlorid 
Agar 
10 g/L 
5 g/L 
5 or 10 g/L 
15 g/L 
BD 
BD 
Roth 
Roth 
SOC Bacto-Trypton 
Bacto Yeast Extract 
Sodium chlorid 
Potassium chlorid 
Magnesium chlorid 
Glucose 
20 g/L 
5 g/L 
0.59 g/L 
0.19 g/L 
10 mM 
20 mM 
BD 
BD 
Carl Roth 
Avantor 
Carl Roth 
Merck 
NZYM Magnesium sulfate 
Protein hydrolysate 
N-Z-amine 
Sodium chloride 
Yeast extract 
2 g/L 
10 g/L 
5 g/L 
5 g/L 
Sigma-Aldrich 
Tab. 4.10: Media for prokaryotic cell culture. 
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4.1.3.7 Media	for	Eukaryotic	Cell	Culture	
Medium Additives Manufacturer 
DMEM 10 % (v/v) FCS 
100 µg/ml Penicillin/Streptomyin 
Sigma-Aldrich 
Alpha-MEM 10 % (v/v) FCS 
100 µg/ml Penicillin/Streptomyin 
Sigma-Aldrich 
GIBCO SF-900 II SFM - Invitrogen 
Tab. 4.11: Media for eukaryotic cell culture. 
 
 
4.1.3.8 DNA	Ladder	
1kb DNA ladder was purchased from New England Biolabs (Frankfurt, Germany). 
 
 
4.1.3.9 Antibiotics	
Antibiotic Concentration 
(1000x) 
Storage Solvent 
Ampicillin 100 mg/ml -20 °C Milli Q Water 
Kanamycin 50 mg/ml -20 °C Milli Q Water 
Gentamycin 7 mg/ml Room temperature Milli Q Water 
Tetracyclin 10 mg/ml -20 °C, light protection Ethanol 
Tab. 4.12: Antibiotics. 
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4.2 Methods 
4.2.1 Biochemical Methods 
4.2.1.1 Sodium	Dodecyl	Sulfate	Polyacrylamide	Gel	Electrophoresis		
• Acrylamid solution:    Rotiphorese Gel 30 (Roth): 
 30 % (w/v) Acrylamid 
0,8 % (w/v) N,N’ -
 Methylenbisacrylamid 
 
• 4 x Separating gel buffer:   1,5 M Tris-HCl, pH 8,8 
 
• 4 x Stacking gel buffer:   0,5 M Tris-HCl, pH 6,8 
 
• 1 x SDS running buffer:   25 mM Tris 
 192 mM Glycin 
 0,1 % (w/v) SDS 
 
• 4 x Protein sample buffer:   200 mM Tris-HCl, pH 6,8 
(reducing)    40 % (v/v) Glycerol 
 12 % (v/v) β-Mercaptoethanol 
 8 % (w/v) SDS 
 0,2 % (w/v) Bromphenolblue 
 
• 4 x Protein sample buffer   200 mM Tris-HCl, pH 6,8 
(non-reducing)    40 % (v/v) Glycerol 
 8 % (w/v) SDS 
 0,2 % (w/v) Bromphenolblue 
 
• Coomassie staining solution:  0,25 % (w/v) Coomassie Brilliant Blue  
 40 % (v/v) Ethanol 
 10 % (v/v) Acetic Acid 
 
• Distaining solution:    20 % (v/v) Ethanol 
 5 % (v/v) Acetic Acid 
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• PBS:      35,7 mM Na2HPO4 
 14,3 mM KH2PO4 
 136 mM NaCl 
 3 mM KCl 
 
• PBS-T:     0,05 % Tween 20 in PBS 
 
4.2.1.2 Sample	preparation	for	SDS-PAGE	
The protein solution was diluted in a ratio of 3:4 in 4x protein sample buffer and 
incubated for 5 min at 95 °C. After a short centrifugation, the samples were loaded 
on a SDS gel.  
 
4.2.1.3 Electrophoresis	Conditions	
Proteins, supplemented with protein sample buffer and denatured at 95 °C, were 
analysed using a BIORAD system, which is based on a modified, discontinuous gel 
system (Laemmli, 1970). The voltage was kept constant both in the stacking and the 
separation gel (200 V during the entire procedure). 
 
4.2.1.4 Coomassie	Staining	
The gels were incubated for 20 min in Coomassie staining solution at room 
temperature. In order to visualise the protein bands, the gels were then washed in 
destaining solution for 1 h at room temperature. 
 
For 2 Gels 4 % 12 % 15 % 
Water 3.05 ml 3.35 ml 2.35 ml 
4 x Stacking gel buffer 1.25 ml - - 
4 x Separating gel buffer - 2.50 ml 2.50 ml 
Acrylamid solution 0.65 ml 4.00 ml 5.00 ml 
10 % APS solution 0.05 ml 0.10 ml 0.10 ml 
10 % SDS solution 0.05 ml 0.10 ml 0.10 ml 
TEMED 0.01 ml 0.01 ml 0.01 ml 
Total volume 5.06 ml 10.06 ml 10.06 ml 
Tab.	4.13:	Coomassie	staining. 
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4.2.1.5 Western	blot	analysis	
• PBS: 14.3 mM KH2PO4, 35.7 mM Na2HPO4, 137 mM NaCl, 3 mM KCl, pH 7.4 
• PBS-T: PBS with 0.05 % Tween 
• Blocking buffer: PBS containing 5 % non-fat dry milk  
• Ponceau S staining solution: 0.8 % Ponceau S, 4 % TCA (Serva, Germany) 
Proteins were transferred from SDS-PAGE gels onto PVDF membranes (Immobilon-
P, Millipore, Eschborn) by the use of “wet” blot or “semi-dry” blot procedure in cells 
manufactured by BioRad (Munich, Germany).  
 
4.2.1.6 Semi-dry	Blot	
• Blot buffer: 25 mM Tris base, 200 mM glycine, 20 % methanol 
Per gel 7 filter papers (Whatman 3 mm) and one PVDF-membrane were cut 7 x 9 
cm. The membrane was pre-activated in methanol. Four papers were soaked in the 
blot buffer and placed on the anode plate. On top of these was placed the PVDF 
membrane followed by the SDS gel. Finally, the 3 remaining filter papers were 
soaked in the blot buffer and applied on top. Proteins were then transferred onto the 
membrane at 18 V (constant voltage) for two hours. 
 
4.2.1.7 Wet	Blot	
• Blot buffer: 25 mM Tris base, 200 mM glycine, 20 % methanol 
Per gel four filter papers (Whatman 3mm) and one PVDF-membrane were cut 7 x 9 
cm. The membrane was pre-activated in methanol. Two papers were soaked in the 
blot buffer and placed on a foam pad over the anode plate (white side of the BioRad 
holder cassette). On top of these was placed the PVDF membrane followed by the 
SDS gel. The two remaining filter papers were soaked in the blot buffer and applied 
above. Finally, a second foam pad was placed on top and the holder cassette was 
closed. Proteins were then transferred onto the membrane at 100 V (constant 
voltage) for two hours or at 30 V (constant voltage) over night. 
 
4.2.1.8 Immunodetection	of	proteins	on	PVDF	membranes	
In order to block unspecific binding sites, the membranes with transferred proteins 
were first incubated for 1 h at room temperature with PBS containing 5 % (w/v) fat-
free milk powder. Afterwards, the membranes were washed 3 times for 10 min in 
PBS-T and incubated for 1 h at room temperature/ overnight at 4 °C with the required 
  
	 MATERIALS	AND	METHODS	 		 	
90 
primary antibody diluted in PBS-T containing 2 % (w/v) bovine serum albumine. 
Subsequently, the blots were washed 3 times for 10 min with PBS-T and incubated 
with the secondary antibody, diluted in PBS-T containing 2 % (w/v) bovine serum 
albumine for 1h at room temperature. From this step on, the membrane was 
protected from light, as the fluorophores coupled to the secondary antibody are light 
sensitive. After three 10-min washes with PBS-T and one 5-min wash with PBS (for 
removal of the Tween), the membrane was exposed to the LI-COR Odyssey system 
manufactured by LI-COR Biosciences (Lincoln, USA). For detection, the protocol of 
the manufacturer was followed. 
 
4.2.1.9 Bradford	Assay	
Protein concentrations were determined using a staining solution purchased from 
BioRad (Munich, Germany). The Bradford reagent was diluted 1:5 with water. All 
samples were prepared in a final volume of 1 ml with the pre-diluted Bradford 
reagent. A 1 mg/ml BSA standard solution was used as a reference. The BSA 
calibration curve consists of 7 points (BSA protein per sample): 0 µg/ml, 2.5 µg/ml, 5 
µg/ml, 10 µg/ml, 15 µg/ml, 20 µg/ml and 25 µg/ml. The concentration of the protein of 
interest was measured in a triplicate. After 5-min incubation at room temperature, 
200 µl of each sample were transferred into a 96-well plate and the optical density at 
620 nm was measured in an ELISA reader. 
 
4.2.1.10 Protein	Expression		
4.2.1.10.1 	Expression	 of	 1-137	 ArfGAP1,	 137-337	 ArfGAP1,	 204-362	 ArfGAP2,	 301-521	
ArfGAP2,	ArfGAP2	QKV	and	ArfGAP3	QKV	in	E.coli	
• LB Medium: 20 g BactoTryptone, 10 g Yeast Extract, 20 g NaCl, 2 l of H2O  
• Ampicillin: 100 mg/ml stock solution, used in 1: 1000 dilution 
• Kanamycin: 50 mg/ml stock solution, used in 1: 1000 dilution 
A single E. coli colony was picked from an LB agar plate and used to inoculate 25 ml 
of LB medium containing the appropriate antibiotics. The pre-culture was incubated 
overnight at 37 °C with agitation. On the next day, 2 l of LB medium containing 
antibiotic were inoculated with 20 ml of the pre-culture and grown at 37 °C, 180 rpm 
until OD600 reached about 0.6. IPTG was then added to 1 mM final concentration and 
the incubation resumed at 37 °C for another 4 h. 
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After the end of the expression, the cells were recovered by centrifugation (4000 x g, 
20 min) and the pellet was washed once in 50 ml PBS. The pellet was then snap 
frozen in liquid nitrogen and stored at -80 °C.  
4.2.1.10.2 	Expression	of	myrArf	from	E.coli	
The two plasmids pHV738 (encodes hNMT1 and Met aminopeptidase), which has a 
kanamycin resistance, and pMON5840-Arf1wt, which has an ampicillin resistance, 
were cotransfected in BL21 (DE3) bacterial strain (for the transfection protocol see 
below).  A pre-culture was prepared overnight at 37 °C from a single colony in NZYM 
medium supplied with 100 µg/ml ampicillin and 30 µg/ml kanamycin. On the next 
day, a main culture was prepared by inoculating 2 l of NZYM medium containing 100 
µg/ml ampicillin and 30 µg/ml kanamycin with 20 ml of the overnight culture. The 
bacteria was grown at 37 °C until OD600=0.6 was reached. The flasks were cooled 
down to 27 °C for 30 min in the cold room (4 °C). From here on, expression was 
performed at 27 °C. In the meantime, the sodium myristate solution/fat-free BSA 
mixture was prepared. Per one liter of culture, 21 mg of sodium myristate were 
dissolved in 1,25 ml of ddH2O by heating up the solution in the microwave. 
Subsequently, 9.1 ml of prewarmed ddH2O and 1.5 ml of 30 % fat-free BSA were 
added. After a ten-minute incubation of the bacterial culture with the sodium 
myristate solution/fat-free BSA mixture, 1 nM IPTG was added to induce the 
expression of the hNMT1 and the Met aminopeptidase, which increases the 
efficiency of the expression by facilitating the myristoylation. After one-hour 
incubation, the bacterial culture was supplied with 30 µg/ml of nalidixic acid dissolved 
in 300 mM NaOH in order to induce the Arf expression. The culture was incubated 
for further four hours at 27 °C and then the bacteria were harvested via a 
centrifugation at 4000 rpm for 20 min. After, a wash with PBS, the pellet was snap-
frozen in liquid nitrogen and stored at -80 °C. 
4.2.1.10.3 	Expression	 of	 ArfGAP1,	 ArfGAP2,	 ArfGAP3,	 His-tagged	 coatomer,	 and	 One-
STrEP-tag	coatomer	from	Sf9	Cells	
In order to express ArfGAP1, ArfGAP2 and ArfGAP3, His-tagged coatomer, and 
One-STrEP-tag coatomer from Sf9 Cells, 500 ml of 2 x 106 SF9 cells/ml were 
infected with the corresponding amount of P2 virus (for the preparation of the virus 
see Cell Culture Methods). The insect cells were then incubated for 72 h at 27 °C 
while stirred at 140 rpm. Subsequently, the cells were spun down at 2000 rpm for 
5min. The obtained pellet was washed once with 30 ml of cold PBS, snap-frozen in 
liquid nitrogen and stored at -80 °C. 
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4.2.1.10.4 	Cell	Lysis	
Cell pellets were thawed in a 20 °C water bath, resuspended in lysis buffer (content 
dependent on the protein preparation, see below) and disrupted by multiple 
passages through a high pressure cell homogeniser (Microfluidizer M-110L, 
2010219, Microfluidics International Corporation, Westwoos, MA, USA): two 
passages for the Sf9 cell lysates and 5 passages for the E.coli bacterial lysates. 
Lysates were then centrifuged at 100 000 x g, 4 °C for 1 h. The obtained supernatant 
was used as a starting material for the purification. 
 
4.2.1.11 		Protein	Purification		
4.2.1.11.1 	Purification	of	myrArf1	Wild	Type	from	E.coli	
• Lysis Buffer: 50 mM Tris, 1 mM DTT, 1 mM MgCl2, 1 mM GDP, 40 µl 
Pepstatin A, 1 mM PMSF, 1 tablet of Roche Protease Inhibitor, pH 8 
• Buffer B: 50 mM Tris, 1 mM DTT, 1 mM MgCl2, pH 8 
• Resuspension Buffer C: 20 mM Tris, 1 mM DTT, 1 mM MgCl2, 200 µl GDP, 1 
tablet of Roche Protease Inhibitor, pH 8 
• PD-10 Buffer D: 10 mM Tris, 1 mM DTT, 1 mM MgCl2, pH 8 
• Equilibration Buffer E: 250 mM Tris, 1 mM DTT, 5 mM MgCl2, pH 8  
• Elution Buffer F: 10 mM Tris, 1 M KCl, 1 mM DTT, 5 mM MgCl2 , pH 8 
All buffers were sterile filtrated and adjusted to the corresponding pH at 4°C. 
Afterwards, they were stored at 4°C. 
After cell lysis in Lysis buffer and ultracentrifugation, the protein extract was adjusted 
to a final volume of 200 ml with Buffer B and subjected to a 35 % ammonium sulfate 
precipitation by addition of 38 g of ammonium sulfate powder. myrArf1 was enriched 
into the precipitate, subsequently centrifuged at 8000x g for 20 min and then 
resuspended in Resuspension Buffer C. Following desalting by a PD-10 gelfiltration 
column (GE Healthcare, Munich) using PD-10 Buffer, the proteins were subjected to 
DEAE anion exchange chromatography with PD-10 Buffer. The column was 
previously equilibrated with: 5x column volumes Equilibration buffer E, 5x column 
volumes PD-10 buffer D, 5x column volumes elution buffer F and 5x column volumes 
PD-10 buffer D. The sample was loaded by a 10 ml Superloop (GE Healthcare, 
Munich) and the column was washed with PD-10 buffer D until a baseline for UV280 
and conductivity was reached. Bound proteins were eluted with a linear gradient from 
0 to 1 M potassium chloride (0 to 100 % Elution buffer F) in 10 column volumes by 
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0.5 ml/min (100 min). 0.5 ml fractions were collected. Normally, Arf1 elutes at 
relatively low conductivity which corresponds to the first peak in the elution profile. By 
this procedure, a 90 % enrichment for the myristoylated form was yielded. Fractions 
were collected and further analysed by SDS-PAGE on a 15 % gel. 
4.2.1.11.2 	Purification	of	His-tagged/	S-tagged	+	His-tagged	ArfGAP1/2/3	from	Sf9	cells	
• Lysis Buffer: 50 mM HEPES, 0.02 % (v/v) MTG, 300 mM KCl, 30 mM 
Imidazole, 1 tablet of Roche Protease Inhibitor, pH 7.4 
• Washing Buffer: 50 mM HEPES, 0.02 % (v/v) MTG, 300 mM KCl, 50 mM 
Imidazole, pH 7.4 
• Elution Buffer: 50 mM HEPES, 0.02 % (v/v) MTG, 300 mM KCl, 250 mM 
Imidazole, pH 7.4 
• Gel Filtration Buffer: 50 mM HEPES, 0.02 % (v/v) MTG, 150 mM KCl, 1mM 
MgCl2 10 % (w/v) Glycerol, pH 7.4 
All buffers were sterile filtered and the pH was adjusted at 4°C. 
The purifcation was performed with one pellet obtained from 500ml of Sf9 culture. 
The cells were resuspended in lysis buffer and lysis was done as described above. 
Upon centrifugation of the cell lysate at 100000 x g for 1h in a 50.2Ti rotor 
(Beckmann Coulter, Krefeld, Germany), the supernatant was subjected to a one-hour 
incubation with 3 ml dry volume of Ni Sepharose Fast Flow beads (GE Healthcare, 
Munich, Germany). The beads were prequilibrated by two washes with water and 
one wash with washing buffer. The protein was eluted by gravity flow in steps of 0.5 
ml. The fractions with the highest concentration were pooled and concentrated in a 
ultra centrifugation units from Sartorius (MWCO= 20 kDa) to a volume of 3 ml. The 
pool was then loaded on a Superdex 200 HighLoad 16/60 prep grade gel filtration 
column from GE Healthcare (Munich, Germany) connected to an Ettan FPLC System 
(GE Healthcare). The fractions containing the protein of interest were pooled and the 
quality of the protein was analysed by SDS-PAGE. Subsequently, the pool was 
aliquoted, snap-frozen in liquid nitrogen and stored at -80 °C. 
4.2.1.11.3 	Purification	of	His-tagged	coatomer	from	Sf9	cells	
• Lysis Buffer: 25 mM HEPES, 0.02 % (v/v) MTG, 200 mM KCl, 30 mM 
Imidazole, 1 tablet of Roche Protease Inhibitor, pH 7.4 
• Washing Buffer: 25 mM HEPES, 0.02 % (v/v) MTG, 200 mM KCl, 50 mM 
Imidazole, pH 7.4 
• Elution Buffer: 25 mM HEPES, 0.02 % (v/v) MTG, 200 mM KCl, 250 mM 
Imidazole, pH 7.4 
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• Gel Filtration Buffer: 25 mM HEPES, 0.02 % (v/v) MTG, 200 mM KCl, 10 % 
(w/v) Glycerol, pH 7.4 
The purifcation was performed with one pellet obtained from 250ml of Sf9 culture 
according to the procedure described in 4.2.1.11.2 The fractions with the highest 
concentration after the elution from the Ni beads were pooled and concentrated in a 
ultracentrifugation units from Sartorius (MWCO= 100 kDa) to a volume of 0.5ml. The 
pool was then loaded on a Superose 6 HighLoad 10/300 GL column from GE 
Healthcare (Munich, Germany) connected to an Ettan FPLC System (GE 
Healthcare). The fractions containing the protein of interest were pooled, analysed by 
SDS-PAGE and aliquoted. After a snap-freezing in liquid nitrogen, the fractions were 
stored at -80 °C. 
4.2.1.11.4 	Purification	of	One-STrEP-tag	coatomer	from	Sf9	cells	
• Column Buffer: 25 mM HEPES, 10 % w/v Glycerol, 200 mM KCl, 1 mM DTT, 
1 tablet of Roche Protease Inhibitor, pH 7.4 
• Elution Buffer: 25 mM HEPES, 10 % w/v Glycerol, 200 mM KCl, 1 mM DTT, 
2.5 mM D-desthiobiotin, 1 tablet of Roche Protease Inhibitor, pH 7.4 
• Buffer W: 100 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 8.0 
• Buffer R: 100 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM HABA (2-(4-
hydroxyphenylazo)-benzoic acid), pH 8.0 
All buffers were sterile filtered and the pH was adjusted at 4 °C for the buffers for the 
purification and at room temperature for the buffers for the regeneration. 
The purifcation was performed with one pellet obtained from 500 ml of Sf9 culture. 
The cells were resuspended in lysis buffer and lysis was done as described above. 
Upon centrifugation of the cell lysate at 100000 x g for 1h in a 50.2Ti rotor 
(Beckmann, Krefeld, Germany), the supernatant was subjected to a two-hour 
incubation with 2 ml dry volume of StrepTactin Sepharose (IBA GmbH, Goettingen, 
Germany). The beads were prequilibrated by two washes with 25ml of Lysis buffer in 
a 25 ml Econo-Pac disposable chromatography column from BioRad (Munich, 
Germany). The protein was eluted by gravity flow in steps of 0.5 ml with 2 min of 
incubation time between the steps. The individual fractions were analysed by SDS-
PAGE and subsequently, the ones with the highest purity, were pooled. Prior to a 
snap-freezing in liquid nitrogen and storage at -80 °C, the buffer was exchanged 
back to the Column buffer via PD-10 desalting coulumns (GE Healthcare, Munich, 
Germany) according to the protocol of the manufacturer. 
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After the purification, the StrepTactin Sepharose was regenerated and used multiple 
times. For the regeneration, the beads were washed twice with 5 column volumns of 
elution buffer, twice with 5 column volumns of buffer W and three times with 5 
column volumns of buffer R. The beads were stored at 4 °C until the next purification. 
4.2.1.11.5 	Purification	 of	 1-137	 ArfGAP1	 ,	 137-337	 ArfGAP1,	 204-362	 ArfGAP2,	 301-521	
ArfGAP2,	ArfGAP2	QKV	and	ArfGAP3	QKV	from	E.coli	
• Resuspension Buffer 1: 20 mM Tris, 2mM MTG, 6 M guanidine hydrochloride, 
1 tablet of Roche Protease Inhibitor, pH 8 
• Resuspension Buffer 2: 20 mM Tris, 2mM MTG, 5 M guanidine hydrochloride, 
pH 8 
• Elution Buffer: 20 mM Tris, 2mM MTG, 5 M Guanidine hydrochloride, 200mM 
Imidazole, pH 8 
• Dialysis Buffer 1: 25 mM HEPES, 1 mM DTT, 300 mM NaCl, pH 7.4 
• Dialysis Buffer 2: 25 mM HEPES, 1 mM DTT, 150 mM NaCl, pH 7.4 
All buffers were sterile filtered and the pH was adjusted at 4 °C. 
One pellet obtained from 2 L bacterial culture was thawn on ice. At the harvesting 
step, it was taken care that the pellet was as much depleted from the PBS used for 
washing as possible.  Then, the pellet was mixed with 250 ml of Resuspension Buffer 
1. In order to remove the released DNA, 1 µl of Benzonase Nuclease from Sigma 
Aldrich (Steinheim, Germany) was added. The suspension was placed in a glass 
beaker at 4 °C and stirred with a magnetic stirrer for 30 min. Subsequently, the 
bacteria was disrupted by five passages through a high pressure cell homogeniser 
(Microfluidizer M-110L, 2010219, Microfluidics International Corporation, Westwoos, 
MA, USA). The lysate was then subjected to a centrifugation at 14 000 rpm for 20 
min in SLC 1400, Sorval rotor. 3ml of Ni Sepharose Fast Flow beads (GE 
Healthcare) per pellet were pre-equlibrated by two washes in ddH2O and one wash in  
Resuspension Buffer 1. The supernatant from the centrifugation was incubated with 
the pre-equilibrated Ni beads for 1 h on a rotary wheel at 4 °C. Afterwards, the 
lysate/beads mixture was transffered in a Econo-Pac disposable chromatography 
column from BioRad (Munich, Germany) and the unbound protein was removed via 
two washes with 25 ml of Resuspension buffer 2. The protein was eluted with Elution 
buffer in 0.5 ml fractions by gravity flow. The individual fractions were analyzed by 
SDS-PAGE and the fractions containing the protein of interest were pooled. The pool 
was transferred in 3 ml Slide-A-Lyzer Dialysis Cassette (Thermo Scientific, Rockfor, 
USA) and dialysed at 4 °C twice for 1 h against 1 L of Dialysis buffer 1, and once 
overnight against 1 L of Dialysis buffer 2. The sample was removed with a syringe 
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from the Slide-A-Lyzer Dialysis Cassette, aliquoted, snap-frozen in liquid nitrogen 
and stored at -80°C. For the handling of the Slide-A-Lyzer Dialysis Cassette see 
protocol of the manufacturer. 
4.2.1.11.6 	Affinity	Purification	of	anti-ArfGAP1/2/3	antibody	
• PBS: 14.3 mM KH2PO4, 35.7 mM Na2HPO4, 137 mM NaCl, 3 mM KCl, pH 7.4 
ArfGAP1 peptide was previously immobilzed on  Thiopropylsepharose beads. 2 ml of 
the Thiopropylsepharose beads were transferred on a 5 ml disposable column with 
frit (Bio-Rad, Munich). The Sepharose was washed 4x with 5 ml PBS. Subsequently, 
3 ml of antisera obtained from a rabbit immunised with ArfGAP1 peptide to produce 
antibodies against ArfGAP1 were loaded on the column. The mixture was incubated 
for 1 hour and 30 min at room temperature on a rotary wheel. Afterwards, the 
sepharose was washed 4x with 5 ml PBS. The antibody was eluted with 0.1 M Glycin 
adjusted to pH 2.8. Before the start of the fraction collection, 8 µl of 1.5 M Tris/HCl 
pH 8.8 were added in each 1.5 ml reaction tube prepared for the elution. 15 fractions, 
250 µl each, were collected. The Sepharose was washed with 5 ml PBS and stored 
in PBS containing 0.02 % Na-azid. The protein concentration was measured on a 
UV/ visible specrofluorometer (Ultraspec 2000, Pharmacia Biotech) at OD280. The 
fractions with the highest concentration were pooled and dialysed twice 1 h and 
subsequently overnight in 500 ml PBS with 10 % Glycin. After the dialysis the 
antibody concentration was measured by Nanodrop, the protein was aliquoted, snap 
frozen in liquid nitrogen and stored at -80 °C. 
4.2.1.12 		Preparation	of	Liposomes	
• HKM Buffer: 25 mM HEPES, 150 mM KCl, 1 mM MgCl2, pH 7.4 
• Lipid Mix (Bigay, 2003): 50 mol % PC, 19 mol % PE, 5 mol % PS, 10 mol % 
PI, 10 mol % Cholesterol 
All phospholipids and cholesterol were purchased from Avanti Polar Lipids (see Tab. 
4.3). The lipid composition of interest was generated by transferring the desired 
concentrations of different lipid stocks, dissolved in chloroform, (for the Golgi-like 
composition see Materials) to a 1.5ml Eppendorf tube (Eppendorf, Hamburg, 
Germany) to a final total lipid concentration of 3 mM in a volume of 300µl. Depending 
on the experimental set-up 30nmol of lyophilized MPB-PE-C-p23 or 1 % of PiP2 
(brain) or Liss Rhod PE (18:1) were added to the reaction mixture. The lipid stock 
was overlaid immediately with Argon in order to prevent oxidation. The lipids were 
dried using a stream of nitrogen until the chloroform was completely evaporated and 
the lipids formed a film on the walls of the tube. The tube was covered with 
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(perforated) parafilm and put under a vacuum for 30 min to remove any residual 
chloroform.  Then, lipid film was resuspended in 900 µl of HKM buffer and vortexed 
until the solution appeared to be homogeneous. In order that unilaminar vesicles 
were formed, the lipids were subjected to ten freeze-thaw cycles: the suspension 
was first immersed into liquid nitrogen until it froze completely, then thawed in a 
water bath prewarmed to 37 °C. Liposomes were either stored frozen at -80 °C or 
extruded directly through a filter (Nuclepore Track-Etch Membrane, Whatman, 
Maidstone, United Kingdom, for the pore size see Results) and used immediately.  
 
4.2.1.13 		Tryptophan	Fluorescence	Measurements	(Bigay	et	al.,	2003)		
• HKM Buffer: 25 mM HEPES, 150 mM KCl, 1 mM MgCl2, pH 7.4 
This fluorometric assay was used to monitor Arf1 nucleotide exchange in vitro. 
Tryptophane fluorescence was measured at 340 nm (bandwidth 20 nm) upon 
excitation at 297.5 nm (bandwidth 3 nm) in a Jasco spectrofluorometer equipped with 
a stirring device and injection platform. All assays were performed at 37 °C and 450 
rpm in a final volume of 600 µl. 
First of all, extruded liposomes (100 µM) were placed into a cylindrical quartz cuvette 
containing HKM buffer. Recombinantly expressed and purified myr-Arf (1 µM) was 
added and activated by the sequential addition of 100 µM GTP and 2 mM EDTA. 
After 10 min, the reaction mixture was supplied with 4 mM MgCl2. GTP hydrolysis 
was initiated by the addition of different concentrations of ArfGAP1/2. For simplicity, 
the fluorescence level of Arf1-GDP was set to zero and the fluorescence level after 
the GTP loading step was set to 100 AU (arbitrary units). Therefore, the fluorescence 
scale shown in the figures directly reflects the fraction of Arf1 that undergoes GTP 
hydrolysis.   
 
4.2.1.14 		Static	Light	Scattering	Measurements	(Bigay	et	al.,	2003)		
• HKM Buffer: 25 mM HEPES, 150 mM KCl, 1 mM MgCl2, pH 7.4 
This fluorometric assay was used to monitor coating and uncoating of COPI vesicles 
in vitro. Static light scattering was measured at 340 nm (bandwidth 20 nm) in a Jasco 
spectrofluorometer equipped with a stirring device and injection platform. All assays 
were performed at 37 °C and 450 rpm in a final volume of 600 µl. 
First of all, extruded liposomes (100 µM) were placed into a cylindrical quartz 
cuvette, which already contained HKM buffer. Recombinantly expressed and purified 
myr-Arf (1 µM) and coatomer (0.2 µM) were added and activated by the sequential 
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addition of 100 µM GTP and 2 mM EDTA. After 10 min, the reaction mixture was 
supplied with 4 mM MgCl2. Uncoating was initiated by the addition of different 
concentrations of ArfGAP1/2. For simplicity, the fluorescence level of Arf1-GDP was 
set to zero and the fluorescence level after the GTP loading step was set to 100 AU 
(arbitrary units). Therefore, the fluorescence scale shown in the figures directly 
reflects the fraction of the coat, which dissociates from the membrane.   
 
4.2.1.15 		Preparation	from	Golgi-enriched	Membranes	from	Rabbit	Liver	
• Homogenization buffer: 10 mM Tris/HCL pH  7.4, 0.5 M Sucrose, 5 mM DTT, 
5 mM EDTA, 1 Tablette/50ml Roche Protease Inhibitor 
• Assay buffer: 25 mM HEPES, 2.5 mM MgOAc, pH 7.2 
Per membrane preparation, eleven male Wistar rats were subjected to a narcosis 
with diethylether, sacrificed and left shortly to bleed out. The livers were instantly 
excised and placed in cold homogenization buffer on ice. Subsequently, the liver was 
cut into small pieces, weight and washed once with homogenization buffer. Three 
volumes of homogenization buffer were added and the liver was homogenized with 
Ultra Thorax (IKA T18 basic, IKA Works, Inc., Wilmington, USA) three times for 20 
sec each.  The homogenate was then centrifuged at 2200 rpm for 10 min at 4°C. The 
post-nuclear supernatant was filtered through three layers of cheesecloth, transferred 
in ten SW32 tubes and overlaid with 20 ml of 1.25 M sucrose dissolved in 10 mM 
Tris-HCL, pH 7.4. The tubes were then subjected to a 100 000 x g centrifugation in 
SW32Ti rotor for 90 min at 4 °C. After removal of the top lipid layer with a vacuum 
pump, the sucrose interface was taken and the refractive index was determined. The 
sucrose final concentration was then adjusted to 1.215 M with sucrose powder. The 
interface was once again separated in ten fractions, transferred into SW32 tubes and 
overlaid with 10 ml of 1.1 M sucrose dissolved in 10 mM Tris-HCL, pH 7.4, 10 ml of 
1.0 M sucrose dissolved in 10 mM Tris-HCL, pH 7.4 and 10 ml of 0.5M sucrose 
dissolved in 10 mM Tris-HCL, pH 7.4. After centrifugation at 100 000 x g in SW32Ti 
rotor for 150 min at 4 °C, the interface between 0.5 M and 1.0 M sucrose was 
collected. The refractive index of the Golgi-enriched fraction was determined and the 
sucrose final concentration was diluted to 250 mM by the addition of 10 mM Tris-
HCL, pH 7.4. Subsequently, the solution was transferred into SW32 tubes and 
underplayed with 1.5 ml of 50 % sucrose solution dissolved in 10 mM Tris-HCL, pH 
7.4. After centrifugation at 100 000 x g in SW32Ti rotor for 60 min at 4 °C, the 
interface was collected and homogenized by pipetting. The Golgi membranes were 
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then salt washed by an adjustment of the KCl concentration to 500 mM with 3 M KCl. 
The solution was transferred to SW32 tubes, underplayed with 3 ml 23 % sucrose 
dissolved in assay buffer and 0.2 ml 50 % sucrose dissolved in assay buffer, and 
subjected to a centrifugation at 100 000 x g in SW32Ti rotor for 60 min at 4 °C. The 
Golgi fraction was then collected. After a determination of the refractive index and the 
protein concentration, it was aliquoted, snap frozen and stored at -80 °C. 
 
4.2.1.16 		Vesicle	Preparation	from	rat-liver	Golgi	modified	from	(Beck	et	al.,	2008)	
• Assay Buffer: 25 mM HEPES, 2.5 mM Mg2Ac, pH 7.2 
COPI vesicles were generated from endogenous Golgi membranes isolated from rat 
liver. 120 µg of the purified mebranes were mixed with 10 µg of recombinant 
myrArf1, 25 µg of recombinant coatomer mix (50 % γ1ζ2, 30 % γ2ζ1 and 20 % γ1ζ2), 
1 mM GTP and 0.25 mM DTT in a final volume of 250 µl. The assay was performed 
in the assay buffer described above. The final concentration of KCl in the assay was 
adjusted to 50 mM and the one of sucrose to 200 mM, where the amounts added 
were back calculated dependent on the concentrations of the two components 
present in the Golgi membrane preparation. After a five-minute incubation at 37 °C, 
the tubes were transferred on ice and the KCl concentration was increased to 250 
nM. 2 % of the reaction mixture were taken as input and the set-ups were allowed to 
incubate for further 10 min on ice. The donor membranes were separated from the 
formed vesicles by a seven-minute centrifugation at 13000 rpm in a table-top 
centrifuge. The supernatant was transferred in a SW60 tube and underlayed with two 
sucrose cushons: 50 µl of 37.5 % w/w sucrose and 5 µl of  50 % w/w sucrose. The 
gradients were then centrifuged for 50 min at 32000 rpm in a SW60 swing-rotor and 
the 16 µl vesicle fraction was isolated from the boarder between the 37.5 % w/w 
sucrose and the  50 % w/w sucrose. 50 % of the vesicle fraction and 1 % of the input 
fraction were loaded on a 12  % polyacrylamid gel and subjected to SDS-PAGE. The 
analysis of the membrane associated material was performed via Western blot with 
specific primary antibodies and secondary antibodies coupled to Alexa dyes. The 
fluorescent signals were quantified in a Li-CORE Odyssey system (Lincoln, USA). 
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4.2.1.17 		Preparation	of	Semi	Intact	Cells	
• Assay Buffer: 25 mM HEPES, 150 mM KOAc, 2 mM MgOAc, pH 7.2 
• PBS: 35.7 mM Na2HPO4, 14.3 mM KH2PO4, 136 mM NaCl, 3 mM KCl, pH 7.4 
The protocol for the semi-intact cell preparation was modified from Mancias and 
Goldberg, 2007 for COPI vesicle preparations (Adolf et al., 2013) (Adolf and Wieland, 
2013). HeLa cells were cultured in 15cm cell culture dishes (Greiner Bio-One GmbH, 
Frickenhausen, Deutschland) until 90 % confluence. After one wash with 15 ml cold 
sterile PBS, the cells were detached by an incubation with 1.5 ml of Trypsin per plate 
for five minutes at 37 °C. Subsequently, 300 µl of 1 mg/ml Trypsin inhibitor (Sigma-
Aldrich) were added per plate and the detached cells were collected in 15 ml/plate of 
cold PBS (cells from three plates in one 50 ml reaction tube). The cells were then 
centrifuged for 5 min at 300 x g and 4 °C, resuspended in 20 ml (per three plates= 1 
50 ml reaction tube) of cold PBS and permeabilized by the addition of 20 µl of 40 
mg/ml Digitonin (Sigma-Aldrich) for 5 min at 4°C. The volume of the cold PBS was 
increased to 50 ml and the permeabilized cells were centrifuged 5 min at 300 x g and 
4 °C. The PBS was discarded, the pellet was resuspended in 50 ml of assay buffer, 
and incubated for 10 min at 4 °C. After a five-minute centrifugation at 300 x g and 4 
°C, the buffer was discarded and the cell pellet from 6 plates was resuspended in 
500 µl of assay buffer. The total protein concentration was determined via a Bradford 
test and the cells were directly used for a vesicle preparation.  
 
4.2.1.18 		Vesicle	 Preparation	 from	 Semi	 Intact	 Cells	modified	 from	 (Adolf	 and	Wieland,	
2013)	
• Assay Buffer: 25 mM HEPES, 150 mM KOAc, 2 mM MgOAc, pH 7.2 
COPI vesicles were generated from freshly permeabilized semi-intact HeLa cells. For 
the COPI vesicle formation, 100 µg of semi-intact cells were incubated for 30 min at 
37 °C with 2 µg of recombinant myrArf1, 10 µg of recombinant coatomer mix (50 % 
γ1ζ2, 30 % γ2ζ1 and 20 % γ1ζ2), 1 mM GTP and 0.25 mM DTT in a final volume of 
200 µl. The assay was performed in the vesicle preparation buffer described above. 
1 % of the reaction mixture were taken as input. The donor membranes were 
separated from the formed vesicles by a ten-minute centrifugation at 10000 x g in a 
table-top centrifuge. The supernatant was transferred in a SW60 tube and underlaid 
with two sucrose cushons: 50 µl of 37.5 % w/w sucrose and 5 µl of  50 % w/w 
sucrose. The gradients were then centrifuged for 50 min at 32000 rpm in a SW60 
swing-rotor. The vesicle fraction was collected in 16 µl on the boarder between the 
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37.5 % w/w sucrose and the  50 % w/w sucrose. 50 % of the vesicle fraction and 1 % 
of the input fraction were loaded on a 12 % polyacrylamid gel and subjected to SDS-
PAGE. The analysis of the membrane associated material was performed via 
Western blot with specific primary antibodies and secondary antibodies coupled to 
Alexa dyes. The fluorescent signals were quantified in a Li-CORE Odyssey system 
(Lincoln, USA). 
 
4.2.1.19 		Isolation	of	cross-linked	COPI	vesicles	via	an	OptiPrep	Gradient	
COPI vesicles were essentially prepared from semi-intact cells according to the 
protocol described in 4.2.1.17 with the exception of the modifications described here. 
All the components of reaction mixture were doubled while the reaction volume was 
kept at 200 µl. After the low speed centrifugation step at 10 000 x g for 10 min, the 
supernatant was transferred to a new 1.5 ml reaction tube and incubated with 
ArfGAP1 full length, 1-137 ArfGAP1 or buffer as a negative control for 10 min at 
room temperature. The set-ups were then transferred on ice and cross-linked via 
0.25 mM NHS-ester reactive, bifunctional cross linker DTTSP (Thermo Fischer 
Scientific Inc.) for twice 15 min (two sequential additions of DTTSP). The sample was 
then adjusted to 40 % Opti Prep (Sigma-Aldrich) in a final volume of 900 µl, 
transferred to a 2.4 ml SW60 tube and subsequently overlaid with 1000 µl of 30 % 
Opti Prep and 400 µl 20 % Opti Prep. All OptiPrep solutions were prepared in assay 
buffer. The reaction mixtures were centrifuged for 14 hours at 50 000 rpm, 4 °C in a 
SW60 rotor. 400 µl corresponding to the top fraction were removed. The next 500 µl 
fraction contains the COPI vesicles and was correspondingly harvested and pelleted 
by a one-hour centrifugation in a TLA45 rotor for 60 min, 4 °C. The supernatant was 
removed; the pellet was dissolved in 10 µl of 2xSDS buffer and subjected to SDS-
PAGE and western blot analysis. 
 
4.2.1.20 		ELISA	modified	from	(Bethune	et	al.,	2006)	
• Binding Buffer: 50 mM HEPES, 90 mM KCl, 300 mM NaCl, 1 mM EDTA, 1 % 
BSA, 0.5 % Triton X-100, pH 7.4 
96-well microtiter plate (Corning, New York, USA) was coated with 10 pmol of 
isotypic coatomer dissolved in 100 µl of PBS per well. As a negativ control, the 
corresponding number of wells was coated with BSA dissolved in 100 µl of PBS. The 
coating of the microtiter plate was perfomed overnight at 4 °C. Subsequently, the 
wells were washed three times with PBS and blocked with 300 µl of PBS-T 
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containing 5 % BSA for 30min at room temperature. After three washes with PBS-T 
and one wash with binding buffer, different concentrations of ArfGAP1, ArfGAP2 and 
ArfGAP3 were added to the microtiter plate, and incubated for one hour at room 
temperature. Concentrations of 0 µM, 0.313 µM, 0.625 µM, 1.250 µM, 2.5 µM and 5 
µM were used. Subsequent to the binding, the wells were washed three times with 
binding buffer and incubated for one hour at room temperature with primary antibody 
against ArfGAP1, ArfGAP2 and ArfGAP3, which was diluted 1: 1000 in binding 
buffer. The microtiter plate was then washed three times with binding buffer and 
incubated for further one hour at room temperature with secondary anti-rabbit 
antibody coupled to HRP, which was diluted 1: 1000 in binding buffer. After the 
antibody incubation, the plate was washed three times with binding buffer and once 
with binding buffer without BSA and Triton X-100. For the detection were added 100 
µl of 0.1 mg/ml 3,3,´5,´5-Tetramethylbenzidine (TMD)  from Sigma-Aldrich 
(Taufkirchen, Germany) dissolved in 50 mM phosphate citrate buffer, pH 5 
supplemented with 0.02 % H2O2. The phosphate buffer containing the HRP substrate 
was prepared directly prior to use. The reaction was stopped with 50 µl of 0.5 M H2O2 
and the absorbance was directly measured at 450 nm (reference filter= 620nm) in an 
Anthos 2001 microtiter plate reader (Anthos Lab Tec, Salzburg, Austria). 
 
4.2.1.21 		Labeling	of	Arf1	and	coatomer	
Myristoylated Arf1 was purified as described above. To allow optimal activity of 
labeled Arf1, its unique cysteine residue was exchanged with a serine residue 
(C159S) and its C-terminal lysine was exchanged for a cysteine (K181C). The 
purified protein was subsequently labeled with 10x molar excess of maleimide 
reactive Alexa647 dye (Life technologies) for 1 h on ice. The free dye was separated 
via gel filtration on a Superdex 75 10/300 column. Coatomer was purified by affinity 
purification as described above. After elution with 2.5 mM D-Desthiobiotin (iba, 
Goettingen, Germany), fractions of interest were pooled and the buffer was 
exchanged on PD10 desalting columns to remove D-Desthiobiotin. The purified 
protein was labeled with NHS-ester reactive ATTO488 dye (Life technologies) for 1 h 
on ice and the residual free dye was separated on a Superose 6 10/300 column. 
 
4.2.1.22 		Fluorescence	Cross	Correlation	Spectroscopy	Measurements	
5 µl of COPI vesicles purified from endogenous rat liver Golgi membranes in the 
presence of Arf1-Alexa647 and coatomer-ATTO488, were mixed with PBS and 
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ArfGAP to a final volume of 20 µl. The reaction mixture was directly pipetted in a 
chamber and imaged with a LSM710 supplied with confocor 3 microscope (Zeiss, 
Oberkochen, Germany). The fluorescence traces were analysed using custom made 
scripts written in Mat Lab (Jonas Ries, EMBL, Heidelberg, Germany). 
Intensity traces with a bin size of 20 µs were calculated and the 90 % percentile of 
the intensity values was chosen as a threshold to distinguish bursts from 
fluorescence background. In 20 equally spaced time windows (length 15 seconds) 
the number of intensity values above the threshold was used as a measure for the 
number of peaks. In addition, the average intensity of the values above the threshold 
was calculated as a measure for the amount of vesicle-bound fluorophores. From 
this, we calculated in each time window the intensity ratio between red and green 
channels, which reports the relative abundance of both proteins on the vesicles. The 
decay constants were calculated from a robust exponential decay fit. The final figures 
were plotted in GraphPadPrism. 
 
4.2.1.23 		Float	Up	
• Assay Buffer: 25 mM HEPES, 150 mM KCl, 1 mM MgCl2, pH 7.2 
For the floatation experiment, liposomes containing p23 lipopetide with a Golgi-like 
composition were generated as described above and extruded through a 100 nm 
track-etch membrane (Whatman, Maidstone, United Kingdom). In the first step, Arf1 
and coatomer were recruited to the membrane. For this purpose, 4 µg Arf1, 29 µg 
coatomer, 400 µM liposomes, 0.19 mM DTT, 1.6 mM EDTA and 100 µM GTP were 
mixed in a final volume of 60 µL and incubated for 10 min at 37 °C. To stop the 
reaction, 4 mM MgCl2 were added. In the second step, different concentrations of 
ArfGAP1 or ArfGAP2 were added and the set-ups were incubated for further 5 min at 
room temperature. 5 µl of the reaction were removed for the inputs and mixed with 
55 µl HKM and 20 µl 4X SDS sample buffer. To the 55 µl of the reactions were 
added 160 µl cold solution of 59.5 % w/w sucrose (final concentration= 47 %w/w). 
The sample was mixed well, transferred carefully at the bottom of 0.7 ml SW60 tubes 
and overlaid with 200 µl 44 % w/w sucrose, 170 µl 41 % w/w sucrose, and 80 µl of 
HKM buffer. To isolate the coated liposomes, the sucrose gradients were centrifuged 
for 1 h 30 min at 50 000 rpm in a SW60 swing-rotor. The 80 µl top fraction was then 
carefully harvested and supplemented with 20 µl of 4xSDS sample buffer. 10 µl of 
the inputs and 10 µl of the float up fraction were loaded on a 12 % gel and analysed 
via SDS-PAGE and Western Blot. 
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4.2.1.24 		Radioactivity	assay	
For the readioactivity experiments, the float-up was essentially performed as 
described in 4.2.1.23. For radioactive labelling of the nucleotide a mixture of 1 mM 
GTP and 1 pmol 3H-GTP (Perkin Elmer) was used. After collecting the top fractions 
of the gradients, 20 µl of the samples were mixed with ArfGAP1 or ArfGAP2 at the 
concentrations indicated in the results part. The reaction was stopped by 1-minute 
incubation at 95 °C. 8µl of the samples were loaded on a Bis-Tris precasted 
NuPAGE gel and subjected to electrophoresis accoring to the instructions of the 
manufacturer. The rest of the sample was subjected to a 3-minute centrifugation at 
13 000 rpm in order to separate the free nucleotide. The supernatant was transferred 
to a new tube. 2 µl of the suppernatant were mixed with 3 µl of szintigraphy solution 
and were subjected to a scintillation counting (cpm). According to the measured 
radioactivity, such a volume of the samples was choosen so that it corresponds to 
4000 cpm. Samples were spotted on a PEI thin layer chromatography plate, 1 cm 
apart on a line, 2.5 cm from the bottom of the plate. Each plate was developed with 
0.7 M freshly prepared LiCl2 in a closed multiplate tank to a solvent front of 5 cm. The 
development required ca. 45 minutes. After drying of the plates with blow-dryer, they 
subjected to a counting with a ß-Imager (Biospace Lab) for 12 hours. 
 
4.2.2 Molecular Biology Methods 
4.2.2.1 Preparation	of	Chemically	Competent	Bacteria	
• Buffer TFB 1: 50 mM MnCl2, 100 mM RbCl, 10 mM CaCl2, 30 mM 
Kaliumacetate, 15 % Glycerol 
• Buffer TFB 2: 10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15 % Glycerol 
To prepare the competent bacteria, 10 ml of LB medium were inoculated from a 
glycerol stock of E. coli DH5α (Invitrogen), which was prepared from a single clone. 
This overnight culture was incubated at 37 °C and 180 rpm for ca. 14 hours. For the 
day culture, two times of 200 ml of LB medium were inoculated each with 4 ml from 
the overnight culture. After the DH5α cells had reached OD600= 0.4, they were 
harvested for 15 min at 4000 rpm and 4 °C in precooled 50 ml reaction tubes. The 
pellet was resuspended in 50 ml of TFB 1 buffer and the cells were spun down 
second time for 10 min at 3000 rpm and 4 °C. Subsequently, the pellet was 
resuspended in 5 ml of buffer TFB 2. Finally, the cells were aliquoted, shock frozen in 
liquid nitrogen and stored at -80 °C.  
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4.2.2.2 Determination	of	DNA-concentration	
DNA concentration was determined by its absorption at 260 nm, using a ND-1000 
Spectrophotometer (NanoDrop; Wilmington, USA). The absorption of the solution of 
interest is determined and the concentration of nucleic acid in the sample is 
automatically calculated applying the formula: c = OD260· 0,05 · DF [µg/µl] (DF= 
dilution factor). 
 
4.2.2.3 Agarose	Gel	Electrophoresis	
• TAE buffer (50x): 2 M Tris-HCl, pH 8.0, 1 M acetic acid and 50 mM EDTA 
• DNA sample buffer (5x): 50 mM Tris-HCl, pH 8.0, 4 M Urea, 25 % (w/v) 
Glycerol, 0.1 % (w/v) Bromphenol blue, 100 mM EDTA 
Analytical and preparative agarose gel electrophoresis was performed on 1 % 
agarose gels prepared in TAE buffer supplied with 0.005 % (v/v) ethidium bromide. 
DNA samples were mixed with DNA sample buffer prior to loading (final 
concentration of the sample buffer= 1x) on the gel. The gel was run at 120 V until the 
desired separation. DNA bands were visualized on a GelDoc System (Biorad, 
Munich). DNA bands of interest were excised and purified from the gel using 
QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany) according to the protocol of 
the manufacturer. 
4.2.2.4 Ligation	
Ligation of endonuclease treated DNA fragments (inserts) with the equivalently 
digested Vector-DNA was performed with T4-DNA-ligase (NEB, Ipswich, 
assachusetts, United States) using the corresponding T4-DNA-ligase buffer 
purchased from NEB. Vector and insert were mixed at a molar ratio of 1:3, 1:5 and 
1:10 and were added to a ligation mix containing the T4-DNA-ligase and T4-DNA-
ligase buffer. The ligation setup was incubated at 16°C over night and subsequently 
used for the transformation of chemically competent E.coli DH5α or stored until 
usage at -20°C. 
 
4.2.2.5 Transformation	of	Chemically	Competent	Bacteria	
• LB Agar: 3 g BactoTryptone, 1.5 g Yeast Extract, 3 g NaCl, 4.5 g Agar, 300 
ml of H2O 
• Ampicillin: 100 mg/ml stock solution, used in 1: 1000 dilution 
• Kanamycin: 50 mg/ml stoch solution, used in 1: 1000 dilution 
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• SOC medium: purchased from Invitrogen 
100 µl BL21star/ Origami 2 (Invitrogen, Carlsbad, California, United States) E. coli 
competent cells were mixed with 0.5 µl of plasmid stock solution and incubated for 10 
min on ice. The cells were then heat shocked at 42 °C for 30 sec and incubated at 
room temperature for 10 min. 80 µl of SOC medium were then added and the cells 
were allowed to grow for 1 h at 37 °C on an agitator. The cells were then plated on 
LB agar plates containing the appropriate antibiotics and incubated overnight at 37 
°C.  
 
4.2.2.6 Transformation	of	Electrically	Competent	Bacteria	
For the tranformation, 10 ng of the plasmid of interest were transfected into 40 µl of 
electro-competent DH10B Bultibac bacteria. The bacteria was incubated with the 
plasmid for 10 to 15 min in a pre-cooled electroporation cuvette on ice. The 
electroporation was conducted at 1,8 KV, 25 µF, and 200 Ohm. The transformed 
bacteria was resuspended in 1 ml SOC-medium, transferred to a 1.5 ml reaction 
tube, and incubated for 6 hours at 37 °C and constant shaking at 180 rpm. The 
culture was then spun down for 1 min at 13000 rpm. 950 µl of the supernatant were 
discarded and the pellet was resuspenden into the remaining 50 µl of medium. The 
bacteria was plated on low-salt agar-plates containing: Ampicillin (100 mg/ml), 
Kanamycin (50 µg/ml), Gentamycin (7 µg/ml), Tetracyclin (10 µg/ml), Blougal (100 
µg/ml), and IPTG (500 µM). The agar plates were incubated for 16 to 24 hours at 37 
°C. Afterwards, the white colonies, corresponding to the ones containing the plasmid 
were picked, while the blue colonies, where the transfection failed, were discarded. 
Per construct 2 to 4 colonies were picked. 
 
4.2.2.7 Restriction	digest	
A restriction digest of DNA fragments by endonucleases was performed in 1 x NEB 
reaction buffer (buffer type dependent on the enzyme) with/without 1 x BSA solution 
for 2 h at 37 °C.  
 
4.2.2.8 Sequencing	
All sequencing reactions were performed by GATC (Konstanz, Germany). 
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4.2.2.9 Polymerase	Chain	Reaction	(PCR)	
Pfu turbo DNA polymerase was used for the amplification of DNA fragments (Agilent 
Technology, Boeblingen, Germany). 50 ng of DNA template, 1 µl of both 10 µM 
forward and 10 µM reverse primer, 1 µl of 10 µM dNTP mix, 1 µl of 2.5 U/µl Pfu 
polymerase were mixed in a final volume of 40µl water. The reaction were performed 
in a thermo cycler (Thermo Fischer Scientific, Rockford, USA) at a temperature 
gradient for the annealing between 52 and 62°C. 
 
4.2.2.10 		Ethanol	Precipitation	
DNA was precipitated by the addition of 1/10 of a volume of 3 M sodium acetate and 
2.5 volumes of Ethanol p.a. Following a 30-minute incubation at -20 °C, the samples 
were centrifuged at 12 000 x g for 10 min at 4 °C. Pellets were dissolved in 20 µl of 
MilliQ water. 
 
4.2.2.11 		Plasmid	Preparation	
Plasmids were prepared using Macherey-Nagel Nucleo Bond PC500 Kit (Dueren, 
Germany) according to the protocol of the manufacturer. 
 
4.2.2.12 		Bacmid	Preparation	
A single white colony, which corresponds to the colonies expressing the plasmid, 
was picked from the low-salt agar-plates containing: Ampicillin (100 mg/ml), 
Kanamycin (50 µg/ml), Gentamycin (7 µg/ml), Tetracyclin (10 µg/ml), Blougal (100 
µg/ml), IPTG (500 µM/ml). For the details of the transformation procedure of 
electrically competent bacteria see above. Two to three colonies were choosen per 
construct and were inoculated in 3 ml of low-salt LB-medium containing the 
antibiotics above. This pre-culture was incubated overnight at 37 °C with a constant 
agitation at 180 rpm. 1.5 ml of the pre-culture were spun down for 1 min at 13000 
rpm. The supernatant was discarded and the pellet was resuspended in 300 µl 
Resuspending buffer S1 from Nucleo-spin plasmid kit from Macherey Nagel (Dueren, 
Germany). 300 µl of Lysis buffer S2 were added carefully and the tube was inverted 
several times. Subsequently, 300 µl of Neutralisation buffer S3 were added and the 
tube was carefully inverted several times. The suspension was then centrifuged for 
10 min at 13000 rpm, and 4 °C. The supernatant was transferred to a new 1,5 ml 
reaction tube and the DNA was precipitated by the addition of 700 µl of isopropanol. 
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After a centrifugation step for 10 min at 13000 rpm, and 4 °C, the supernatant was 
discarded. The pellet was washed with 1 of 70 % ethanol and centrifuged again for 
10 min at 13000 rpm, and 4 °C. The supernatant was carefully removed and the 
pellet was spun down shortly again in order to remove the remainin ethanol. 50 µl of 
fresh ethanol were added and the tube was transferred to the sterile  cell culture 
hood. The enthanol was then removed under the hood and the pellet was air-dried 
for 10 to 15 min under the hood directly prior to the transfection. 
 
4.2.3 Cell Culture Methods 
4.2.3.1 Adherent	Cell	Culture	of	HeLa	Cells	
Hela cells were cultured in alpha MEM supplemented with 10 % fetal calf serum 
(FCS) 100 µg/ml penicillin, 100 µg/µl streptomycin and 2 mM L-glutamine, at 5  % 
CO2, 37 °C. Once the cells reached 80-90 % confluence, they were detached by the 
addition of Trypsin/EDTA (Sigma-Aldrich, Taufkirchen, Germany) and splitted either 
1:3 or 1:8 in a new cell culture dish. 
 
4.2.3.2 Cell	Culture	of	Sf9	Insect	Cells	
Sf9 insect cells were cultured in GIBCO SF-900 II SFM medium either as an 
adherent culture in 10 -25 cm2 flasks (Greiner Bio-One, Frickenhausen, Germany) at 
27 °C or as a suspension culture in 2.5 l Cellmaster Roller Bottles (Greiner Bio-One, 
Frickenhausen, Germany) at 27 °C and 150 rpm. The cells were split twice per week 
to 1x106 Cells/ml. 
 
4.2.3.3 Transfection	of	Sf9	Insect	Cells		
Sf9 cells were counted and 0,7 -0,8x106 cells/well were seeded in a 6-well-plate 
(Costar, Corning, USA). Per construct were prepared two wells for the actual 
transfection and two wells for a mock transfection (no DNA addition to the 
transfection mixture). The cells were allowed to adhere to the surface for 10 min. In 
the meantime, the transfection mixture was prepared. The dried DNA pellet from the 
bacmid preparation (for details see above) was carefully resuspended in 20 µl of 
sterile filtered ddH2O and then supplemented with 200µl of GIBCO SF-900 II SFM 
medium (tube A). 100 µl of GIBCO SF-900 II SFM medium were transferred in a 
sterile 1.5 ml reaction tube and 10 µl of FUGENE (Roche) were pipetted into the 
medium (tube B). Subsequently, 100 µl of the medium/FUGENE mixture (tube B) 
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were transferred into the tube containing the bacmid DNA (tube A). After a careful 
mixing, 150 µl of the Medium/FUGENE/DNA mixture were added dropwise to each 
well of the 6-well plate. Mock transfection was conducted by the addition of the same 
volume of Medium/FUGENE mixture in the absence of DNA. The 6-well plate was 
sealed with parafilm and incubated for 48 h at 27 °C. 
 
  
	 LITERATURE	 		 	
110 
5 References 
 
Adolf, F., Herrmann, A., Hellwig, A., Beck, R., Brugger, B., and Wieland, F.T. (2013). 
Scission of COPI and COPII vesicles is independent of GTP hydrolysis. Traffic 14, 
922-932. 
Adolf, F., and Wieland, F.T. (2013). Analysis of Golgi complex functions: in vitro 
reconstitution systems. Methods Cell Biol 118, 3-14. 
Aguilera-Romero, A., Kaminska, J., Spang, A., Riezman, H., and Muniz, M. (2008). 
The yeast p24 complex is required for the formation of COPI retrograde transport 
vesicles from the Golgi apparatus. J Cell Biol 180, 713-720. 
Ahle, S., Mann, A., Eichelsbacher, U., and Ungewickell, E. (1988). Structural 
relationships between clathrin assembly proteins from the Golgi and the plasma 
membrane. Embo J 7, 919-929. 
Anantharaman, V., and Aravind, L. (2002). The GOLD domain, a novel protein 
module involved in Golgi function and secretion. Genome Biol 3, research0023. 
Andag, U., and Schmitt, H.D. (2003). Dsl1p, an essential component of the Golgi-
endoplasmic reticulum retrieval system in yeast, uses the same sequence motif to 
interact with different subunits of the COPI vesicle coat. J Biol Chem 278, 51722-
51734. 
Andreev, J., Simon, J.P., Sabatini, D.D., Kam, J., Plowman, G., Randazzo, P.A., and 
Schlessinger, J. (1999). Identification of a new Pyk2 target protein with Arf-GAP 
activity. Mol Cell Biol 19, 2338-2350. 
Antonny, B. (2011). Mechanisms of membrane curvature sensing. Annu Rev 
Biochem 80, 101-123. 
Antonny, B., Huber, I., Paris, S., Chabre, M., and Cassel, D. (1997). Activation of 
ADP-ribosylation factor 1 GTPase-activating protein by phosphatidylcholine-derived 
diacylglycerols. J Biol Chem 272, 30848-30851. 
Antonny, B., Madden, D., Hamamoto, S., Orci, L., and Schekman, R. (2001). 
Dynamics of the COPII coat with GTP and stable analogues. Nature cell biology 3, 
531-537. 
Aoe, T., Cukierman, E., Lee, A., Cassel, D., Peters, P.J., and Hsu, V.W. (1997). The 
KDEL receptor, ERD2, regulates intracellular traffic by recruiting a GTPase-activating 
protein for ARF1. EMBO J 16, 7305-7316. 
Appenzeller-Herzog, C., and Hauri, H.P. (2006). The ER-Golgi intermediate 
compartment (ERGIC): in search of its identity and function. Journal of cell science 
119, 2173-2183. 
Arakel, E.C., Richter, K.P., Clancy, A., and Schwappach, B. (2016). delta-COP 
contains a helix C-terminal to its longin domain key to COPI dynamics and function. 
Proc Natl Acad Sci U S A 113, 6916-6921. 
Aridor, M., Bannykh, S.I., Rowe, T., and Balch, W.E. (1995). Sequential coupling 
between COPII and COPI vesicle coats in endoplasmic reticulum to Golgi transport. 
J Cell Biol 131, 875-893. 
Austin, C., Hinners, I., and Tooze, S.A. (2000). Direct and GTP-dependent 
interaction of ADP-ribosylation factor 1 with clathrin adaptor protein AP-1 on 
immature secretory granules. J Biol Chem 275, 21862-21869. 
Bai, M., Gad, H., Turacchio, G., Cocucci, E., Yang, J.S., Li, J., Beznoussenko, G.V., 
Nie, Z., Luo, R., Fu, L., et al. (2011). ARFGAP1 promotes AP-2-dependent 
endocytosis. Nature cell biology 13, 559-567. 
Bannykh, S.I., Rowe, T., and Balch, W.E. (1996). The organization of endoplasmic 
reticulum export complexes. J Cell Biol 135, 19-35. 
  
	 LITERATURE	 		 	
111 
Barlowe, C., d'Enfert, C., and Schekman, R. (1993). Purification and characterization 
of SAR1p, a small GTP-binding protein required for transport vesicle formation from 
the endoplasmic reticulum. J Biol Chem 268, 873-879. 
Barlowe, C., Orci, L., Yeung, T., Hosobuchi, M., Hamamoto, S., Salama, N., Rexach, 
M.F., Ravazzola, M., Amherdt, M., and Schekman, R. (1994). COPII: a membrane 
coat formed by Sec proteins that drive vesicle budding from the endoplasmic 
reticulum. Cell 77, 895-907. 
Barlowe, C., and Schekman, R. (1993). SEC12 encodes a guanine-nucleotide-
exchange factor essential for transport vesicle budding from the ER. Nature 365, 
347-349. 
Barlowe, C.K., and Miller, E.A. (2013). Secretory protein biogenesis and traffic in the 
early secretory pathway. Genetics 193, 383-410. 
Beck, R., Adolf, F., Weimer, C., Bruegger, B., and Wieland, F.T. (2009). ArfGAP1 
activity and COPI vesicle biogenesis. Traffic 10, 307-315. 
Beck, R., Brugger, B., and Wieland, F. (2011a). GAPs in the context of COPI: 
Enzymes, coat components or both? Cell Logist 1, 52-54. 
Beck, R., Prinz, S., Diestelkotter-Bachert, P., Rohling, S., Adolf, F., Hoehner, K., 
Welsch, S., Ronchi, P., Brugger, B., Briggs, J.A., et al. (2011b). Coatomer and 
dimeric ADP ribosylation factor 1 promote distinct steps in membrane scission. J Cell 
Biol 194, 765-777. 
Beck, R., Sun, Z., Adolf, F., Rutz, C., Bassler, J., Wild, C., Sinning, I., Hurt, E., 
Bruegger, B., Béthune, J., et al. (2008). Membrane curvature induced by Arf1-GTP is 
essential for vesicle formation. Proc Natl Acad Sci U S A In press. 
Beckers, C.J., Keller, D.S., and Balch, W.E. (1987). Semi-intact cells permeable to 
macromolecules: use in reconstitution of protein transport from the endoplasmic 
reticulum to the Golgi complex. Cell 50, 523-534. 
Belden, W.J., and Barlowe, C. (2001a). Deletion of yeast p24 genes activates the 
unfolded protein response. Mol Biol Cell 12, 957-969. 
Belden, W.J., and Barlowe, C. (2001b). Distinct roles for the cytoplasmic tail 
sequences of Emp24p and Erv25p in transport between the endoplasmic reticulum 
and Golgi complex. J Biol Chem 276, 43040-43048. 
Bethune, J., Kol, M., Hoffmann, J., Reckmann, I., Brugger, B., and Wieland, F. 
(2006). Coatomer, the Coat Protein of COPI Transport Vesicles, Discriminates 
Endoplasmic Reticulum Residents from p24 Proteins. Mol Cell Biol 26, 8011-8021. 
Bi, X., Corpina, R.A., and Goldberg, J. (2002). Structure of the Sec23/24-Sar1 pre-
budding complex of the COPII vesicle coat. Nature 419, 271-277. 
Bigay, J., and Antonny, B. (2005). Real-time assays for the assembly-disassembly 
cycle of COP coats on liposomes of defined size. Methods in enzymology 404, 95-
107. 
Bigay, J., Gounon, P., Robineau, S., and Antonny, B. (2003). Lipid packing sensed 
by ArfGAP1 couples COPI coat disassembly to membrane bilayer curvature. Nature 
426, 563-566. 
Blum, R., Pfeiffer, F., Feick, P., Nastainczyk, W., Kohler, B., Schafer, K.H., and 
Schulz, I. (1999). Intracellular localization and in vivo trafficking of p24A and p23. 
Journal of cell science 112 ( Pt 4), 537-548. 
Bocking, T., Aguet, F., Harrison, S.C., and Kirchhausen, T. (2011). Single-molecule 
analysis of a molecular disassemblase reveals the mechanism of Hsc70-driven 
clathrin uncoating. Nat Struct Mol Biol 18, 295-301. 
Boehm, M., Aguilar, R.C., and Bonifacino, J.S. (2001). Functional and physical 
interactions of the adaptor protein complex AP-4 with ADP-ribosylation factors 
(ARFs). Embo J 20, 6265-6276. 
Boman, A.L., Zhang, C., Zhu, X., and Kahn, R.A. (2000). A family of ADP-ribosylation 
factor effectors that can alter membrane transport through the trans-Golgi. Mol Biol 
Cell 11, 1241-1255. 
  
	 LITERATURE	 		 	
112 
Bonfanti, L., Mironov, A.A., Jr., Martinez-Menarguez, J.A., Martella, O., Fusella, A., 
Baldassarre, M., Buccione, R., Geuze, H.J., Mironov, A.A., and Luini, A. (1998). 
Procollagen traverses the Golgi stack without leaving the lumen of cisternae: 
evidence for cisternal maturation. Cell 95, 993-1003. 
Bonifacino, J.S., and Glick, B.S. (2004). The mechanisms of vesicle budding and 
fusion. Cell 116, 153-166. 
Borner, G.H., Antrobus, R., Hirst, J., Bhumbra, G.S., Kozik, P., Jackson, L.P., 
Sahlender, D.A., and Robinson, M.S. (2012). Multivariate proteomic profiling 
identifies novel accessory proteins of coated vesicles. J Cell Biol 197, 141-160. 
Braell, W.A., Schlossman, D.M., Schmid, S.L., and Rothman, J.E. (1984). 
Dissociation of clathrin coats coupled to the hydrolysis of ATP: role of an uncoating 
ATPase. J Cell Biol 99, 734-741. 
Bremser, M., Nickel, W., Schweikert, M., Ravazzola, M., Amherdt, M., Hughes, C.A., 
Sollner, T.H., Rothman, J.E., and Wieland, F.T. (1999). Coupling of coat assembly 
and vesicle budding to packaging of putative cargo receptors. Cell 96, 495-506. 
Brown, M.T., Andrade, J., Radhakrishna, H., Donaldson, J.G., Cooper, J.A., and 
Randazzo, P.A. (1998). ASAP1, a phospholipid-dependent arf GTPase-activating 
protein that associates with and is phosphorylated by Src. Mol Cell Biol 18, 7038-
7051. 
Buchanan, R., Kaufman, A., Kung-Tran, L., and Miller, E.A. (2010). Genetic analysis 
of yeast Sec24p mutants suggests cargo binding is not co-operative during ER 
export. Traffic 11, 1034-1043. 
Caro, L.G., and Palade, G.E. (1964). Protein Synthesis, Storage, and Discharge in 
the Pancreatic Exocrine Cell. an Autoradiographic Study. J Cell Biol 20, 473-495. 
Casanova, J.E. (2007). Regulation of Arf activation: the Sec7 family of guanine 
nucleotide exchange factors. Traffic 8, 1476-1485. 
Cavenagh, M.M., Whitney, J.A., Carroll, K., Zhang, C., Boman, A.L., Rosenwald, 
A.G., Mellman, I., and Kahn, R.A. (1996). Intracellular distribution of Arf proteins in 
mammalian cells. Arf6 is uniquely localized to the plasma membrane. J Biol Chem 
271, 21767-21774. 
Chen, S., Cai, H., Park, S.K., Menon, S., Jackson, C.L., and Ferro-Novick, S. (2011). 
Trs65p, a subunit of the Ypt1p GEF TRAPPII, interacts with the Arf1p exchange 
factor Gea2p to facilitate COPI-mediated vesicle traffic. Mol Biol Cell 22, 3634-3644. 
Chun, J., Shapovalova, Z., Dejgaard, S.Y., Presley, J.F., and Melancon, P. (2008). 
Characterization of class I and II ADP-ribosylation factors (Arfs) in live cells: GDP-
bound class II Arfs associate with the ER-Golgi intermediate compartment 
independently of GBF1. Mol Biol Cell 19, 3488-3500. 
Ciufo, L.F., and Boyd, A. (2000). Identification of a lumenal sequence specifying the 
assembly of Emp24p into p24 complexes in the yeast secretory pathway. J Biol 
Chem 275, 8382-8388. 
Claing, A., Perry, S.J., Achiriloaie, M., Walker, J.K., Albanesi, J.P., Lefkowitz, R.J., 
and Premont, R.T. (2000). Multiple endocytic pathways of G protein-coupled 
receptors delineated by GIT1 sensitivity. Proc Natl Acad Sci U S A 97, 1119-1124. 
Claude, A., Zhao, B.P., Kuziemsky, C.E., Dahan, S., Berger, S.J., Yan, J.P., Armold, 
A.D., Sullivan, E.M., and Melancon, P. (1999). GBF1: A novel Golgi-associated BFA-
resistant guanine nucleotide exchange factor that displays specificity for ADP-
ribosylation factor 5. J Cell Biol 146, 71-84. 
Collins, B.M., McCoy, A.J., Kent, H.M., Evans, P.R., and Owen, D.J. (2002). 
Molecular architecture and functional model of the endocytic AP2 complex. Cell 109, 
523-535. 
Cosson, P., and Letourneur, F. (1994). Coatomer interaction with di-lysine 
endoplasmic reticulum retention motifs. Science 263, 1629-1631. 
  
	 LITERATURE	 		 	
113 
Cukierman, E., Huber, I., Rotman, M., and Cassel, D. (1995). The ARF1 GTPase-
activating protein: zinc finger motif and Golgi complex localization. Science 270, 
1999-2002. 
d'Enfert, C., Wuestehube, L.J., Lila, T., and Schekman, R. (1991). Sec12p-
dependent membrane binding of the small GTP-binding protein Sar1p promotes 
formation of transport vesicles from the ER. J Cell Biol 114, 663-670. 
D'Souza-Schorey, C., van Donselaar, E., Hsu, V.W., Yang, C., Stahl, P.D., and 
Peters, P.J. (1998). ARF6 targets recycling vesicles to the plasma membrane: 
insights from an ultrastructural investigation. J Cell Biol 140, 603-616. 
de Graffenried, C.L., and Bertozzi, C.R. (2004). The roles of enzyme localisation and 
complex formation in glycan assembly within the Golgi apparatus. Curr Opin Cell Biol 
16, 356-363. 
Dell'Angelica, E.C., Klumperman, J., Stoorvogel, W., and Bonifacino, J.S. (1998). 
Association of the AP-3 adaptor complex with clathrin. Science 280, 431-434. 
Dell'Angelica, E.C., Mullins, C., and Bonifacino, J.S. (1999). AP-4, a novel protein 
complex related to clathrin adaptors. J Biol Chem 274, 7278-7285. 
Dell'Angelica, E.C., Ohno, H., Ooi, C.E., Rabinovich, E., Roche, K.W., and 
Bonifacino, J.S. (1997). AP-3: an adaptor-like protein complex with ubiquitous 
expression. Embo J 16, 917-928. 
Dell'Angelica, E.C., Puertollano, R., Mullins, C., Aguilar, R.C., Vargas, J.D., Hartnell, 
L.M., and Bonifacino, J.S. (2000). GGAs: a family of ADP ribosylation factor-binding 
proteins related to adaptors and associated with the Golgi complex. J Cell Biol 149, 
81-94. 
Deng, Y., Golinelli-Cohen, M.P., Smirnova, E., and Jackson, C.L. (2009). A COPI 
coat subunit interacts directly with an early-Golgi localized Arf exchange factor. 
EMBO reports 10, 58-64. 
Denzel, A., Otto, F., Girod, A., Pepperkok, R., Watson, R., Rosewell, I., Bergeron, 
J.J., Solari, R.C., and Owen, M.J. (2000). The p24 family member p23 is required for 
early embryonic development. Curr Biol 10, 55-58. 
Di Cesare, A., Paris, S., Albertinazzi, C., Dariozzi, S., Andersen, J., Mann, M., 
Longhi, R., and de Curtis, I. (2000). p95-APP1 links membrane transport to Rac-
mediated reorganization of actin. Nature cell biology 2, 521-530. 
Dodonova, S.O., Diestelkoetter-Bachert, P., von Appen, A., Hagen, W.J., Beck, R., 
Beck, M., Wieland, F., and Briggs, J.A. (2015). VESICULAR TRANSPORT. A 
structure of the COPI coat and the role of coat proteins in membrane vesicle 
assembly. Science 349, 195-198. 
Dominguez, M., Dejgaard, K., Fullekrug, J., Dahan, S., Fazel, A., Paccaud, J.P., 
Thomas, D.Y., Bergeron, J.J., and Nilsson, T. (1998). gp25L/emp24/p24 protein 
family members of the cis-Golgi network bind both COP I and II coatomer. J Cell Biol 
140, 751-765. 
Donaldson, J.G., Cassel, D., Kahn, R.A., and Klausner, R.D. (1992). ADP-
ribosylation factor, a small GTP-binding protein, is required for binding of the 
coatomer protein beta-COP to Golgi membranes. Proc Natl Acad Sci U S A 89, 
6408-6412. 
Duden, R., Griffiths, G., Frank, R., Argos, P., and Kreis, T.E. (1991). Beta-COP, a 
110 kd protein associated with non-clathrin-coated vesicles and the Golgi complex, 
shows homology to beta-adaptin. Cell 64, 649-665. 
Dunphy, W.G., Fries, E., Urbani, L.J., and Rothman, J.E. (1981). Early and late 
functions associated with the Golgi apparatus reside in distinct compartments. Proc 
Natl Acad Sci U S A 78, 7453-7457. 
Dunphy, W.G., and Rothman, J.E. (1983). Compartmentation of asparagine-linked 
oligosaccharide processing in the Golgi apparatus. J Cell Biol 97, 270-275. 
Emery, G., Rojo, M., and Gruenberg, J. (2000). Coupled transport of p24 family 
members. Journal of cell science 113 ( Pt 13), 2507-2516. 
  
	 LITERATURE	 		 	
114 
Espenshade, P., Gimeno, R.E., Holzmacher, E., Teung, P., and Kaiser, C.A. (1995). 
Yeast SEC16 gene encodes a multidomain vesicle coat protein that interacts with 
Sec23p. J Cell Biol 131, 311-324. 
Eugster, A., Frigerio, G., Dale, M., and Duden, R. (2000). COP I domains required for 
coatomer integrity, and novel interactions with ARF and ARF-GAP. Embo J 19, 3905-
3917. 
Faini, M., Prinz, S., Beck, R., Schorb, M., Riches, J.D., Bacia, K., Brugger, B., 
Wieland, F.T., and Briggs, J.A. (2012). The structures of COPI-coated vesicles reveal 
alternate coatomer conformations and interactions. Science 336, 1451-1454. 
Forster, R., Weiss, M., Zimmermann, T., Reynaud, E.G., Verissimo, F., Stephens, 
D.J., and Pepperkok, R. (2006). Secretory cargo regulates the turnover of COPII 
subunits at single ER exit sites. Curr Biol 16, 173-179. 
Fotin, A., Cheng, Y., Sliz, P., Grigorieff, N., Harrison, S.C., Kirchhausen, T., and 
Walz, T. (2004). Molecular model for a complete clathrin lattice from electron 
cryomicroscopy. Nature 432, 573-579. 
Frigerio, G., Grimsey, N., Dale, M., Majoul, I., and Duden, R. (2007). Two human 
ARFGAPs associated with COP-I-coated vesicles. Traffic 8, 1644-1655. 
Fullekrug, J., Suganuma, T., Tang, B.L., Hong, W., Storrie, B., and Nilsson, T. 
(1999). Localization and recycling of gp27 (hp24gamma3): complex formation with 
other p24 family members. Mol Biol Cell 10, 1939-1955. 
Futai, E., Hamamoto, S., Orci, L., and Schekman, R. (2004). GTP/GDP exchange by 
Sec12p enables COPII vesicle bud formation on synthetic liposomes. EMBO J 23, 
4146-4155. 
Futatsumori, M., Kasai, K., Takatsu, H., Shin, H.W., and Nakayama, K. (2000). 
Identification and characterization of novel isoforms of COP I subunits. Journal of 
biochemistry 128, 793-801. 
Gaidarov, I., Chen, Q., Falck, J.R., Reddy, K.K., and Keen, J.H. (1996). A functional 
phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain in the 
clathrin adaptor AP-2 alpha subunit. Implications for the endocytic pathway. J Biol 
Chem 271, 20922-20929. 
Gaidarov, I., and Keen, J.H. (1999). Phosphoinositide-AP-2 interactions required for 
targeting to plasma membrane clathrin-coated pits. J Cell Biol 146, 755-764. 
Garcia-Mata, R., Szul, T., Alvarez, C., and Sztul, E. (2003). ADP-ribosylation 
factor/COPI-dependent events at the endoplasmic reticulum-Golgi interface are 
regulated by the guanine nucleotide exchange factor GBF1. Mol Biol Cell 14, 2250-
2261. 
Gillingham, A.K., and Munro, S. (2007). The small G proteins of the Arf family and 
their regulators. Annu Rev Cell Dev Biol 23, 579-611. 
Gimeno, R.E., Espenshade, P., and Kaiser, C.A. (1996). COPII coat subunit 
interactions: Sec24p and Sec23p bind to adjacent regions of Sec16p. Mol Biol Cell 7, 
1815-1823. 
Glick, B.S., and Luini, A. (2011). Models for Golgi traffic: a critical assessment. Cold 
Spring Harb Perspect Biol 3, a005215. 
Glick, B.S., and Malhotra, V. (1998). The curious status of the Golgi apparatus. Cell 
95, 883-889. 
Glickman, J.N., Conibear, E., and Pearse, B.M. (1989). Specificity of binding of 
clathrin adaptors to signals on the mannose-6-phosphate/insulin-like growth factor II 
receptor. Embo J 8, 1041-1047. 
Goldberg, J. (1999). Structural and functional analysis of the ARF1-ARFGAP 
complex reveals a role for coatomer in GTP hydrolysis. Cell 96, 893-902. 
Gommel, D., Orci, L., Emig, E.M., Hannah, M.J., Ravazzola, M., Nickel, W., Helms, 
J.B., Wieland, F.T., and Sohn, K. (1999). p24 and p23, the major transmembrane 
proteins of COPI-coated transport vesicles, form hetero-oligomeric complexes and 
  
	 LITERATURE	 		 	
115 
cycle between the organelles of the early secretory pathway. FEBS Lett 447, 179-
185. 
Gommel, D.U., Memon, A.R., Heiss, A., Lottspeich, F., Pfannstiel, J., Lechner, J., 
Reinhard, C., Helms, J.B., Nickel, W., and Wieland, F.T. (2001). Recruitment to Golgi 
membranes of ADP-ribosylation factor 1 is mediated by the cytoplasmic domain of 
p23. Embo J 20, 6751-6760. 
Goud, B., and Gleeson, P.A. (2010). TGN golgins, Rabs and cytoskeleton: regulating 
the Golgi trafficking highways. Trends in cell biology 20, 329-336. 
Griffiths, G., Quinn, P., and Warren, G. (1983). Dissection of the Golgi complex. I. 
Monensin inhibits the transport of viral membrane proteins from medial to trans Golgi 
cisternae in baby hamster kidney cells infected with Semliki Forest virus. J Cell Biol 
96, 835-850. 
Gu, F., Crump, C.M., and Thomas, G. (2001). Trans-Golgi network sorting. Cell Mol 
Life Sci 58, 1067-1084. 
Hammond, A.T., and Glick, B.S. (2000). Dynamics of transitional endoplasmic 
reticulum sites in vertebrate cells. Mol Biol Cell 11, 3013-3030. 
Hara-Kuge, S., Kuge, O., Orci, L., Amherdt, M., Ravazzola, M., Wieland, F.T., and 
Rothman, J.E. (1994). En bloc incorporation of coatomer subunits during the 
assembly of COP-coated vesicles. J Cell Biol 124, 883-892. 
Harter, C., and Wieland, F.T. (1998). A single binding site for dilysine retrieval motifs 
and p23 within the gamma subunit of coatomer. Proc Natl Acad Sci U S A 95, 11649-
11654. 
Hill, K., Li, Y., Bennett, M., McKay, M., Zhu, X., Shern, J., Torre, E., Lah, J.J., Levey, 
A.I., and Kahn, R.A. (2003). Munc18 interacting proteins: ADP-ribosylation factor-
dependent coat proteins that regulate the traffic of beta-Alzheimer's precursor 
protein. J Biol Chem 278, 36032-36040. 
Hinners, I., and Tooze, S.A. (2003). Changing directions: clathrin-mediated transport 
between the Golgi and endosomes. Journal of cell science 116, 763-771. 
Hirst, J., Barlow, L.D., Francisco, G.C., Sahlender, D.A., Seaman, M.N., Dacks, J.B., 
and Robinson, M.S. (2011). The fifth adaptor protein complex. PLoS biology 9, 
e1001170. 
Hirst, J., Bright, N.A., Rous, B., and Robinson, M.S. (1999). Characterization of a 
fourth adaptor-related protein complex. Mol Biol Cell 10, 2787-2802. 
Hirst, J., Lui, W.W., Bright, N.A., Totty, N., Seaman, M.N., and Robinson, M.S. 
(2000). A family of proteins with gamma-adaptin and VHS domains that facilitate 
trafficking between the trans-Golgi network and the vacuole/lysosome. J Cell Biol 
149, 67-80. 
Hsu, V.W. (2011). Role of ArfGAP1 in COPI vesicle biogenesis. Cell Logist 1, 55-56. 
Huang, M., Weissman, J.T., Beraud-Dufour, S., Luan, P., Wang, C., Chen, W., 
Aridor, M., Wilson, I.A., and Balch, W.E. (2001). Crystal structure of Sar1-GDP at 1.7 
A resolution and the role of the NH2 terminus in ER export. J Cell Biol 155, 937-948. 
Hughes, H., Budnik, A., Schmidt, K., Palmer, K.J., Mantell, J., Noakes, C., Johnson, 
A., Carter, D.A., Verkade, P., Watson, P., et al. (2009). Organisation of human ER-
exit sites: requirements for the localisation of Sec16 to transitional ER. Journal of cell 
science 122, 2924-2934. 
I, S.T., Nie, Z., Stewart, A., Najdovska, M., Hall, N.E., He, H., Randazzo, P.A., and 
Lock, P. (2004). ARAP3 is transiently tyrosine phosphorylated in cells attaching to 
fibronectin and inhibits cell spreading in a RhoGAP-dependent manner. Journal of 
cell science 117, 6071-6084. 
Inoue, H., and Randazzo, P.A. (2007). Arf GAPs and their interacting proteins. Traffic 
8, 1465-1475. 
Ivan, V., de Voer, G., Xanthakis, D., Spoorendonk, K.M., Kondylis, V., and Rabouille, 
C. (2008). Drosophila Sec16 mediates the biogenesis of tER sites upstream of Sar1 
through an arginine-rich motif. Mol Biol Cell 19, 4352-4365. 
  
	 LITERATURE	 		 	
116 
Jackson, L.P. (2014). Structure and mechanism of COPI vesicle biogenesis. Curr 
Opin Cell Biol 29, 67-73. 
Jackson, M.R., Nilsson, T., and Peterson, P.A. (1990). Identification of a consensus 
motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J 
9, 3153-3162. 
Jacques, K.M., Nie, Z., Stauffer, S., Hirsch, D.S., Chen, L.X., Stanley, K.T., and 
Randazzo, P.A. (2002). Arf1 dissociates from the clathrin adaptor GGA prior to being 
inactivated by Arf GTPase-activating proteins. J Biol Chem 277, 47235-47241. 
Jamieson, J.D., and Palade, G.E. (1967). Intracellular transport of secretory proteins 
in the pancreatic exocrine cell. I. Role of the peripheral elements of the Golgi 
complex. J Cell Biol 34, 577-596. 
Kahn, R.A., Cherfils, J., Elias, M., Lovering, R.C., Munro, S., and Schurmann, A. 
(2006). Nomenclature for the human Arf family of GTP-binding proteins: ARF, ARL, 
and SAR proteins. J Cell Biol 172, 645-650. 
Kaiser, C.A., and Schekman, R. (1990). Distinct sets of SEC genes govern transport 
vesicle formation and fusion early in the secretory pathway. Cell 61, 723-733. 
Karrenbauer, A., Jeckel, D., Just, W., Birk, R., Schmidt, R.R., Rothman, J.E., and 
Wieland, F.T. (1990). The rate of bulk flow from the Golgi to the plasma membrane. 
Cell 63, 259-267. 
Kartberg, F., Asp, L., Dejgaard, S.Y., Smedh, M., Fernandez-Rodriguez, J., Nilsson, 
T., and Presley, J.F. (2010). ARFGAP2 and ARFGAP3 are essential for COPI coat 
assembly on the Golgi membrane of living cells. J Biol Chem 285, 36709-36720. 
Kirchhausen, T. (2000). Clathrin. Annu Rev Biochem 69, 699-727. 
Kirchhausen, T., and Harrison, S.C. (1981). Protein organization in clathrin trimers. 
Cell 23, 755-761. 
Kirchhausen, T., Owen, D., and Harrison, S.C. (2014). Molecular structure, function, 
and dynamics of clathrin-mediated membrane traffic. Cold Spring Harb Perspect Biol 
6, a016725. 
Kliouchnikov, L., Bigay, J., Mesmin, B., Parnis, A., Rawet, M., Goldfeder, N., 
Antonny, B., and Cassel, D. (2009). Discrete determinants in ArfGAP2/3 conferring 
Golgi localization and regulation by the COPI coat. Mol Biol Cell 20, 859-869. 
Krugmann, S., Anderson, K.E., Ridley, S.H., Risso, N., McGregor, A., Coadwell, J., 
Davidson, K., Eguinoa, A., Ellson, C.D., Lipp, P., et al. (2002). Identification of 
ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective 
capture on phosphoinositide affinity matrices. Molecular cell 9, 95-108. 
Kuehn, M.J., Herrmann, J.M., and Schekman, R. (1998). COPII-cargo interactions 
direct protein sorting into ER-derived transport vesicles. Nature 391, 187-190. 
Kung, L.F., Pagant, S., Futai, E., D'Arcangelo, J.G., Buchanan, R., Dittmar, J.C., 
Reid, R.J., Rothstein, R., Hamamoto, S., Snapp, E.L., et al. (2012). Sec24p and 
Sec16p cooperate to regulate the GTP cycle of the COPII coat. EMBO J 31, 1014-
1027. 
Langer, J.D., Roth, C.M., Bethune, J., Stoops, E.H., Brugger, B., Herten, D.P., and 
Wieland, F.T. (2008). A conformational change in the alpha-subunit of coatomer 
induced by ligand binding to gamma-COP revealed by single-pair FRET. Traffic 9, 
597-607. 
Langer, J.D., Stoops, E.H., Bethune, J., and Wieland, F.T. (2007). Conformational 
changes of coat proteins during vesicle formation. FEBS Lett 581, 2083-2088. 
Lanoix, J., Ouwendijk, J., Lin, C.C., Stark, A., Love, H.D., Ostermann, J., and 
Nilsson, T. (1999). GTP hydrolysis by arf-1 mediates sorting and concentration of 
Golgi resident enzymes into functional COP I vesicles. Embo J 18, 4935-4948. 
Lanoix, J., Ouwendijk, J., Stark, A., Szafer, E., Cassel, D., Dejgaard, K., Weiss, M., 
and Nilsson, T. (2001). Sorting of Golgi resident proteins into different 
subpopulations of COPI vesicles: a role for ArfGAP1. J Cell Biol 155, 1199-1212. 
  
	 LITERATURE	 		 	
117 
Lee, S.Y., Yang, J.S., Hong, W., Premont, R.T., and Hsu, V.W. (2005). ARFGAP1 
plays a central role in coupling COPI cargo sorting with vesicle formation. J Cell Biol 
168, 281-290. 
Lenhard, J.M., Kahn, R.A., and Stahl, P.D. (1992). Evidence for ADP-ribosylation 
factor (ARF) as a regulator of in vitro endosome-endosome fusion. J Biol Chem 267, 
13047-13052. 
Letourneur, F., Gaynor, E.C., Hennecke, S., Demolliere, C., Duden, R., Emr, S.D., 
Riezman, H., and Cosson, P. (1994). Coatomer is essential for retrieval of dilysine-
tagged proteins to the endoplasmic reticulum. Cell 79, 1199-1207. 
Levi, V., Villamil Giraldo, A.M., Castello, P.R., Rossi, J.P., and Gonzalez Flecha, F.L. 
(2008). Effects of phosphatidylethanolamine glycation on lipid-protein interactions 
and membrane protein thermal stability. The Biochemical journal 416, 145-152. 
Lewis, S.M., Poon, P.P., Singer, R.A., Johnston, G.C., and Spang, A. (2004). The 
ArfGAP Glo3 is required for the generation of COPI vesicles. Mol Biol Cell 15, 4064-
4072. 
Li, J., Peters, P.J., Bai, M., Dai, J., Bos, E., Kirchhausen, T., Kandror, K.V., and Hsu, 
V.W. (2007). An ACAP1-containing clathrin coat complex for endocytic recycling. J 
Cell Biol 178, 453-464. 
Lord, C., Bhandari, D., Menon, S., Ghassemian, M., Nycz, D., Hay, J., Ghosh, P., 
and Ferro-Novick, S. (2011). Sequential interactions with Sec23 control the direction 
of vesicle traffic. Nature 473, 181-186. 
Love, H.D., Lin, C.C., Short, C.S., and Ostermann, J. (1998). Isolation of functional 
Golgi-derived vesicles with a possible role in retrograde transport. J Cell Biol 140, 
541-551. 
Majoul, I., Straub, M., Hell, S.W., Duden, R., and Soling, H.D. (2001). KDEL-cargo 
regulates interactions between proteins involved in COPI vesicle traffic: 
measurements in living cells using FRET. Developmental cell 1, 139-153. 
Malsam, J., Gommel, D., Wieland, F.T., and Nickel, W. (1999). A role for ADP 
ribosylation factor in the control of cargo uptake during COPI-coated vesicle 
biogenesis. FEBS Lett 462, 267-272. 
Mancias, J.D., and Goldberg, J. (2007). The transport signal on Sec22 for packaging 
into COPII-coated vesicles is a conformational epitope. Molecular cell 26, 403-414. 
Marzioch, M., Henthorn, D.C., Herrmann, J.M., Wilson, R., Thomas, D.Y., Bergeron, 
J.J., Solari, R.C., and Rowley, A. (1999). Erp1p and Erp2p, partners for Emp24p and 
Erv25p in a yeast p24 complex. Mol Biol Cell 10, 1923-1938. 
Massol, R.H., Boll, W., Griffin, A.M., and Kirchhausen, T. (2006). A burst of auxilin 
recruitment determines the onset of clathrin-coated vesicle uncoating. Proc Natl 
Acad Sci U S A 103, 10265-10270. 
Matsuoka, K., Orci, L., Amherdt, M., Bednarek, S.Y., Hamamoto, S., Schekman, R., 
and Yeung, T. (1998). COPII-coated vesicle formation reconstituted with purified coat 
proteins and chemically defined liposomes. Cell 93, 263-275. 
McMahon, H.T., and Mills, I.G. (2004). COP and clathrin-coated vesicle budding: 
different pathways, common approaches. Curr Opin Cell Biol 16, 379-391. 
Melancon, P., Glick, B.S., Malhotra, V., Weidman, P.J., Serafini, T., Gleason, M.L., 
Orci, L., and Rothman, J.E. (1987). Involvement of GTP-binding "G" proteins in 
transport through the Golgi stack. Cell 51, 1053-1062. 
Mellman, I. (1996). Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 12, 
575-625. 
Mesmin, B., Drin, G., Levi, S., Rawet, M., Cassel, D., Bigay, J., and Antonny, B. 
(2007). Two lipid-packing sensor motifs contribute to the sensitivity of ArfGAP1 to 
membrane curvature. Biochemistry 46, 1779-1790. 
Miller, E., Antonny, B., Hamamoto, S., and Schekman, R. (2002). Cargo selection 
into COPII vesicles is driven by the Sec24p subunit. EMBO J 21, 6105-6113. 
  
	 LITERATURE	 		 	
118 
Miller, E.A., and Barlowe, C. (2010). Regulation of coat assembly--sorting things out 
at the ER. Curr Opin Cell Biol 22, 447-453. 
Miller, E.A., Beilharz, T.H., Malkus, P.N., Lee, M.C., Hamamoto, S., Orci, L., and 
Schekman, R. (2003). Multiple cargo binding sites on the COPII subunit Sec24p 
ensure capture of diverse membrane proteins into transport vesicles. Cell 114, 497-
509. 
Miller, E.A., and Schekman, R. (2013). COPII - a flexible vesicle formation system. 
Curr Opin Cell Biol 25, 420-427. 
Miura, K., Jacques, K.M., Stauffer, S., Kubosaki, A., Zhu, K., Hirsch, D.S., Resau, J., 
Zheng, Y., and Randazzo, P.A. (2002). ARAP1: a point of convergence for Arf and 
Rho signaling. Molecular cell 9, 109-119. 
Moelleken, J., Malsam, J., Betts, M.J., Movafeghi, A., Reckmann, I., Meissner, I., 
Hellwig, A., Russell, R.B., Sollner, T., Brugger, B., et al. (2007). Differential 
localization of coatomer complex isoforms within the Golgi apparatus. Proc Natl Acad 
Sci U S A 104, 4425-4430. 
Mogelsvang, S., Gomez-Ospina, N., Soderholm, J., Glick, B.S., and Staehelin, L.A. 
(2003). Tomographic evidence for continuous turnover of Golgi cisternae in Pichia 
pastoris. Mol Biol Cell 14, 2277-2291. 
Montegna, E.A., Bhave, M., Liu, Y., Bhattacharyya, D., and Glick, B.S. (2012). Sec12 
binds to Sec16 at transitional ER sites. PLoS One 7, e31156. 
Mossessova, E., Bickford, L.C., and Goldberg, J. (2003). SNARE selectivity of the 
COPII coat. Cell 114, 483-495. 
Muniz, M., Nuoffer, C., Hauri, H.P., and Riezman, H. (2000). The Emp24 complex 
recruits a specific cargo molecule into endoplasmic reticulum-derived vesicles. J Cell 
Biol 148, 925-930. 
Munro, S. (2001). What can yeast tell us about N-linked glycosylation in the Golgi 
apparatus? FEBS Lett 498, 223-227. 
Munro, S. (2011). The golgin coiled-coil proteins of the Golgi apparatus. Cold Spring 
Harb Perspect Biol 3. 
Nakano, A., and Muramatsu, M. (1989). A novel GTP-binding protein, Sar1p, is 
involved in transport from the endoplasmic reticulum to the Golgi apparatus. J Cell 
Biol 109, 2677-2691. 
Nakatsu, F., and Ohno, H. (2003). Adaptor protein complexes as the key regulators 
of protein sorting in the post-Golgi network. Cell Struct Funct 28, 419-429. 
Natsume, W., Tanabe, K., Kon, S., Yoshida, N., Watanabe, T., Torii, T., and Satake, 
M. (2006). SMAP2, a novel ARF GTPase-activating protein, interacts with clathrin 
and clathrin assembly protein and functions on the AP-1-positive early 
endosome/trans-Golgi network. Mol Biol Cell 17, 2592-2603. 
Nickel, W., Malsam, J., Gorgas, K., Ravazzola, M., Jenne, N., Helms, J.B., and 
Wieland, F.T. (1998). Uptake by COPI-coated vesicles of both anterograde and 
retrograde cargo is inhibited by GTPgammaS in vitro. Journal of cell science 111 ( Pt 
20), 3081-3090. 
Nickel, W., Sohn, K., Bunning, C., and Wieland, F.T. (1997). p23, a major COPI-
vesicle membrane protein, constitutively cycles through the early secretory pathway. 
Proc Natl Acad Sci U S A 94, 11393-11398. 
Nie, Z., Boehm, M., Boja, E.S., Vass, W.C., Bonifacino, J.S., Fales, H.M., and 
Randazzo, P.A. (2003a). Specific regulation of the adaptor protein complex AP-3 by 
the Arf GAP AGAP1. Developmental cell 5, 513-521. 
Nie, Z., Fei, J., Premont, R.T., and Randazzo, P.A. (2005). The Arf GAPs AGAP1 
and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3. 
Journal of cell science 118, 3555-3566. 
Nie, Z., Hirsch, D.S., Luo, R., Jian, X., Stauffer, S., Cremesti, A., Andrade, J., 
Lebowitz, J., Marino, M., Ahvazi, B., et al. (2006). A BAR domain in the N terminus of 
  
	 LITERATURE	 		 	
119 
the Arf GAP ASAP1 affects membrane structure and trafficking of epidermal growth 
factor receptor. Curr Biol 16, 130-139. 
Nie, Z., Hirsch, D.S., and Randazzo, P.A. (2003b). Arf and its many interactors. Curr 
Opin Cell Biol 15, 396-404. 
Nilsson, T., Au, C.E., and Bergeron, J.J. (2009). Sorting out glycosylation enzymes in 
the Golgi apparatus. FEBS Lett 583, 3764-3769. 
Niu, T.K., Pfeifer, A.C., Lippincott-Schwartz, J., and Jackson, C.L. (2005). Dynamics 
of GBF1, a Brefeldin A-sensitive Arf1 exchange factor at the Golgi. Mol Biol Cell 16, 
1213-1222. 
Novick, P., Field, C., and Schekman, R. (1980). Identification of 23 complementation 
groups required for post-translational events in the yeast secretory pathway. Cell 21, 
205-215. 
Ooi, C.E., Dell'Angelica, E.C., and Bonifacino, J.S. (1998). ADP-Ribosylation factor 1 
(ARF1) regulates recruitment of the AP-3 adaptor complex to membranes. J Cell Biol 
142, 391-402. 
Opat, A.S., Houghton, F., and Gleeson, P.A. (2001). Steady-state localization of a 
medial-Golgi glycosyltransferase involves transit through the trans-Golgi network. 
The Biochemical journal 358, 33-40. 
Orci, L., Palmer, D.J., Ravazzola, M., Perrelet, A., Amherdt, M., and Rothman, J.E. 
(1993). Budding from Golgi membranes requires the coatomer complex of non-
clathrin coat proteins. Nature 362, 648-652. 
Orci, L., Stamnes, M., Ravazzola, M., Amherdt, M., Perrelet, A., Sollner, T.H., and 
Rothman, J.E. (1997). Bidirectional transport by distinct populations of COPI-coated 
vesicles. Cell 90, 335-349. 
Ostermann, J., Orci, L., Tani, K., Amherdt, M., Ravazzola, M., Elazar, Z., and 
Rothman, J.E. (1993). Stepwise assembly of functionally active transport vesicles. 
Cell 75, 1015-1025. 
Owen, D.J., Collins, B.M., and Evans, P.R. (2004). Adaptors for clathrin coats: 
structure and function. Annu Rev Cell Dev Biol 20, 153-191. 
Paczkowski, J.E., Richardson, B.C., and Fromme, J.C. (2015). Cargo adaptors: 
structures illuminate mechanisms regulating vesicle biogenesis. Trends in cell 
biology 25, 408-416. 
Palade, G. (1975). Intracellular aspects of the process of protein synthesis. Science 
189, 347-358. 
Palmer, D.J., Helms, J.B., Beckers, C.J., Orci, L., and Rothman, J.E. (1993). Binding 
of coatomer to Golgi membranes requires ADP-ribosylation factor. J Biol Chem 268, 
12083-12089. 
Parlati, F., McNew, J.A., Fukuda, R., Miller, R., Sollner, T.H., and Rothman, J.E. 
(2000). Topological restriction of SNARE-dependent membrane fusion. Nature 407, 
194-198. 
Pearse, B.M., and Robinson, M.S. (1990). Clathrin, adaptors, and sorting. Annu Rev 
Cell Biol 6, 151-171. 
Peden, A.A., Rudge, R.E., Lui, W.W., and Robinson, M.S. (2002). Assembly and 
function of AP-3 complexes in cells expressing mutant subunits. J Cell Biol 156, 327-
336. 
Pepperkok, R., Whitney, J.A., Gomez, M., and Kreis, T.E. (2000). COPI vesicles 
accumulating in the presence of a GTP restricted arf1 mutant are depleted of 
anterograde and retrograde cargo. Journal of cell science 113 ( Pt 1), 135-144. 
Peters, P.J., Hsu, V.W., Ooi, C.E., Finazzi, D., Teal, S.B., Oorschot, V., Donaldson, 
J.G., and Klausner, R.D. (1995). Overexpression of wild-type and mutant ARF1 and 
ARF6: distinct perturbations of nonoverlapping membrane compartments. J Cell Biol 
128, 1003-1017. 
  
	 LITERATURE	 		 	
120 
Pevzner, I., Strating, J., Lifshitz, L., Parnis, A., Glaser, F., Herrmann, A., Brugger, B., 
Wieland, F., and Cassel, D. (2012). Distinct role of subcomplexes of the COPI coat in 
the regulation of ArfGAP2 activity. Traffic 13, 849-856. 
Pfeffer, S.R. (2010). How the Golgi works: a cisternal progenitor model. Proc Natl 
Acad Sci U S A 107, 19614-19618. 
Poon, P.P., Cassel, D., Spang, A., Rotman, M., Pick, E., Singer, R.A., and Johnston, 
G.C. (1999). Retrograde transport from the yeast Golgi is mediated by two ARF GAP 
proteins with overlapping function. EMBO J 18, 555-564. 
Popoff, V., Adolf, F., Brugger, B., and Wieland, F. (2011a). COPI budding within the 
Golgi stack. Cold Spring Harb Perspect Biol 3, a005231. 
Popoff, V., Langer, J.D., Reckmann, I., Hellwig, A., Kahn, R.A., Brugger, B., and 
Wieland, F.T. (2011b). Several ADP-ribosylation factor (Arf) isoforms support COPI 
vesicle formation. J Biol Chem 286, 35634-35642. 
Premont, R.T., Perry, S.J., Schmalzigaug, R., Roseman, J.T., Xing, Y., and Claing, 
A. (2004). The GIT/PIX complex: an oligomeric assembly of GIT family ARF 
GTPase-activating proteins and PIX family Rac1/Cdc42 guanine nucleotide 
exchange factors. Cell Signal 16, 1001-1011. 
Presley, J.F., Cole, N.B., Schroer, T.A., Hirschberg, K., Zaal, K.J., and Lippincott-
Schwartz, J. (1997). ER-to-Golgi transport visualized in living cells. Nature 389, 81-
85. 
Presley, J.F., Ward, T.H., Pfeifer, A.C., Siggia, E.D., Phair, R.D., and Lippincott-
Schwartz, J. (2002). Dissection of COPI and Arf1 dynamics in vivo and role in Golgi 
membrane transport. Nature 417, 187-193. 
Puertollano, R., Randazzo, P.A., Presley, J.F., Hartnell, L.M., and Bonifacino, J.S. 
(2001). The GGAs promote ARF-dependent recruitment of clathrin to the TGN. Cell 
105, 93-102. 
Quinn, P., Griffiths, G., and Warren, G. (1983). Dissection of the Golgi complex. II. 
Density separation of specific Golgi functions in virally infected cells treated with 
monensin. J Cell Biol 96, 851-856. 
Rambourg, A., and Clermont, Y. (1990). Three-dimensional electron microscopy: 
structure of the Golgi apparatus. Eur J Cell Biol 51, 189-200. 
Ramirez, I.B., and Lowe, M. (2009). Golgins and GRASPs: holding the Golgi 
together. Semin Cell Dev Biol 20, 770-779. 
Randazzo, P.A., and Hirsch, D.S. (2004). Arf GAPs: multifunctional proteins that 
regulate membrane traffic and actin remodelling. Cell Signal 16, 401-413. 
Rapoport, T.A. (2008). Protein transport across the endoplasmic reticulum 
membrane. FEBS J 275, 4471-4478. 
Rawet, M., Levi-Tal, S., Szafer-Glusman, E., Parnis, A., and Cassel, D. (2010). 
ArfGAP1 interacts with coat proteins through tryptophan-based motifs. Biochem 
Biophys Res Commun 394, 553-557. 
Rehling, P., Darsow, T., Katzmann, D.J., and Emr, S.D. (1999). Formation of AP-3 
transport intermediates requires Vps41 function. Nature cell biology 1, 346-353. 
Reilly, B.A., Kraynack, B.A., VanRheenen, S.M., and Waters, M.G. (2001). Golgi-to-
endoplasmic reticulum (ER) retrograde traffic in yeast requires Dsl1p, a component 
of the ER target site that interacts with a COPI coat subunit. Mol Biol Cell 12, 3783-
3796. 
Reinhard, C., Harter, C., Bremser, M., Brugger, B., Sohn, K., Helms, J.B., and 
Wieland, F. (1999). Receptor-induced polymerization of coatomer. Proc Natl Acad 
Sci U S A 96, 1224-1228. 
Reinhard, C., Schweikert, M., Wieland, F.T., and Nickel, W. (2003). Functional 
reconstitution of COPI coat assembly and disassembly using chemically defined 
components. Proc Natl Acad Sci U S A 100, 8253-8257. 
Robinson, D.G., and Pimpl, P. (2014). Clathrin and post-Golgi trafficking: a very 
complicated issue. Trends Plant Sci 19, 134-139. 
  
	 LITERATURE	 		 	
121 
Robinson, M.S. (2004). Adaptable adaptors for coated vesicles. Trends in cell 
biology 14, 167-174. 
Rodriguez-Boulan, E., and Musch, A. (2005). Protein sorting in the Golgi complex: 
shifting paradigms. Biochim Biophys Acta 1744, 455-464. 
Rohde, G., Wenzel, D., and Haucke, V. (2002). A phosphatidylinositol (4,5)-
bisphosphate binding site within mu2-adaptin regulates clathrin-mediated 
endocytosis. J Cell Biol 158, 209-214. 
Rothman, J.E., and Wieland, F.T. (1996). Protein sorting by transport vesicles. 
Science 272, 227-234. 
Sanchez-Velar, N., Udofia, E.B., Yu, Z., and Zapp, M.L. (2004). hRIP, a cellular 
cofactor for Rev function, promotes release of HIV RNAs from the perinuclear region. 
Genes Dev 18, 23-34. 
Sato, K., and Nakano, A. (2005). Dissection of COPII subunit-cargo assembly and 
disassembly kinetics during Sar1p-GTP hydrolysis. Nat Struct Mol Biol 12, 167-174. 
Scheffzek, K., Ahmadian, M.R., and Wittinghofer, A. (1998). GTPase-activating 
proteins: helping hands to complement an active site. Trends Biochem Sci 23, 257-
262. 
Schimmoller, F., Singer-Kruger, B., Schroder, S., Kruger, U., Barlowe, C., and 
Riezman, H. (1995). The absence of Emp24p, a component of ER-derived COPII-
coated vesicles, causes a defect in transport of selected proteins to the Golgi. EMBO 
J 14, 1329-1339. 
Schledzewski, K., Brinkmann, H., and Mendel, R.R. (1999). Phylogenetic analysis of 
components of the eukaryotic vesicle transport system reveals a common origin of 
adaptor protein complexes 1, 2, and 3 and the F subcomplex of the coatomer COPI. 
J Mol Evol 48, 770-778. 
Schlossman, D.M., Schmid, S.L., Braell, W.A., and Rothman, J.E. (1984). An 
enzyme that removes clathrin coats: purification of an uncoating ATPase. J Cell Biol 
99, 723-733. 
Schmalzigaug, R., Phee, H., Davidson, C.E., Weiss, A., and Premont, R.T. (2007). 
Differential expression of the ARF GAP genes GIT1 and GIT2 in mouse tissues. J 
Histochem Cytochem 55, 1039-1048. 
Schmid, S.L., Braell, W.A., Schlossman, D.M., and Rothman, J.E. (1984). A role for 
clathrin light chains in the recognition of clathrin cages by 'uncoating ATPase'. Nature 
311, 228-231. 
Schoberer, J., and Strasser, R. (2011). Sub-compartmental organization of Golgi-
resident N-glycan processing enzymes in plants. Mol Plant 4, 220-228. 
Serafini, T., Orci, L., Amherdt, M., Brunner, M., Kahn, R.A., and Rothman, J.E. 
(1991a). ADP-ribosylation factor is a subunit of the coat of Golgi-derived COP-coated 
vesicles: a novel role for a GTP-binding protein. Cell 67, 239-253. 
Serafini, T., Stenbeck, G., Brecht, A., Lottspeich, F., Orci, L., Rothman, J.E., and 
Wieland, F.T. (1991b). A coat subunit of Golgi-derived non-clathrin-coated vesicles 
with homology to the clathrin-coated vesicle coat protein beta-adaptin. Nature 349, 
215-220. 
Simpson, F., Peden, A.A., Christopoulou, L., and Robinson, M.S. (1997). 
Characterization of the adaptor-related protein complex, AP-3. J Cell Biol 137, 835-
845. 
Sohn, K., Orci, L., Ravazzola, M., Amherdt, M., Bremser, M., Lottspeich, F., Fiedler, 
K., Helms, J.B., and Wieland, F.T. (1996). A major transmembrane protein of Golgi-
derived COPI-coated vesicles involved in coatomer binding. J Cell Biol 135, 1239-
1248. 
Spang, A., Matsuoka, K., Hamamoto, S., Schekman, R., and Orci, L. (1998). 
Coatomer, Arf1p, and nucleotide are required to bud coat protein complex I-coated 
vesicles from large synthetic liposomes. Proc Natl Acad Sci U S A 95, 11199-11204. 
  
	 LITERATURE	 		 	
122 
Springer, S., Chen, E., Duden, R., Marzioch, M., Rowley, A., Hamamoto, S., 
Merchant, S., and Schekman, R. (2000). The p24 proteins are not essential for 
vesicular transport in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 97, 4034-
4039. 
Stamnes, M.A., Craighead, M.W., Hoe, M.H., Lampen, N., Geromanos, S., Tempst, 
P., and Rothman, J.E. (1995). An integral membrane component of coatomer-coated 
transport vesicles defines a family of proteins involved in budding. Proc Natl Acad Sci 
U S A 92, 8011-8015. 
Stamnes, M.A., and Rothman, J.E. (1993). The binding of AP-1 clathrin adaptor 
particles to Golgi membranes requires ADP-ribosylation factor, a small GTP-binding 
protein. Cell 73, 999-1005. 
Suda, Y., and Nakano, A. (2012). The yeast Golgi apparatus. Traffic 13, 505-510. 
Sun, Z., Anderl, F., Frohlich, K., Zhao, L., Hanke, S., Brugger, B., Wieland, F., and 
Bethune, J. (2007). Multiple and stepwise interactions between coatomer and ADP-
ribosylation factor-1 (Arf1)-GTP. Traffic 8, 582-593. 
Supek, F., Madden, D.T., Hamamoto, S., Orci, L., and Schekman, R. (2002). Sec16p 
potentiates the action of COPII proteins to bud transport vesicles. J Cell Biol 158, 
1029-1038. 
Szul, T., Garcia-Mata, R., Brandon, E., Shestopal, S., Alvarez, C., and Sztul, E. 
(2005). Dissection of membrane dynamics of the ARF-guanine nucleotide exchange 
factor GBF1. Traffic 6, 374-385. 
Szul, T., and Sztul, E. (2011). COPII and COPI traffic at the ER-Golgi interface. 
Physiology (Bethesda) 26, 348-364. 
Tanabe, K., Kon, S., Natsume, W., Torii, T., Watanabe, T., and Satake, M. (2006). 
Involvement of a novel ADP-ribosylation factor GTPase-activating protein, SMAP, in 
membrane trafficking: implications in cancer cell biology. Cancer Sci 97, 801-806. 
Tanabe, K., Torii, T., Natsume, W., Braesch-Andersen, S., Watanabe, T., and 
Satake, M. (2005). A novel GTPase-activating protein for ARF6 directly interacts with 
clathrin and regulates clathrin-dependent endocytosis. Mol Biol Cell 16, 1617-1628. 
Tanigawa, G., Orci, L., Amherdt, M., Ravazzola, M., Helms, J.B., and Rothman, J.E. 
(1993). Hydrolysis of bound GTP by ARF protein triggers uncoating of Golgi-derived 
COP-coated vesicles. J Cell Biol 123, 1365-1371. 
Thacker, E., Kearns, B., Chapman, C., Hammond, J., Howell, A., and Theibert, A. 
(2004). The arf6 GAP centaurin alpha-1 is a neuronal actin-binding protein which 
also functions via GAP-independent activity to regulate the actin cytoskeleton. Eur J 
Cell Biol 83, 541-554. 
Thor, F., Gautschi, M., Geiger, R., and Helenius, A. (2009). Bulk flow revisited: 
transport of a soluble protein in the secretory pathway. Traffic 10, 1819-1830. 
Traub, L.M., Ostrom, J.A., and Kornfeld, S. (1993). Biochemical dissection of AP-1 
recruitment onto Golgi membranes. J Cell Biol 123, 561-573. 
Tu, L., and Banfield, D.K. (2010). Localization of Golgi-resident glycosyltransferases. 
Cell Mol Life Sci 67, 29-41. 
Ungewickell, E., and Branton, D. (1981). Assembly units of clathrin coats. Nature 
289, 420-422. 
Ungewickell, E., Ungewickell, H., Holstein, S.E., Lindner, R., Prasad, K., Barouch, 
W., Martin, B., Greene, L.E., and Eisenberg, E. (1995). Role of auxilin in uncoating 
clathrin-coated vesicles. Nature 378, 632-635. 
Venkateswarlu, K., Brandom, K.G., and Lawrence, J.L. (2004). Centaurin-alpha1 is 
an in vivo phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating 
protein for ARF6 that is involved in actin cytoskeleton organization. J Biol Chem 279, 
6205-6208. 
Vetter, I.R., and Wittinghofer, A. (2001). The guanine nucleotide-binding switch in 
three dimensions. Science 294, 1299-1304. 
  
	 LITERATURE	 		 	
123 
Vitale, N., Patton, W.A., Moss, J., Vaughan, M., Lefkowitz, R.J., and Premont, R.T. 
(2000). GIT proteins, A novel family of phosphatidylinositol 3,4, 5-trisphosphate-
stimulated GTPase-activating proteins for ARF6. J Biol Chem 275, 13901-13906. 
Volpicelli-Daley, L.A., Li, Y., Zhang, C.J., and Kahn, R.A. (2005). Isoform-selective 
effects of the depletion of ADP-ribosylation factors 1-5 on membrane traffic. Mol Biol 
Cell 16, 4495-4508. 
Waters, M.G., Serafini, T., and Rothman, J.E. (1991). 'Coatomer': a cytosolic protein 
complex containing subunits of non-clathrin-coated Golgi transport vesicles. Nature 
349, 248-251. 
Watson, P., Townley, A.K., Koka, P., Palmer, K.J., and Stephens, D.J. (2006). Sec16 
defines endoplasmic reticulum exit sites and is required for secretory cargo export in 
mammalian cells. Traffic 7, 1678-1687. 
Watson, P.J., Frigerio, G., Collins, B.M., Duden, R., and Owen, D.J. (2004). Gamma-
COP appendage domain - structure and function. Traffic 5, 79-88. 
Weber, T., Zemelman, B.V., McNew, J.A., Westermann, B., Gmachl, M., Parlati, F., 
Sollner, T.H., and Rothman, J.E. (1998). SNAREpins: minimal machinery for 
membrane fusion. Cell 92, 759-772. 
Wegmann, D., Hess, P., Baier, C., Wieland, F.T., and Reinhard, C. (2004). Novel 
isotypic gamma/zeta subunits reveal three coatomer complexes in mammals. Mol 
Cell Biol 24, 1070-1080. 
Weidler, M., Reinhard, C., Friedrich, G., Wieland, F.T., and Rosch, P. (2000). 
Structure of the cytoplasmic domain of p23 in solution: implications for the formation 
of COPI vesicles. Biochem Biophys Res Commun 271, 401-408. 
Weimer, C., Beck, R., Eckert, P., Reckmann, I., Moelleken, J., Brugger, B., and 
Wieland, F. (2008). Differential roles of ArfGAP1, ArfGAP2, and ArfGAP3 in COPI 
trafficking. J Cell Biol 183, 725-735. 
Whittle, J.R., and Schwartz, T.U. (2010). Structure of the Sec13-Sec16 edge 
element, a template for assembly of the COPII vesicle coat. J Cell Biol 190, 347-361. 
Wieland, F.T., Gleason, M.L., Serafini, T.A., and Rothman, J.E. (1987). The rate of 
bulk flow from the endoplasmic reticulum to the cell surface. Cell 50, 289-300. 
Xing, Y., Bocking, T., Wolf, M., Grigorieff, N., Kirchhausen, T., and Harrison, S.C. 
(2010). Structure of clathrin coat with bound Hsc70 and auxilin: mechanism of 
Hsc70-facilitated disassembly. EMBO J 29, 655-665. 
Xu, D., and Hay, J.C. (2004). Reconstitution of COPII vesicle fusion to generate a 
pre-Golgi intermediate compartment. J Cell Biol 167, 997-1003. 
Yahara, N., Sato, K., and Nakano, A. (2006). The Arf1p GTPase-activating protein 
Glo3p executes its regulatory function through a conserved repeat motif at its C-
terminus. Journal of cell science 119, 2604-2612. 
Yang, J.S., Lee, S.Y., Gao, M., Bourgoin, S., Randazzo, P.A., Premont, R.T., and 
Hsu, V.W. (2002). ARFGAP1 promotes the formation of COPI vesicles, suggesting 
function as a component of the coat. J Cell Biol 159, 69-78. 
Ye, K., and Snyder, S.H. (2004). PIKE GTPase: a novel mediator of phosphoinositide 
signaling. Journal of cell science 117, 155-161. 
Yorimitsu, T., and Sato, K. (2012). Insights into structural and regulatory roles of 
Sec16 in COPII vesicle formation at ER exit sites. Mol Biol Cell 23, 2930-2942. 
Yoshihisa, T., Barlowe, C., and Schekman, R. (1993). Requirement for a GTPase-
activating protein in vesicle budding from the endoplasmic reticulum. Science 259, 
1466-1468. 
Yu, X., Breitman, M., and Goldberg, J. (2012). A structure-based mechanism for 
Arf1-dependent recruitment of coatomer to membranes. Cell 148, 530-542. 
Zendeh-boodi, Z., Yamamoto, T., Sakane, H., and Tanaka, K. (2013). Identification 
of a second amphipathic lipid-packing sensor-like motif that contributes to Gcs1p 
function in the early endosome-to-TGN pathway. Journal of biochemistry 153, 573-
587. 
  
	 LITERATURE	 		 	
124 
Zhao, L., Helms, J.B., Brugger, B., Harter, C., Martoglio, B., Graf, R., Brunner, J., 
and Wieland, F.T. (1997). Direct and GTP-dependent interaction of ADP ribosylation 
factor 1 with coatomer subunit beta. Proc Natl Acad Sci U S A 94, 4418-4423. 
Zhao, L., Helms, J.B., Brunner, J., and Wieland, F.T. (1999). GTP-dependent binding 
of ADP-ribosylation factor to coatomer in close proximity to the binding site for 
dilysine retrieval motifs and p23. J Biol Chem 274, 14198-14203. 
Zhao, X., Claude, A., Chun, J., Shields, D.J., Presley, J.F., and Melancon, P. (2006). 
GBF1, a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi protein 
traffic. Journal of cell science 119, 3743-3753. 
Zink, S., Wenzel, D., Wurm, C.A., and Schmitt, H.D. (2009). A link between ER 
tethering and COP-I vesicle uncoating. Developmental cell 17, 403-416. 
6 
  
	 APPENDIX	 		 	
125 
Abbreviations 
ACAP ArfGAP with coiled coil, ankyrin repeat and PH domains 
ADAP    ArfGAP with dual PH domains 
AGAP ArfGAP with GTPase Domain, ankyrin repeat and PH Domain 
AGFG ArfGAP with FG repeats 
AP  adaptor protein complex 
APS    ammonium persulfate 
Arf    ADP-ribosylation factor 
ArfGAP  ADP-ribosylation factor GTPase activating protein 
ARAP ArfGAP with Rho GAP domain, ankyrin repeats and PH 
domain 
ASAP   ArfGAP with SH3 Domain, ankyrin repeat and PH Domain 
ATP    adenosine 5′ -triphosphate 
BFA    brefeldin A 
bp    base pair 
BSA    bovine serum albumin 
CCV    Clathrin-coated vesicle 
cDNA    complementary DNA 
COPI    coat protein complex I 
COPII    coat protein complex II 
DMEM   Dulbecco’s modified eagle’s medium 
DMSO   dimethyl sulfoxide 
DNA    desoxyribonucleic acid 
DTT    dithiothretiol 
EDTA    ethylendiaminetetraacetic acid 
ENTH    doamin epsin N-terminal homology domain 
ER    endoplasmic reticulum 
ERGIC   ER-Golgi intermediate compartment 
FCCS   Fluorescence cross-correlation spectroscopy 
GAP    GTPase activating protein 
GBF1    Golgi-specific brefeldin-A-resistant factor 1 
GDP    guanosine 5′ -diphosphate 
Gea1/2   guanine nucleotide exchange on Arf protein1/2 
GEF    guanosine nucleotide exchange factor 
GET   1-5 Golgi to ER traffic protein 1-5 
GGA  Golgi-associated γ -adaptin ear homology domain containing, 
Arf-binding protein 
GIT G-protein-coupled receptor (GPCR)-kinase-interacting 
ArfGAPs 
GM130   cis-Golgi matrix protein of 130 kDa 
GMP-PNP   guanosine 5′ -[β,γ -imido]-triphosphate 
GTP    guanosine 5′ -triphosphate 
GTPγ S   guanosine 5′ -[γ -thio]-triphosphate 
HEK293T  cells human embryonic kidney cell line 293, with SV-40 large 
T-antigen 
HeLa cells  human epithelial carcinoma cell line; derived from the patient 
Henrietta Lacks 
HEPES   4-(2-hydroxyethyl)-1-piperazin-ethansulfonic acid 
IMAC    immobilized metal affinity chromatography 
IPTG    isopropyl-1-thio-β -D-galactopyranoside 
KD    dissociation constant 
KDELr   KDEL receptor 
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kb    kilo base pairs 
kDa    kilo dalton 
LB medium   Luria Bertani medium 
MCS    multiple cloning site 
NIH/3T3 cells  NIH mouse embryonic fibroblast cell line; 3-day transfer, 
inoculum 3 x 105 cells 
NP-40    Nonidet® P40 (Nonylphenylpolyethylene glycol) 
NRK cells   normal rat kidney epithelial cell line 
OD    optical density 
PBS    phosphate buffer saline 
PBS-T   phosphate buffer saline + Tween 20 
PCR    polymerase chain reaction 
PMSF    phenylmethulsulfonyl fluoride 
PDI    protein disulfide isomerase 
PVDF    polyvinyldifluoride 
Ras G    protein of the Ras (Rat sarcoma) superfamily 
RLC    rat liver cytosol 
Sar1    secretion-associated and Ras-related protein 1 
SDS-PAGE   sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SEC    secretion mutant 
SMAP   small ArfGAP proteins 
Sf9 cells   cell line derived from Sf21 cell line 
TEMED   N, N, N’, N’-Tetramethylethylenediamine 
TGN    trans Golgi network 
TMB    tetramethylbenzidin 
 
 
Amino Acids Code 
A  Ala  Alanine 
C  Cys  Cysteine 
D  Asp  Aspartic acid 
E  Glu  Glutamic acid 
F  Phe  Phenylalanine 
G  Gly  Glycine 
H  His  Histidine 
I  Ile  Isoleucine 
K  Lys  Lysine 
L  Leu  Leucine 
M  Met  Methionine 
N  Asn  Asparagines 
P  Pro  Proline 
Q  Gln  Glutamine 
R  Arg  Arginine 
S  Ser  Serine 
T  Thr  Threonine 
V  Val  Valine 
W  Trp  Tryptophane 
Y  Tyr  Tyrosine 
Φ  -  bulky, hydrophobic residue 
B  -  basic residue 
X  -  any residue 
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